No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4qv8L_, 1.0000, 0.00, 1.000, 222, 222, YCP BETA5-C52F MUTANT
2, d4qv8Z_, 0.9999, 0.01, 1.000, 222, 222, YCP BETA5-C52F MUTANT
3, d4qv1Z_, 0.9999, 0.05, 1.000, 222, 222, YCP BETA5-M45A MUTANT
4, d4qv1L_, 0.9999, 0.06, 1.000, 222, 222, YCP BETA5-M45A MUTANT
5, d4r00Z_, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
6, d4r00L_, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
7, d4qv7Z_, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-A50V MUTANT
8, d4qv7L_, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-A50V MUTANT
9, d4qv5Z_, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-M45I MUTANT
10, d4qv5L_, 0.9998, 0.07, 1.000, 222, 222, YCP BETA5-M45I MUTANT
11, d4qv4Z_, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-M45T MUTANT
12, d4qv4L_, 0.9998, 0.06, 1.000, 222, 222, YCP BETA5-M45T MUTANT
13, d4qv3Z_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-M45V MUTANT
14, d4qv3L_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-M45V MUTANT
15, d4qv0Z_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT
16, d4qv0L_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT
17, d4quyZ_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49S-MUTANT
18, d4quyL_, 0.9998, 0.08, 1.000, 222, 222, YCP BETA5-A49S-MUTANT
19, d5fgaZ_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
20, d5fgaL_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
21, d5fg7L_, 0.9997, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T1A MUTANT
22, d5d0wZ_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT
23, d5d0wL_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT
24, d5czaZ_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT
25, d5czaL_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT
26, d5cz6Z_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
27, d5cz6L_, 0.9997, 0.09, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
28, d4y9yZ_, 0.9997, 0.08, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT
29, d4y9yL_, 0.9997, 0.08, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT
30, d4qzzZ_, 0.9997, 0.08, 1.000, 222, 222, YCP IN COMPLEX WITH OMURALIDE
31, d4qzzL_, 0.9997, 0.08, 1.000, 222, 222, YCP IN COMPLEX WITH OMURALIDE
32, d4quxZ_, 0.9997, 0.09, 1.000, 222, 222, YCP BETA5-A49T-MUTANT
33, d4quxL_, 0.9997, 0.09, 1.000, 222, 222, YCP BETA5-A49T-MUTANT
34, d5fg9Z_, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
35, d5fg9L_, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
36, d5fg7Z_, 0.9996, 0.10, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-T1A MUTANT
37, d5cz7Z_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
38, d5cz7L_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
39, d5cgfZ_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT
40, d5cgfL_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT
41, d5bxlZ_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT
42, d5bxlL_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT
43, d4ya4Z_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT
44, d4ya4L_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT
45, d4y8rZ_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT
46, d4y8rL_, 0.9996, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT
47, d4qvyZ_, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
48, d4qvyL_, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
49, d4qv9Z_, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-C63F MUTANT
50, d4qv9L_, 0.9996, 0.10, 1.000, 222, 222, YCP BETA5-C63F MUTANT
51, d5l5aZ_, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
52, d5l5aL_, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
53, d4z1lZ_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
54, d4z1lL_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
55, d4ya1Z_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT
56, d4ya1L_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT
57, d4y8mZ_, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
58, d4y8mL_, 0.9995, 0.12, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
59, d4rurZ_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
60, d4rurL_, 0.9995, 0.11, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
61, d5l5bZ_, 0.9994, 0.13, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
62, d5l5bL_, 0.9994, 0.13, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
63, d5bouZ_, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
64, d5bouL_, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
65, p4y6vZ_, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
66, p4y6vL_, 0.9994, 0.13, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
67, d4r17Z_, 0.9994, 0.13, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
68, d4r17L_, 0.9994, 0.13, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
69, d4qvwZ_, 0.9994, 0.13, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
70, d4qvwL_, 0.9994, 0.13, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
71, p6gopZ_, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
72, p6gopL_, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
73, d5m2bZ_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
74, d5m2bL_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
75, d5laiZ_, 0.9993, 0.14, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
76, d5laiL_, 0.9993, 0.14, 1.000, 222, 222, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
77, d5l6cZ_, 0.9993, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
78, d5l6cL_, 0.9993, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
79, d5l67Z_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
80, d5l67L_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
81, d5l5rZ_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
82, d5l5rL_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
83, d5l5eZ_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
84, d5l5eL_, 0.9993, 0.14, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
85, p4y8nZ_, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
86, p4y8nL_, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
87, p4y69Z_, 0.9993, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
88, p4y69L_, 0.9993, 0.14, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
89, d4qw0Z_, 0.9993, 0.15, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
90, d4qw0L_, 0.9993, 0.15, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
91, d4qvlZ_, 0.9993, 0.14, 1.000, 222, 222, YCP IN COMPLEX WITH BORTEZOMIB
92, d4qvlL_, 0.9993, 0.14, 1.000, 222, 222, YCP IN COMPLEX WITH BORTEZOMIB
93, d5lajZ_, 0.9992, 0.15, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
94, d5lajL_, 0.9992, 0.15, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
95, d5l6bZ_, 0.9992, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
96, d5l6bL_, 0.9992, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
97, d5l5fZ_, 0.9992, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
98, d5l5fL_, 0.9992, 0.15, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
99, p4ya5Z_, 0.9992, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
100, p4ya5L_, 0.9992, 0.15, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
101, d4qv6Z_, 0.9992, 0.15, 1.000, 222, 222, YCP BETA5-A49V MUTANT
102, d4qv6L_, 0.9992, 0.15, 1.000, 222, 222, YCP BETA5-A49V MUTANT
103, d5l6aZ_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
104, d5l6aL_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
105, d5l65Z_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
106, d5l65L_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
107, d5l5dZ_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
108, d5l5dL_, 0.9991, 0.16, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
109, p5fghZ_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
110, p5fghL_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
111, d5cz4Z_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
112, d5cz4L_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
113, p4y8uZ_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
114, p4y8uL_, 0.9991, 0.16, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
115, d4r18Z_, 0.9991, 0.16, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
116, d4r18L_, 0.9991, 0.16, 1.000, 222, 222, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
117, d5bxnZ_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
118, d5bxnL_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
119, p4y8tZ_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
120, p4y8tL_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
121, p4y6aZ_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
122, p4y6aL_, 0.9990, 0.17, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
123, d4qwuZ_, 0.9990, 0.17, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
124, d4qwuL_, 0.9990, 0.17, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
125, d5l5wZ_, 0.9989, 0.18, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
126, d5l5wL_, 0.9989, 0.18, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
127, d5d0xZ_, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
128, d5d0xL_, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
129, p4ya0Z_, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
130, p4ya0L_, 0.9989, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
131, d5l68Z_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
132, d5l68L_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
133, d5l66Z_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
134, d5l66L_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
135, d5l5zZ_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
136, d5l5zL_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
137, d5l5pZ_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
138, d5l5pL_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
139, d5l5oZ_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
140, d5l5oL_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
141, d5l5iZ_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
142, d5l5iL_, 0.9988, 0.19, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
143, p4ya3Z_, 0.9988, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
144, p4ya3L_, 0.9988, 0.18, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
145, d4qw1Z_, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
146, d4qw1L_, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
147, d4qvmZ_, 0.9988, 0.19, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
148, d5lttZ_, 0.9987, 0.19, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
149, d5lttL_, 0.9987, 0.19, 1.000, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
150, d5l64Z_, 0.9987, 0.20, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
151, d5l64L_, 0.9987, 0.20, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
152, d4qvvZ_, 0.9987, 0.20, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
153, d4qvvL_, 0.9987, 0.20, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
154, d4qvmL_, 0.9987, 0.19, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
155, d5d0tZ_, 0.9986, 0.20, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
156, d5d0tL_, 0.9986, 0.20, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
157, d5l5uL_, 0.9985, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
158, d5l5tZ_, 0.9985, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
159, d4qw3Z_, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
160, d4qw3L_, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
161, d4qvpZ_, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
162, d4qvpL_, 0.9985, 0.21, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
163, d3gpwZ_, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
164, d3gpwL_, 0.9985, 0.22, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
165, d2fakZ_, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
166, d2fakL_, 0.9985, 0.21, 1.000, 222, 222, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
167, d5l69Z_, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
168, d5l69L_, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
169, d5l5uZ_, 0.9984, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
170, d5l5tL_, 0.9984, 0.21, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
171, d4lqiZ_, 0.9984, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
172, d4lqiL_, 0.9984, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
173, d5l5hZ_, 0.9983, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
174, d5l5hL_, 0.9983, 0.22, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
175, d4q1sL_, 0.9983, 0.22, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
176, d3hyeZ_, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
177, d3hyeL_, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
178, d1ryp1_, 0.9983, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
179, d5l63Z_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
180, d5l63L_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
181, d5l62Z_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
182, d5l62L_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
183, d5l5vZ_, 0.9982, 0.23, 0.977, 222, 222,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
184, d5l5vL_, 0.9982, 0.23, 0.977, 222, 222,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
185, d5l5qZ_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
186, d5l5qL_, 0.9982, 0.23, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
187, d4qvnZ_, 0.9982, 0.23, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
188, d4qvnL_, 0.9982, 0.23, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
189, d4eu2M_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
190, d4eu21_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
191, d3tddZ_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
192, d3tddL_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
193, d3gptZ_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
194, d3gptL_, 0.9982, 0.23, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
195, d5l5xZ_, 0.9981, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
196, d4q1sZ_, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
197, d4j70Z_, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
198, d4j70L_, 0.9981, 0.24, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
199, d2gplZ_, 0.9981, 0.24, 1.000, 222, 222, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
200, d2gplL_, 0.9981, 0.24, 1.000, 222, 222, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
201, d1rypM_, 0.9981, 0.24, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
202, d5l61Z_, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
203, d5l61L_, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
204, d5l5xL_, 0.9980, 0.24, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
205, d5l5sZ_, 0.9980, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
206, d5l5sL_, 0.9980, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
207, d5l60Z_, 0.9979, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
208, d5l60L_, 0.9979, 0.25, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
209, d3un8Z_, 0.9979, 0.25, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
210, d3un8L_, 0.9979, 0.25, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
211, d3shjZ_, 0.9979, 0.25, 1.000, 222, 222, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
212, d3shjL_, 0.9979, 0.25, 1.000, 222, 222, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
213, d4qvqZ_, 0.9978, 0.26, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
214, d4qvqL_, 0.9978, 0.26, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
215, d5dkiZ_, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
216, d5dkiL_, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
217, p4x6zM_, 0.9976, 0.27, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
218, d2fnyZ_, 0.9976, 0.27, 1.000, 222, 222,  
219, d2fnyL_, 0.9976, 0.27, 1.000, 222, 222,  
220, p5nifM_, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
221, p5nif1_, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
222, p4zzg1_, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
223, d4inrZ_, 0.9975, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
224, d3e47Z_, 0.9975, 0.27, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
225, d3e47L_, 0.9975, 0.27, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
226, d1g0uZ_, 0.9975, 0.27, 1.000, 222, 222, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
227, d5dkjZ_, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
228, d5dkjL_, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
229, p4zzgM_, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
230, d4inrL_, 0.9974, 0.28, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
231, d1g0uL_, 0.9974, 0.28, 1.000, 222, 222, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
232, p4x6z1_, 0.9973, 0.29, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
233, d3wxr1_, 0.9972, 0.29, 1.000, 222, 222, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
234, d3dy3Z_, 0.9972, 0.29, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
235, d3dy3L_, 0.9972, 0.29, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
236, d3oevZ_, 0.9970, 0.30, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
237, d3dy4Z_, 0.9970, 0.30, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
238, d3dy4L_, 0.9970, 0.30, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
239, d4r02Z_, 0.9969, 0.31, 1.000, 222, 222, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
240, d4jt0Z_, 0.9969, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
241, d4jt0L_, 0.9969, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
242, d3nzjZ_, 0.9969, 0.31, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
243, d5l5yZ_, 0.9968, 0.31, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
244, d5l5yL_, 0.9968, 0.31, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
245, d5fgfZ_, 0.9968, 0.32, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
246, d5fgfL_, 0.9968, 0.32, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
247, d3wxrM_, 0.9968, 0.31, 1.000, 222, 222, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
248, d3nzjL_, 0.9968, 0.31, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
249, d5l5jZ_, 0.9966, 0.32, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
250, d5l5jL_, 0.9966, 0.32, 0.977, 222, 222, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
251, d3mg4L_, 0.9965, 0.33, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
252, d5fgdZ_, 0.9964, 0.34, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
253, d5fgdL_, 0.9964, 0.34, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
254, d4r02L_, 0.9964, 0.34, 1.000, 222, 222, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
255, d3oevL_, 0.9964, 0.34, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
256, d3mg4Z_, 0.9962, 0.35, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
257, p4y8kZ_, 0.9960, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
258, d4inuZ_, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
259, d4intZ_, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
260, d4intL_, 0.9960, 0.35, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
261, p4y8kL_, 0.9959, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
262, d5fgeZ_, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
263, d5fgeL_, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
264, d4inuL_, 0.9958, 0.36, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
265, d4jsqZ_, 0.9957, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
266, d4jsqL_, 0.9957, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
267, d4fzcZ_, 0.9957, 0.36, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
268, d4fzcL_, 0.9957, 0.37, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
269, d3okjL_, 0.9957, 0.36, 1.000, 222, 222, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
270, d3oeuZ_, 0.9957, 0.36, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
271, d3mg7Z_, 0.9956, 0.37, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
272, d4jsuZ_, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
273, d4jsuL_, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
274, p3un4Z_, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
275, p3un4L_, 0.9955, 0.37, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
276, d4fzgZ_, 0.9954, 0.38, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
277, d4fzgL_, 0.9954, 0.38, 1.000, 222, 222, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
278, d5fhsZ_, 0.9952, 0.39, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
279, d5fhsL_, 0.9951, 0.39, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
280, d3oeuL_, 0.9949, 0.40, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
281, d3gpjZ_, 0.9948, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
282, d3gpjL_, 0.9948, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
283, d4no1Z_, 0.9947, 0.41, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
284, d4no1L_, 0.9947, 0.41, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
285, d3bdmZ_, 0.9947, 0.41, 1.000, 222, 222, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
286, d3bdmL_, 0.9947, 0.41, 1.000, 222, 222, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
287, d2f16Z_, 0.9947, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
288, d2f16L_, 0.9947, 0.40, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
289, d3nzxZ_, 0.9946, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
290, d3mg0Z_, 0.9946, 0.41, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
291, p5cghZ_, 0.9945, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
292, p5cghL_, 0.9945, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
293, d3nzxL_, 0.9945, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
294, d1z7qM1, 0.9945, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
295, d4qwrZ_, 0.9944, 0.42, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
296, d4qwrL_, 0.9944, 0.42, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
297, p1z7qa_, 0.9944, 0.41, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
298, p4y7xZ_, 0.9943, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
299, p4y7xL_, 0.9943, 0.42, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
300, d5d0vZ_, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
301, d5cz9Z_, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
302, d5cz9L_, 0.9942, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
303, p4v7oM_, 0.9942, 0.43, 1.000, 222, 222, 
304, p4v7oAA_, 0.9942, 0.42, 1.000, 222, 222, 
305, d4qlsZ_, 0.9942, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
306, d4qlsL_, 0.9942, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
307, d3l5qQ_, 0.9942, 0.43, 1.000, 222, 222,  
308, d3l5q3_, 0.9942, 0.42, 1.000, 222, 222,  
309, d1vsyM_, 0.9942, 0.42, 1.000, 222, 222,  
310, d5fggZ_, 0.9941, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
311, d5d0vL_, 0.9941, 0.43, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
312, p4v7oIB_, 0.9941, 0.43, 1.000, 222, 222, 
313, d4no8Z_, 0.9941, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
314, d4no8L_, 0.9941, 0.43, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
315, d3mg0L_, 0.9941, 0.43, 1.000, 222, 222, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
316, d1vsy1_, 0.9941, 0.43, 1.000, 222, 222,  
317, d5fggL_, 0.9940, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
318, d4ltcZ_, 0.9940, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
319, d3sdkZ_, 0.9940, 0.43, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
320, d3nzwZ_, 0.9940, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
321, d3nzwL_, 0.9939, 0.43, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
322, p4y8sZ_, 0.9938, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
323, p4y8sL_, 0.9938, 0.44, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
324, d3mg6Z_, 0.9938, 0.44, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
325, d5fgiZ_, 0.9937, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
326, d5fgiL_, 0.9937, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
327, d3mg7L_, 0.9937, 0.44, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
328, p5cggZ_, 0.9936, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
329, p5cggL_, 0.9936, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
330, d4qzwZ_, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
331, d4qzwL_, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
332, d4qwjZ_, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
333, d4qwjL_, 0.9936, 0.45, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
334, d4ltcL_, 0.9936, 0.45, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
335, d4qwkZ_, 0.9935, 0.45, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
336, d4qwkL_, 0.9935, 0.45, 1.000, 222, 222, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
337, d4qlvZ_, 0.9935, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
338, d4qlvL_, 0.9935, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
339, d4g4sM_, 0.9935, 0.45, 1.000, 222, 222, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
340, d4qwsZ_, 0.9934, 0.46, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
341, p4qbyZ_, 0.9934, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
342, p4qbyL_, 0.9934, 0.45, 1.000, 222, 222, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
343, p4gk7Z_, 0.9934, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
344, p4gk7L_, 0.9934, 0.45, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
345, d3sdkL_, 0.9934, 0.46, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
346, d5d0sZ_, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
347, d5d0sL_, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
348, d5cz5Z_, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
349, p4y8qZ_, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
350, p4y8qL_, 0.9933, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
351, d4qwsL_, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
352, d4qwiZ_, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
353, d4qwiL_, 0.9933, 0.46, 1.000, 222, 222, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
354, d5d0zZ_, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
355, d5d0zL_, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
356, d5cz5L_, 0.9932, 0.46, 1.000, 222, 222, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
357, d4qluZ_, 0.9932, 0.46, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
358, d4qw7Z_, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
359, d4qw7L_, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
360, d4qw5Z_, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
361, d4qw5L_, 0.9931, 0.47, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
362, d4qluL_, 0.9931, 0.46, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
363, d5l54Z_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
364, d5l54L_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
365, d5jhsZ_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
366, d5jhsL_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
367, d5jhrZ_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
368, d5jhrL_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
369, d5cz8Z_, 0.9930, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
370, d4qwgZ_, 0.9930, 0.47, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
371, d4qwgL_, 0.9930, 0.47, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
372, d5cz8L_, 0.9929, 0.47, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
373, d3mg8Z_, 0.9929, 0.47, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
374, p4ya2L_, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
375, p4y82Z_, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
376, p4y82L_, 0.9928, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
377, d4qz6Z_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
378, d4qz6L_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
379, d4qwlZ_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
380, d4qwlL_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
381, d4qw6Z_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
382, d4qw6L_, 0.9928, 0.48, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
383, d3mg6L_, 0.9928, 0.48, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
384, p4ya2Z_, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
385, p4y81Z_, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
386, p4y81L_, 0.9927, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
387, d3sdiZ_, 0.9927, 0.48, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
388, p4y78Z_, 0.9926, 0.48, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
389, d5ahjZ_, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
390, d5ahjL_, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
391, p4y78L_, 0.9925, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
392, d4qwfZ_, 0.9925, 0.49, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
393, d4qwfL_, 0.9925, 0.49, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
394, p1fntM_, 0.9925, 0.48, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
395, p4y8pZ_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
396, p4y8pL_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
397, p4y8lL_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
398, p4y6zZ_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
399, p4y6zL_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
400, d4qw4L_, 0.9924, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH CARFILZOMIB
401, d4no6Z_, 0.9924, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
402, d2zcyZ_, 0.9924, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
403, p1fnta_, 0.9924, 0.49, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
404, p4y8lZ_, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
405, p4y77Z_, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
406, p4y77L_, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
407, d4qw4Z_, 0.9923, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH CARFILZOMIB
408, d4no6L_, 0.9923, 0.49, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
409, d3sdiL_, 0.9923, 0.49, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
410, d2zcyL_, 0.9923, 0.49, 1.000, 222, 222, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
411, p4y80L_, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
412, p4y7yZ_, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
413, p4y7yL_, 0.9922, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
414, p4ya9Z_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
415, p4ya9L_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
416, p4y80Z_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
417, p4y7wZ_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
418, p4y7wL_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
419, p4y75Z_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
420, p4y75L_, 0.9921, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
421, d4no9Z_, 0.9921, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
422, d4no9L_, 0.9921, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
423, d3mg8L_, 0.9921, 0.50, 1.000, 222, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
424, p4ya7Z_, 0.9920, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
425, p4ya7L_, 0.9920, 0.50, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
426, d4qltZ_, 0.9920, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
427, d4qltL_, 0.9920, 0.50, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
428, p4y9zZ_, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
429, p4y9zL_, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
430, p4y70Z_, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
431, p4y70L_, 0.9919, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
432, d4qz5Z_, 0.9919, 0.51, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
433, d4qz5L_, 0.9919, 0.51, 1.000, 222, 222, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
434, d5l55Z_, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
435, d5l55L_, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
436, d5l52Z_, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
437, d5l52L_, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
438, p4y8hZ_, 0.9918, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
439, p4y8oZ_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
440, p4y8oL_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
441, p4y8jZ_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
442, p4y8jL_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
443, p4y8iL_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
444, p4y8hL_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
445, p4y74Z_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
446, p4y74L_, 0.9917, 0.51, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
447, d4qz3Z_, 0.9917, 0.51, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
448, d4qz3L_, 0.9917, 0.51, 1.000, 222, 222, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
449, p4y8iZ_, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
450, p4y8gZ_, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
451, p4y8gL_, 0.9916, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
452, d4qzxZ_, 0.9916, 0.51, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
453, d4qzxL_, 0.9916, 0.51, 1.000, 222, 222, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
454, d1g65Z_, 0.9916, 0.51, 1.000, 222, 222, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
455, d1g65L_, 0.9916, 0.52, 1.000, 222, 222, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
456, p4y84Z_, 0.9915, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
457, p4y84L_, 0.9915, 0.52, 1.000, 222, 222, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
458, d4nnnZ_, 0.9915, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH MG132
459, d4nnnL_, 0.9915, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH MG132
460, d4qz7Z_, 0.9914, 0.52, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
461, d4qz7L_, 0.9914, 0.52, 1.000, 222, 222, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
462, d4nnwZ_, 0.9914, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
463, d4nnwL_, 0.9914, 0.52, 1.000, 222, 222, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
464, d3d29L_, 0.9914, 0.52, 1.000, 222, 222, PROTEASOME INHIBITION BY FELLUTAMIDE B
465, d4hnpZ_, 0.9913, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
466, d3d29Z_, 0.9913, 0.52, 1.000, 222, 222, PROTEASOME INHIBITION BY FELLUTAMIDE B
467, p5cgiZ_, 0.9912, 0.53, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
468, p5cgiL_, 0.9912, 0.53, 1.000, 222, 222, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
469, d4hnpL_, 0.9912, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
470, d3okjZ_, 0.9912, 0.36, 1.000, 221, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
471, d4qz0Z_, 0.9911, 0.53, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
472, d4qz0L_, 0.9911, 0.53, 1.000, 222, 222, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
473, d4qxjZ_, 0.9910, 0.53, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
474, d4qxjL_, 0.9910, 0.53, 1.000, 222, 222, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
475, d4qwxZ_, 0.9910, 0.54, 1.000, 222, 222, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
476, d4qwxL_, 0.9910, 0.54, 1.000, 222, 222, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
477, d1jd2L_, 0.9910, 0.53, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
478, d1jd2S_, 0.9908, 0.54, 1.000, 222, 222, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
479, d4qz4Z_, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
480, d4qz4L_, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
481, d4qz2Z_, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
482, d4qz2L_, 0.9907, 0.54, 1.000, 222, 222, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
483, d4qz1Z_, 0.9905, 0.55, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
484, d4qz1L_, 0.9905, 0.55, 1.000, 222, 222, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
485, d4hrcZ_, 0.9905, 0.55, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
486, d4qlqZ_, 0.9902, 0.56, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
487, d4qlqL_, 0.9902, 0.56, 1.000, 222, 222, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
488, d4hrcL_, 0.9902, 0.56, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
489, d4hrdZ_, 0.9897, 0.57, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
490, d4hrdL_, 0.9895, 0.58, 1.000, 222, 222, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
491, p5mp96_, 0.9884, 0.60, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
492, p3jcpA_, 0.9876, 0.62, 1.000, 222, 222, 
493, p3jcpH_, 0.9875, 0.63, 1.000, 222, 222, 
494, p5mp9m_, 0.9872, 0.63, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
495, p5mpa6_, 0.9843, 0.70, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
496, p5mpam_, 0.9834, 0.73, 1.000, 222, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
497, p3jcoH_, 0.9834, 0.72, 1.000, 222, 222, 
498, p3jcoA_, 0.9833, 0.73, 1.000, 222, 222, 
499, p5wvkM_, 0.9699, 0.99, 1.000, 222, 222, 
500, p5wvkF_, 0.9687, 1.02, 1.000, 222, 222, 
501, d4cr26_, 0.9667, 1.08, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
502, p5mpbAA_, 0.9629, 1.13, 1.000, 222, 222, 
503, p5mpbM_, 0.9620, 1.13, 1.000, 222, 222, 
504, p5a5b6_, 0.9603, 1.18, 1.000, 222, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
505, p4cr36_, 0.9603, 1.18, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
506, p4cr46_, 0.9581, 1.25, 1.000, 222, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
507, p5gjrSA_, 0.9422, 0.78, 0.484, 213, 213, 
508, d4r3oM_, 0.9422, 0.78, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME
509, d4r3o1_, 0.9422, 0.79, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME
510, p5gjrEA_, 0.9421, 0.78, 0.484, 213, 213, 
511, p6avoX_, 0.9416, 0.79, 0.484, 213, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
512, p6avoS_, 0.9416, 0.79, 0.484, 213, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
513, p3une2_, 0.9415, 0.80, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
514, p3uneL_, 0.9414, 0.80, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
515, d5le5L_, 0.9413, 0.80, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
516, d5le5Z_, 0.9409, 0.81, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
517, p3uneZ_, 0.9407, 0.81, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
518, d5lexL_, 0.9406, 0.82, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
519, d5lf1L_, 0.9402, 0.82, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
520, p5gjqf_, 0.9401, 0.82, 0.484, 213, 213, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
521, d1iruM_, 0.9401, 0.83, 0.484, 213, 213, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
522, d1iru1_, 0.9401, 0.83, 0.484, 213, 213, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
523, p5leyL_, 0.9400, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
524, p5gjqt_, 0.9400, 0.83, 0.484, 213, 213, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
525, p4r67o_, 0.9400, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
526, d4r67M_, 0.9400, 0.82, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
527, d4r671_, 0.9400, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
528, d5lf1Z_, 0.9399, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
529, p4r67a_, 0.9399, 0.83, 0.484, 213, 213, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
530, p5lf6L_, 0.9398, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
531, d5lf4L_, 0.9398, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
532, d5lf7L_, 0.9397, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
533, d5lexZ_, 0.9397, 0.84, 0.484, 213, 213, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
534, p3unen_, 0.9397, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME
535, d5lf4Z_, 0.9396, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
536, d5lf3L_, 0.9396, 0.83, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
537, d5lf7Z_, 0.9393, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
538, p5leyZ_, 0.9393, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
539, p5lf6Z_, 0.9392, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
540, d5lf3Z_, 0.9391, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
541, p5lf0L_, 0.9390, 0.84, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
542, p5lezL_, 0.9390, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
543, p5l4gV_, 0.9390, 0.85, 0.484, 213, 213, 
544, d3unbZ_, 0.9390, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
545, d3unb2_, 0.9388, 0.84, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
546, p5lf0Z_, 0.9387, 0.85, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
547, d3unbL_, 0.9385, 0.86, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
548, p5vfqLA_, 0.9383, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
549, p3unbn_, 0.9383, 0.86, 0.469, 213, 213, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
550, p5vfpKA_, 0.9382, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
551, p5vfos_, 0.9382, 0.86, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
552, p5lezZ_, 0.9382, 0.87, 0.484, 213, 213, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
553, p5vfqM_, 0.9380, 0.86, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
554, p5vfpM_, 0.9376, 0.87, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
555, p3unhZ_, 0.9375, 0.89, 0.469, 213, 213, MOUSE 20S IMMUNOPROTEASOME
556, p3unhL_, 0.9375, 0.89, 0.469, 213, 213, MOUSE 20S IMMUNOPROTEASOME
557, p5vfoS_, 0.9373, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
558, p5vfuRA_, 0.9372, 0.87, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
559, p5vfsM_, 0.9372, 0.88, 0.484, 213, 213, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
560, p5vfts_, 0.9371, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
561, p5vfsLA_, 0.9370, 0.88, 0.484, 213, 213, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
562, p5vfrS_, 0.9370, 0.88, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
563, p5l4gH_, 0.9368, 0.90, 0.484, 213, 213, 
564, p5vfrs_, 0.9366, 0.89, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
565, d3unfZ_, 0.9361, 0.91, 0.469, 213, 213, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
566, d3unfL_, 0.9361, 0.91, 0.469, 213, 213, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
567, p5vfuDA_, 0.9360, 0.91, 0.484, 213, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
568, p5vftS_, 0.9360, 0.91, 0.484, 213, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
569, p5t0cKB_, 0.9350, 0.92, 0.484, 213, 213, 
570, p5t0cEA_, 0.9350, 0.92, 0.484, 213, 213, 
571, p5t0gS_, 0.9307, 1.00, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
572, p5m32Z_, 0.9305, 1.02, 0.484, 213, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
573, p5m32L_, 0.9305, 1.02, 0.484, 213, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
574, p5t0hS_, 0.9159, 1.24, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p5t0jS_, 0.9155, 1.25, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
576, p5t0iS_, 0.9101, 1.35, 0.484, 213, 213, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
577, p4v7oUA_, 0.8928, 0.35, 1.000, 199, 199, 
578, p5ln36_, 0.8902, 1.57, 0.481, 213, 212, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
579, p5fmgM_, 0.8633, 1.13, 0.377, 199, 199, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
580, p5fmga_, 0.8633, 1.13, 0.377, 199, 199, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
581, p5mpcM_, 0.8597, 0.83, 1.000, 195, 195, 
582, p5mpcAA_, 0.8540, 0.95, 1.000, 195, 195, 
583, d5l63W_, 0.8491, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
584, d5l63I_, 0.8491, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
585, d5l5yW_, 0.8490, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
586, d5l5yI_, 0.8490, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
587, d5l6aW_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
588, d5l6aI_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
589, d5l64W_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
590, d5l64I_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
591, d5l62W_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
592, d5l62I_, 0.8489, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
593, d5l61W_, 0.8488, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
594, d5l61I_, 0.8488, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
595, d5l60W_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
596, d5l60I_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
597, d5l5xW_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
598, d5l5xI_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
599, d5l5oW_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
600, d5l5oI_, 0.8487, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
601, d5m2bI_, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
602, d5l5zW_, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
603, d5l5pW_, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
604, d5l5pI_, 0.8486, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
605, d4hnpW_, 0.8486, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
606, d5m2bW_, 0.8485, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
607, d5l66W_, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
608, d5l66I_, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
609, d5l5zI_, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
610, d5l5uW_, 0.8485, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
611, d5fggW_, 0.8485, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
612, d5fggI_, 0.8485, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
613, d5l6cW_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
614, d5l6cI_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
615, d5l69W_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
616, d5l69I_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
617, d5l67W_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
618, d5l67I_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
619, d5l5uI_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
620, d5l5tW_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
621, d5l5tI_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
622, d5l5jW_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
623, d5l5jI_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
624, d5l5hW_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
625, d5l5hI_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
626, d5l5dI_, 0.8484, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
627, d5l5bI_, 0.8484, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
628, d4inuW_, 0.8484, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
629, d5l5wW_, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
630, d5l5wI_, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
631, d5l5rI_, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
632, d5l5dW_, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
633, d5l5bW_, 0.8483, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
634, d5fgfW_, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
635, d5fgfI_, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
636, d5fgeW_, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
637, d5fgeI_, 0.8483, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
638, d5ahjW_, 0.8483, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
639, d5l68W_, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
640, d5l68I_, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
641, d5l65W_, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
642, d5l65I_, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
643, d5l5vW_, 0.8482, 1.70, 0.229, 204, 201,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
644, d5l5vI_, 0.8482, 1.70, 0.229, 204, 201,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
645, d5l5rW_, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
646, d5l5qW_, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
647, d5l5qI_, 0.8482, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
648, d5fgdW_, 0.8482, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
649, d5fgdI_, 0.8482, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
650, d5ahjI_, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
651, d4qvnW_, 0.8482, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
652, d4qvnI_, 0.8482, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
653, d4inuI_, 0.8482, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
654, d5lttW_, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
655, d5l5sW_, 0.8481, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
656, d5l5sI_, 0.8481, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
657, d5l5fW_, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
658, d5l5fI_, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
659, p5cggW_, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
660, p5cggI_, 0.8481, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
661, d5lttI_, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
662, d5l6bW_, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
663, d5l6bI_, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
664, d5jhrW_, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
665, d5jhrI_, 0.8480, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
666, d4inrW_, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
667, d4inrI_, 0.8480, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
668, d5l5eI_, 0.8479, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
669, p4y8gW_, 0.8479, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
670, p4y8gI_, 0.8479, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
671, d4hrdW_, 0.8479, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
672, d4hnpI_, 0.8479, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
673, d3tddW_, 0.8479, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
674, d3tddI_, 0.8479, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
675, d5l5iW_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
676, d5l5iI_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
677, d5l5eW_, 0.8478, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
678, d5d0vW_, 0.8478, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
679, d5cz9W_, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
680, d5cz9I_, 0.8478, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
681, d5bxnW_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
682, d5bxnI_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
683, d4qwfW_, 0.8478, 1.68, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
684, d4qwfI_, 0.8478, 1.68, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
685, d4qw6W_, 0.8478, 1.68, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
686, d4jsqW_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
687, d4jsqI_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
688, d4intW_, 0.8478, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
689, d2f16W_, 0.8478, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
690, d2f16I_, 0.8478, 1.69, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
691, d5l55W_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
692, d5l55I_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
693, d5jhsW_, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
694, d5jhsI_, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
695, d5fhsW_, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
696, d5fhsI_, 0.8477, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
697, d5dkjW_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
698, d5d0zW_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
699, d5d0zI_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
700, d5d0vI_, 0.8477, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
701, d5bouI_, 0.8477, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
702, d4ya4I_, 0.8477, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT
703, d4qw7W_, 0.8477, 1.68, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
704, d4qw7I_, 0.8477, 1.68, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
705, d4qw6I_, 0.8477, 1.68, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
706, d4j70W_, 0.8477, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
707, d4intI_, 0.8477, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
708, d3mg0W_, 0.8477, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
709, d3mg0I_, 0.8477, 1.70, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
710, d3hyeW_, 0.8477, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
711, d3hyeI_, 0.8477, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
712, d1g65W_, 0.8477, 1.68, 0.229, 204, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
713, d5dkjI_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
714, d5d0sW_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
715, d5d0sI_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
716, p5cghW_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
717, p5cghI_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
718, d5bouW_, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
719, d4ya4W_, 0.8476, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT
720, p4ya2W_, 0.8476, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
721, p4ya2I_, 0.8476, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
722, p4y8tW_, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
723, p4y8tI_, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
724, p4y8hW_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
725, p4y8hI_, 0.8476, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
726, d4qzzW_, 0.8476, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH OMURALIDE
727, d4qzzI_, 0.8476, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH OMURALIDE
728, d4j70I_, 0.8476, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
729, d5l5aW_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
730, d5l5aI_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
731, d5czaW_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
732, d5czaI_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT
733, p4ya9W_, 0.8475, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
734, p4ya9I_, 0.8475, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
735, d4ya1W_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
736, d4ya1I_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT
737, d4r02W_, 0.8475, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
738, d4qvpW_, 0.8475, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
739, d4qvpI_, 0.8475, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
740, d4jt0W_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
741, d4jt0I_, 0.8475, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
742, d4hrcI_, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
743, d3gptW_, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
744, d3gptI_, 0.8475, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
745, d3gpjW_, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
746, d3gpjI_, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
747, d1jd2P_, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
748, d1jd2I_, 0.8475, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
749, d1g65I_, 0.8475, 1.68, 0.229, 204, 201, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
750, d5l52W_, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
751, d5l52I_, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
752, d5fgiI_, 0.8474, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
753, d5d0wW_, 0.8474, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT
754, d5d0wI_, 0.8474, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT
755, d5cz6W_, 0.8474, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
756, d5bxlW_, 0.8474, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT
757, p4y8kW_, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
758, p4y8kI_, 0.8474, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
759, d4r17W_, 0.8474, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
760, d4r17I_, 0.8474, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
761, d4qz0W_, 0.8474, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
762, d4qvyW_, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
763, d4qvyI_, 0.8474, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
764, d4qvqW_, 0.8474, 1.69, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
765, d4qvqI_, 0.8474, 1.69, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
766, d4qvlW_, 0.8474, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH BORTEZOMIB
767, d4qvlI_, 0.8474, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH BORTEZOMIB
768, d4qv5W_, 0.8474, 1.71, 0.229, 204, 201, YCP BETA5-M45I MUTANT
769, d4qv5I_, 0.8474, 1.71, 0.229, 204, 201, YCP BETA5-M45I MUTANT
770, d4qlqW_, 0.8474, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
771, d4qlqI_, 0.8474, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
772, d3gpwW_, 0.8474, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
773, d2fakW_, 0.8474, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
774, d5fgiW_, 0.8473, 1.68, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
775, d5cz7W_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
776, d5cz7I_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
777, d5cz6I_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
778, d4y8mW_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
779, d4y8mI_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
780, p4y75W_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
781, p4y75I_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
782, p4y6aW_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
783, p4y6aI_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
784, d4r18I_, 0.8473, 1.71, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
785, d4qz7W_, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
786, d4qz7I_, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
787, d4qz0I_, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
788, d4qwlW_, 0.8473, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
789, d4qwlI_, 0.8473, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
790, d4qw5W_, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
791, d4qw5I_, 0.8473, 1.69, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
792, d4jsuW_, 0.8473, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
793, d4jsuI_, 0.8473, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
794, d3un8W_, 0.8473, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
795, p3un4W_, 0.8473, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
796, d3gpwI_, 0.8473, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
797, d2fakI_, 0.8473, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
798, d5laiW_, 0.8472, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
799, d5laiI_, 0.8472, 1.70, 0.229, 204, 201, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
800, d5fgaI_, 0.8472, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
801, d5d0tW_, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
802, d5d0tI_, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
803, d5bxlI_, 0.8472, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-G170A MUTANT
804, p4y8sW_, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
805, p4y8sI_, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
806, p4y84W_, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
807, p4y84I_, 0.8472, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
808, d4r18W_, 0.8472, 1.71, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
809, d4qwrW_, 0.8472, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
810, d4qv6W_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-A49V MUTANT
811, d4qv6I_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-A49V MUTANT
812, d4qv4W_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45T MUTANT
813, d4qv4I_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45T MUTANT
814, d4qv1W_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45A MUTANT
815, d4qv1I_, 0.8472, 1.71, 0.229, 204, 201, YCP BETA5-M45A MUTANT
816, d4no8W_, 0.8472, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
817, d4nnwW_, 0.8472, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
818, d4nnwI_, 0.8472, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
819, d4hrdI_, 0.8472, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
820, d3un8I_, 0.8472, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
821, p3un4I_, 0.8472, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
822, d3mg4W_, 0.8472, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
823, d3d29I_, 0.8472, 1.70, 0.229, 204, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
824, d5fgaW_, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
825, d5fg7W_, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T1A MUTANT
826, d5fg7I_, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T1A MUTANT
827, p5cgiW_, 0.8471, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
828, p5cgiI_, 0.8471, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
829, p4ya7W_, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
830, p4ya7I_, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
831, p4y8pW_, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
832, p4y8pI_, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
833, p4y77W_, 0.8471, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
834, p4y74W_, 0.8471, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
835, d4qz6W_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
836, d4qz6I_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
837, d4qz4W_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
838, d4qz4I_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
839, d4qwxW_, 0.8471, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
840, d4qwxI_, 0.8471, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
841, d4qwuW_, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
842, d4qwuI_, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
843, d4qwrI_, 0.8471, 1.69, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
844, d4qw1W_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
845, d4qw1I_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
846, d4qw0W_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
847, d4qvwW_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
848, d4qvwI_, 0.8471, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
849, d4qv7W_, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-A50V MUTANT
850, d4qv7I_, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-A50V MUTANT
851, d4quyI_, 0.8471, 1.71, 0.229, 204, 201, YCP BETA5-A49S-MUTANT
852, d4no8I_, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
853, d4no1W_, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
854, d4no1I_, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
855, d4nnnW_, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH MG132
856, d4nnnI_, 0.8471, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH MG132
857, d3d29W_, 0.8471, 1.71, 0.229, 204, 201, PROTEASOME INHIBITION BY FELLUTAMIDE B
858, d3bdmW_, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
859, d3bdmI_, 0.8471, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
860, d2fnyW_, 0.8471, 1.70, 0.229, 204, 201,  
861, d5fg9W_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
862, d5fg9I_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
863, d5cgfW_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
864, d5cgfI_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-G48C MUTANT
865, d4y8rW_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT
866, d4y8rI_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT
867, p4y77I_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
868, p4y74I_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
869, p4y6vW_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
870, p4y6vI_, 0.8470, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
871, d4qw4W_, 0.8470, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH CARFILZOMIB
872, d4qw4I_, 0.8470, 1.69, 0.229, 204, 201, YCP IN COMPLEX WITH CARFILZOMIB
873, d4qw0I_, 0.8470, 1.70, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
874, d4qv9W_, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-C63F MUTANT
875, d4qv9I_, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-C63F MUTANT
876, d4qv3W_, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-M45V MUTANT
877, d4qv3I_, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-M45V MUTANT
878, d4quyW_, 0.8470, 1.71, 0.229, 204, 201, YCP BETA5-A49S-MUTANT
879, d4quxW_, 0.8470, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT
880, d4quxI_, 0.8470, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT
881, d4lqiW_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
882, d4lqiI_, 0.8470, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
883, d4fzgW_, 0.8470, 1.70, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
884, d4fzgI_, 0.8470, 1.70, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
885, d4eu2X_, 0.8470, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
886, d3mg7I_, 0.8470, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
887, d3mg4I_, 0.8470, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
888, d2fnyI_, 0.8470, 1.70, 0.229, 204, 201,  
889, d1rypJ_, 0.8470, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
890, p6gopW_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
891, p6gopI_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
892, p5fghW_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
893, p5fghI_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
894, d5cz5W_, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
895, d5cz5I_, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
896, d4z1lW_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
897, d4z1lI_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
898, d4y9yW_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT
899, d4y9yI_, 0.8469, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT
900, p4y8uW_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
901, p4y8nW_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
902, p4y8nI_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
903, p4y7xW_, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
904, p4y7xI_, 0.8469, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
905, d4rurW_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
906, d4rurI_, 0.8469, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
907, d4r00W_, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
908, d4r00I_, 0.8469, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
909, d4qv8W_, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-C52F MUTANT
910, d4qv8I_, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-C52F MUTANT
911, d4qv0W_, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT
912, d4qv0I_, 0.8469, 1.71, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT
913, d4q1sW_, 0.8469, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
914, d3nzjW_, 0.8469, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
915, d3nzjI_, 0.8469, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
916, d3mg7W_, 0.8469, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
917, d3e47W_, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
918, d3e47I_, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
919, d3dy4W_, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
920, d3dy4I_, 0.8469, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
921, d2gplW_, 0.8469, 1.70, 0.229, 204, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
922, d2gplI_, 0.8469, 1.70, 0.229, 204, 201, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
923, d1rypX_, 0.8469, 1.70, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
924, d5lajW_, 0.8468, 1.71, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
925, d5lajI_, 0.8468, 1.71, 0.229, 204, 201, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
926, p4y8uI_, 0.8468, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
927, p4y6zW_, 0.8468, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
928, p4y6zI_, 0.8468, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
929, d4qzwW_, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
930, d4qzwI_, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
931, d4qz3W_, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
932, d4qz3I_, 0.8468, 1.70, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
933, d4ltcW_, 0.8468, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
934, p4y9zW_, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
935, p4y9zI_, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
936, p4y82W_, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
937, p4y69W_, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
938, p4y69I_, 0.8467, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
939, d4qwsW_, 0.8467, 1.69, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
940, d4qwgW_, 0.8467, 1.69, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
941, d4qvmW_, 0.8467, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
942, d4qvmI_, 0.8467, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
943, d4qlsW_, 0.8467, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
944, d4qlsI_, 0.8467, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
945, d4eu2J_, 0.8467, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
946, d2zcyI_, 0.8467, 1.73, 0.229, 204, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
947, d1g0uW_, 0.8467, 1.71, 0.229, 204, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
948, d5dkiW_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
949, d5dkiI_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
950, d5cz8W_, 0.8466, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
951, d5cz8I_, 0.8466, 1.69, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
952, p4ya5W_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
953, p4ya5I_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
954, p4y8lI_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
955, p4y82I_, 0.8466, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
956, d4qz2W_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
957, d4qz2I_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
958, d4qwsI_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
959, d4qwkW_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
960, d4qwkI_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
961, d4qwgI_, 0.8466, 1.69, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
962, d4ltcI_, 0.8466, 1.73, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
963, d4hrcW_, 0.8466, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
964, d4fzcW_, 0.8466, 1.72, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
965, d4fzcI_, 0.8466, 1.72, 0.229, 204, 201, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
966, d3okjW_, 0.8466, 1.71, 0.229, 204, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
967, d3okjI_, 0.8466, 1.71, 0.229, 204, 201, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
968, d3mg8W_, 0.8466, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
969, d2zcyW_, 0.8466, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
970, d5d0xW_, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
971, d5d0xI_, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
972, p4y8lW_, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
973, p4y70W_, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
974, p4y70I_, 0.8465, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
975, d4qz5W_, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
976, d4qz5I_, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
977, d4qwiW_, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
978, d4qwiI_, 0.8465, 1.70, 0.229, 204, 201, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
979, d4qluW_, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
980, d4qluI_, 0.8465, 1.70, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
981, d4no9W_, 0.8465, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
982, d4no9I_, 0.8465, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
983, d3oevW_, 0.8465, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
984, d3nzwW_, 0.8465, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
985, d3mg6I_, 0.8465, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
986, d5l54W_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
987, p4y8jW_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
988, p4y8jI_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
989, p4y80W_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
990, p4y80I_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
991, p4y7wW_, 0.8464, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
992, d4qzxW_, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
993, d4qzxI_, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
994, d4qz1W_, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
995, d4qz1I_, 0.8464, 1.70, 0.229, 204, 201, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
996, d3sdiW_, 0.8464, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
997, d3oevI_, 0.8464, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
998, d3oeuW_, 0.8464, 1.72, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
999, d3nzxW_, 0.8464, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1000, d3nzxI_, 0.8464, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1001, d3nzwI_, 0.8464, 1.71, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1002, d1g0uI_, 0.8464, 1.72, 0.229, 204, 201, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1003, d5l54I_, 0.8463, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1004, p4y8qI_, 0.8463, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1005, p4y7wI_, 0.8463, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1006, d3sdkI_, 0.8463, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1007, d3sdiI_, 0.8463, 1.71, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1008, d3mg8I_, 0.8463, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1009, d3mg6W_, 0.8463, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1010, d3dy3W_, 0.8463, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1011, d3dy3I_, 0.8463, 1.72, 0.229, 204, 201, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1012, p4y8qW_, 0.8462, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1013, d4r02I_, 0.8462, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1014, d4no6W_, 0.8462, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1015, d4no6I_, 0.8462, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1016, p4y81W_, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1017, p4y81I_, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1018, p4y7yW_, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1019, p4y7yI_, 0.8461, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1020, d4qw3W_, 0.8461, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1021, d4qw3I_, 0.8461, 1.70, 0.229, 204, 201, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1022, d4qltW_, 0.8461, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1023, d4qltI_, 0.8461, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1024, p4gk7W_, 0.8461, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1025, p4gk7I_, 0.8461, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1026, d3oeuI_, 0.8461, 1.74, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1027, d1z7qX1, 0.8461, 1.77, 0.234, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1028, d5cz4W_, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1029, d5cz4I_, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1030, p4ya3W_, 0.8460, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1031, p4y8iW_, 0.8460, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1032, p4y8iI_, 0.8460, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1033, p4x6zJ_, 0.8460, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1034, d4qxjW_, 0.8460, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1035, d4qxjI_, 0.8460, 1.70, 0.229, 204, 201, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1036, d4qvvW_, 0.8460, 1.71, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1037, d4qvvI_, 0.8460, 1.71, 0.229, 204, 201, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1038, p4qbyW_, 0.8460, 1.73, 0.229, 204, 201, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1039, p4qbyI_, 0.8460, 1.73, 0.229, 204, 201, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1040, d4q1sI_, 0.8460, 1.72, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1041, d3shjW_, 0.8460, 1.72, 0.229, 204, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1042, d3shjI_, 0.8460, 1.72, 0.229, 204, 201, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1043, d3sdkW_, 0.8460, 1.73, 0.229, 204, 201, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1044, d1z7qJ1, 0.8460, 1.77, 0.234, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1045, p4zzgJ_, 0.8459, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1046, p4ya3I_, 0.8459, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1047, p4y8oW_, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1048, p4y8oI_, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1049, p4y78W_, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1050, p4y78I_, 0.8459, 1.70, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1051, p5nifJ_, 0.8458, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1052, d4qwjW_, 0.8458, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1053, d4qlvW_, 0.8458, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1054, d4qlvI_, 0.8458, 1.71, 0.229, 204, 201, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1055, d3wxrX_, 0.8458, 1.75, 0.229, 204, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1056, p3jcpSA_, 0.8458, 1.73, 0.229, 204, 201, 
1057, p3jcpE_, 0.8458, 1.73, 0.229, 204, 201, 
1058, d4qwjI_, 0.8457, 1.70, 0.229, 204, 201, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1059, p5nifX_, 0.8455, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1060, p4ya0W_, 0.8454, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1061, p4ya0I_, 0.8454, 1.71, 0.229, 204, 201, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1062, d3wxrJ_, 0.8454, 1.76, 0.229, 204, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1063, p4zzgX_, 0.8453, 1.74, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1064, p4x6zX_, 0.8453, 1.76, 0.229, 204, 201, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1065, p6avoU_, 0.8452, 1.87, 0.223, 204, 202, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1066, p5mp9j_, 0.8451, 1.74, 0.229, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1067, p4r67z_, 0.8450, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1068, p6avoY_, 0.8449, 1.88, 0.223, 204, 202, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1069, d4r67X_, 0.8449, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1070, p4r67l_, 0.8449, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1071, d4r67J_, 0.8449, 1.89, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1072, d5lf7W_, 0.8448, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1073, d3unbI_, 0.8448, 1.91, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1074, p4v7oJ_, 0.8447, 1.92, 0.233, 204, 202, 
1075, d3l5qN_, 0.8447, 1.92, 0.233, 204, 202,  
1076, p5lf6I_, 0.8446, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1077, p5lezI_, 0.8446, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1078, d5le5W_, 0.8446, 1.90, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1079, p4v7oX_, 0.8446, 1.76, 0.229, 204, 201, 
1080, p3unbk_, 0.8446, 1.91, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1081, d3l5qZ_, 0.8446, 1.76, 0.229, 204, 201,  
1082, p5lf6W_, 0.8445, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1083, p4v7oFB_, 0.8445, 1.78, 0.229, 204, 201, 
1084, d1vsyX_, 0.8445, 1.78, 0.229, 204, 201,  
1085, d5lf7I_, 0.8444, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1086, p5lezW_, 0.8444, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1087, p5leyI_, 0.8444, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1088, p4v7oRA_, 0.8444, 1.78, 0.229, 204, 201, 
1089, d4g4sJ_, 0.8444, 1.77, 0.234, 203, 201, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1090, d1vsyJ_, 0.8444, 1.78, 0.229, 204, 201,  
1091, d5lf1W_, 0.8443, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1092, d5lf1I_, 0.8443, 1.89, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1093, p5leyW_, 0.8443, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1094, d5le5I_, 0.8443, 1.90, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1095, d5lf3W_, 0.8442, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1096, d5lexW_, 0.8442, 1.91, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1097, d5lf3I_, 0.8441, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1098, p5lf0W_, 0.8441, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1099, p5lf0I_, 0.8440, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1100, d5lf4I_, 0.8439, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1101, d5lexI_, 0.8439, 1.91, 0.223, 204, 202, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1102, d1iruX_, 0.8439, 1.90, 0.223, 204, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1103, d1iruJ_, 0.8439, 1.90, 0.223, 204, 202, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1104, p5mp93_, 0.8438, 1.81, 0.229, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1105, d4r3oX_, 0.8438, 1.91, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
1106, d4r3oJ_, 0.8438, 1.91, 0.223, 204, 202, HUMAN CONSTITUTIVE 20S PROTEASOME
1107, d5lf4W_, 0.8437, 1.90, 0.223, 204, 202, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1108, p3uneW_, 0.8436, 1.93, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1109, p5t0gP_, 0.8435, 1.77, 0.224, 204, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1110, p3uneI_, 0.8435, 1.92, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1111, p1fntJ_, 0.8435, 1.79, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1112, p1fntX_, 0.8434, 1.79, 0.229, 204, 201, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1113, p5gjqc_, 0.8430, 1.93, 0.223, 204, 202, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1114, p5vfoP_, 0.8429, 1.77, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1115, p3uney_, 0.8429, 1.93, 0.218, 204, 202, MOUSE CONSTITUTIVE 20S PROTEASOME
1116, p5vfsIA_, 0.8427, 1.92, 0.223, 204, 202, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1117, p5gjrPA_, 0.8427, 1.77, 0.224, 204, 201, 
1118, p5gjrBA_, 0.8427, 1.77, 0.224, 204, 201, 
1119, p3unek_, 0.8427, 1.78, 0.219, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME
1120, p5vfpJ_, 0.8423, 1.78, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1121, p5vfqJ_, 0.8422, 1.78, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1122, p5t0cHB_, 0.8422, 1.77, 0.224, 204, 201, 
1123, p5t0cBA_, 0.8422, 1.77, 0.224, 204, 201, 
1124, d3unfI_, 0.8421, 1.94, 0.218, 204, 202, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1125, p5vfqIA_, 0.8420, 1.80, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1126, p3unhW_, 0.8420, 1.94, 0.218, 204, 202, MOUSE 20S IMMUNOPROTEASOME
1127, p3unhI_, 0.8420, 1.94, 0.218, 204, 202, MOUSE 20S IMMUNOPROTEASOME
1128, d3unfW_, 0.8420, 1.94, 0.218, 204, 202, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1129, d3unbW_, 0.8420, 1.80, 0.219, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1130, p5vfuOA_, 0.8419, 1.93, 0.223, 204, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1131, p5vftp_, 0.8419, 1.93, 0.223, 204, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1132, p3jcoSA_, 0.8418, 1.76, 0.229, 204, 201, 
1133, p3jcoE_, 0.8418, 1.76, 0.229, 204, 201, 
1134, p5vfop_, 0.8417, 1.80, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1135, p5vfsJ_, 0.8416, 1.78, 0.224, 204, 201, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1136, p5vfpHA_, 0.8415, 1.79, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1137, p5vfrP_, 0.8414, 1.79, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1138, p3unby_, 0.8411, 1.79, 0.219, 204, 201, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1139, p5mpcX_, 0.8410, 1.77, 0.229, 204, 201, 
1140, p5l4gJ_, 0.8409, 1.92, 0.223, 204, 202, 
1141, p5mpaj_, 0.8408, 1.80, 0.234, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1142, p5l4gX_, 0.8408, 1.78, 0.224, 204, 201, 
1143, p5mpa3_, 0.8407, 1.83, 0.229, 204, 201, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1144, p5vfrp_, 0.8405, 1.82, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1145, p5gjqq_, 0.8404, 1.81, 0.224, 204, 201, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1146, p5vfuAA_, 0.8394, 1.84, 0.224, 204, 201, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1147, p5vftP_, 0.8394, 1.84, 0.224, 204, 201, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1148, p5m32W_, 0.8392, 1.95, 0.223, 204, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1149, p5m32I_, 0.8392, 1.95, 0.223, 204, 202, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1150, p5mpcJ_, 0.8386, 1.85, 0.229, 204, 201, 
1151, p5t0iP_, 0.8361, 1.87, 0.224, 204, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1152, p5l4gK_, 0.8358, 2.11, 0.201, 207, 204, 
1153, p6epd6_, 0.8355, 2.34, 0.038, 213, 210, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
1154, p5l4gY_, 0.8354, 2.14, 0.206, 207, 204, 
1155, d4cr23_, 0.8351, 1.85, 0.229, 204, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1156, p5gjqu_, 0.8345, 2.16, 0.201, 207, 204, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1157, p5wvkC_, 0.8344, 1.82, 0.229, 204, 201, 
1158, p6avoW_, 0.8338, 2.03, 0.202, 206, 203, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1159, p6avoa_, 0.8338, 2.03, 0.202, 206, 203, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1160, p5vfuEA_, 0.8337, 1.92, 0.208, 205, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1161, p5vftT_, 0.8337, 1.92, 0.208, 205, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1162, p5vfsMA_, 0.8336, 2.00, 0.202, 205, 203, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1163, p5vfoT_, 0.8335, 1.93, 0.203, 205, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1164, p5gjrTA_, 0.8335, 2.17, 0.201, 207, 204, 
1165, p4r67p_, 0.8335, 2.15, 0.201, 207, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1166, d4r67N_, 0.8335, 2.15, 0.201, 217, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1167, p4r67b_, 0.8335, 2.15, 0.201, 207, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1168, d4r672_, 0.8335, 2.15, 0.201, 217, 204, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1169, p5t0hP_, 0.8334, 2.00, 0.223, 204, 202, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1170, p5mpbJ_, 0.8333, 1.89, 0.229, 204, 201, 
1171, p5vfsN_, 0.8332, 2.01, 0.202, 205, 203, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1172, p5vfot_, 0.8332, 1.94, 0.203, 205, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1173, p5gjqg_, 0.8331, 2.04, 0.207, 206, 203, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1174, d4r3oN_, 0.8331, 2.16, 0.206, 217, 204, HUMAN CONSTITUTIVE 20S PROTEASOME
1175, d4r3o2_, 0.8331, 2.16, 0.206, 217, 204, HUMAN CONSTITUTIVE 20S PROTEASOME
1176, p5m32M_, 0.8330, 2.01, 0.197, 206, 203, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1177, p5wvkJ_, 0.8329, 1.84, 0.229, 204, 201, 
1178, p5m32a_, 0.8327, 2.01, 0.197, 206, 203, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1179, p4cr43_, 0.8327, 1.85, 0.224, 204, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1180, p5wviRA_, 0.8326, 1.34, 0.959, 196, 195, 
1181, p5gjrFA_, 0.8325, 2.04, 0.202, 206, 203, 
1182, p6epe6_, 0.8324, 2.44, 0.048, 213, 210, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
1183, d5lf1M_, 0.8323, 2.18, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1184, p5wviJA_, 0.8321, 1.42, 1.000, 196, 196, 
1185, d5lf4M_, 0.8321, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1186, d5lf3M_, 0.8321, 2.18, 0.206, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1187, p5vfpLA_, 0.8319, 1.95, 0.203, 205, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1188, d5lf7M_, 0.8319, 2.18, 0.201, 216, 204, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1189, p5lf1a_, 0.8319, 2.05, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1190, p5lf3a_, 0.8318, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1191, p5lf0a_, 0.8318, 2.05, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1192, d5le5M_, 0.8318, 2.18, 0.206, 216, 204, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1193, p5lf4a_, 0.8317, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1194, d5lexM_, 0.8317, 2.18, 0.206, 216, 204, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1195, p5le5a_, 0.8317, 2.05, 0.207, 206, 203, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1196, p5vfuSA_, 0.8316, 1.97, 0.208, 205, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1197, p5vftt_, 0.8316, 1.97, 0.208, 205, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1198, p5leya_, 0.8315, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1199, p5vfpN_, 0.8314, 1.96, 0.203, 205, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1200, p5lf0M_, 0.8314, 2.06, 0.202, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1201, p3unea_, 0.8314, 2.06, 0.207, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
1202, p5lf7a_, 0.8313, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1203, p5lf6a_, 0.8313, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1204, p5lexa_, 0.8313, 2.06, 0.207, 206, 203, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1205, p5mpbX_, 0.8312, 1.93, 0.229, 204, 201, 
1206, d1iruN_, 0.8312, 2.20, 0.201, 217, 204, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1207, d1iru2_, 0.8312, 2.20, 0.201, 217, 204, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1208, p5vfqMA_, 0.8311, 1.97, 0.203, 205, 202, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1209, p5lf6M_, 0.8311, 2.06, 0.202, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1210, p5leza_, 0.8311, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1211, p5leyM_, 0.8310, 2.06, 0.202, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1212, d3unb3_, 0.8310, 2.19, 0.206, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1213, p5vfrT_, 0.8308, 2.03, 0.202, 205, 203, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1214, d3unbM_, 0.8307, 2.20, 0.206, 216, 204, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1215, p5vfqN_, 0.8306, 2.04, 0.202, 205, 203, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1216, p5vfrt_, 0.8305, 1.97, 0.203, 205, 202, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1217, p5lezM_, 0.8305, 2.06, 0.207, 206, 203, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1218, p3une3_, 0.8305, 2.07, 0.207, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
1219, d4g4sN_, 0.8302, 2.32, 0.155, 233, 206, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1220, p3uneo_, 0.8302, 2.07, 0.207, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
1221, d3unfM_, 0.8301, 2.19, 0.206, 216, 204, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1222, p3uneM_, 0.8301, 2.07, 0.207, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME
1223, p5mpa7_, 0.8300, 2.17, 0.161, 218, 205, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1224, p4q1sa_, 0.8299, 2.44, 0.155, 218, 207, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1225, p5mp9n_, 0.8297, 2.19, 0.161, 217, 205, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1226, d5fgiH_, 0.8296, 2.07, 0.188, 234, 202, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1227, p5fg7a_, 0.8296, 2.30, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1228, p3unbo_, 0.8296, 2.08, 0.207, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1229, p5cz5b_, 0.8295, 2.04, 0.225, 206, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1230, p3unba_, 0.8295, 2.08, 0.212, 206, 203, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1231, d5fgiV_, 0.8294, 2.07, 0.188, 234, 202, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1232, p3unhM_, 0.8294, 2.08, 0.207, 206, 203, MOUSE 20S IMMUNOPROTEASOME
1233, p3unha_, 0.8294, 2.08, 0.207, 206, 203, MOUSE 20S IMMUNOPROTEASOME
1234, d3gpj1_, 0.8294, 2.45, 0.155, 233, 207, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1235, d4q1sM_, 0.8293, 2.44, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1236, d5l5rM_, 0.8292, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1237, p5l5ra_, 0.8292, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1238, p4r18a_, 0.8292, 2.32, 0.155, 218, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1239, d4intM_, 0.8292, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1240, p3unfa_, 0.8292, 2.07, 0.207, 206, 203, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1241, d3mg41_, 0.8292, 2.32, 0.155, 233, 206, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1242, d3gpjM_, 0.8292, 2.45, 0.150, 233, 207, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1243, d5l6aM_, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1244, p5l6aa_, 0.8291, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1245, d5l5uM_, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1246, d5l5qM_, 0.8291, 2.44, 0.155, 233, 207, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1247, d5l5bM_, 0.8291, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1248, d4qvnM_, 0.8291, 2.32, 0.155, 233, 206, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1249, p5l5da_, 0.8290, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1250, d4lqiM_, 0.8290, 2.45, 0.155, 233, 207, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1251, d5laiM_, 0.8289, 2.44, 0.155, 233, 207, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1252, d5fg7M_, 0.8289, 2.16, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1253, p4qv6a_, 0.8289, 2.33, 0.155, 218, 206, YCP BETA5-A49V MUTANT
1254, d3sdkM_, 0.8289, 2.17, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1255, d3nzwM_, 0.8289, 2.46, 0.155, 233, 207, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1256, d3nzw1_, 0.8289, 2.46, 0.155, 233, 207, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1257, d3d29M_, 0.8289, 2.32, 0.155, 233, 206, PROTEASOME INHIBITION BY FELLUTAMIDE B
1258, d3d291_, 0.8289, 2.32, 0.155, 233, 206, PROTEASOME INHIBITION BY FELLUTAMIDE B
1259, d5l61M_, 0.8288, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1260, p5l5ta_, 0.8288, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1261, d4r17M_, 0.8288, 2.32, 0.155, 233, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1262, p4r17a_, 0.8288, 2.32, 0.155, 218, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1263, d5lajM_, 0.8287, 2.32, 0.155, 228, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1264, p5laja_, 0.8287, 2.32, 0.155, 218, 206, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1265, p5l6ca_, 0.8287, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1266, p5l5sa_, 0.8287, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1267, d3oevM_, 0.8287, 2.32, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1268, d3mg7M_, 0.8287, 2.32, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1269, d2zcy0_, 0.8287, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1270, d5m2bM_, 0.8286, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1271, d5cz5N_, 0.8286, 2.05, 0.225, 206, 200, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1272, p4ya1a_, 0.8286, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1273, d2zcyM_, 0.8286, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1274, p5l67a_, 0.8285, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1275, d5l5hM_, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1276, p5fgib_, 0.8285, 1.90, 0.226, 213, 199, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1277, d4qv5M_, 0.8285, 2.32, 0.155, 233, 206, YCP BETA5-M45I MUTANT
1278, p4qv1a_, 0.8285, 2.33, 0.155, 218, 206, YCP BETA5-M45A MUTANT
1279, p4quxa_, 0.8285, 2.33, 0.155, 218, 206, YCP BETA5-A49T-MUTANT
1280, d3mg71_, 0.8285, 2.32, 0.146, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1281, d3bdmM_, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1282, d3bdm0_, 0.8285, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1283, p5mpan_, 0.8284, 2.18, 0.161, 218, 205, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1284, p5l68a_, 0.8284, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1285, d5l66M_, 0.8284, 2.32, 0.155, 233, 206, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1286, p5l5ha_, 0.8284, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1287, d5fgiN_, 0.8284, 1.90, 0.226, 213, 199, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1288, p5fg9a_, 0.8284, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1289, p5boua_, 0.8284, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1290, p4y9ya_, 0.8284, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1291, d4qwuM_, 0.8284, 2.33, 0.155, 233, 206, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1292, p4qv7a_, 0.8284, 2.33, 0.155, 218, 206, YCP BETA5-A50V MUTANT
1293, d4qltM_, 0.8284, 2.33, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1294, p4qlta_, 0.8284, 2.33, 0.155, 218, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1295, d3oev1_, 0.8284, 2.33, 0.155, 233, 206, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1296, d5l5vM_, 0.8283, 2.32, 0.155, 233, 206,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1297, p5l5qa_, 0.8283, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1298, p5l54a_, 0.8283, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1299, p5cz6a_, 0.8283, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1300, p5cgfa_, 0.8283, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1301, d5bxnM_, 0.8283, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1302, p5bxna_, 0.8283, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1303, p4ya4a_, 0.8283, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1304, d4r18M_, 0.8283, 2.19, 0.156, 233, 205, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1305, p4qvna_, 0.8283, 2.19, 0.156, 218, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1306, d4inuM_, 0.8283, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1307, p5l5ua_, 0.8282, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1308, d5l5dM_, 0.8282, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1309, p5l5ba_, 0.8282, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1310, d5l54M_, 0.8282, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1311, d5d0wM_, 0.8282, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1312, p5d0wa_, 0.8282, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1313, d4ya4M_, 0.8282, 2.19, 0.156, 229, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1314, d4qv9M_, 0.8282, 2.33, 0.155, 233, 206, YCP BETA5-C63F MUTANT
1315, d3oeuM_, 0.8282, 2.18, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1316, d3nzjM_, 0.8282, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1317, d3nzj1_, 0.8282, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1318, d2fnyM_, 0.8282, 2.33, 0.155, 233, 206,  
1319, d2fny1_, 0.8282, 2.33, 0.155, 233, 206,  
1320, d5l5pM_, 0.8281, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1321, p5l5pa_, 0.8281, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1322, d5ahjM_, 0.8281, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1323, p5ahja_, 0.8281, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1324, p4y6vM_, 0.8281, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1325, p4y6va_, 0.8281, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1326, d4qlvM_, 0.8281, 2.33, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1327, d4qlsM_, 0.8281, 2.34, 0.155, 233, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1328, p4lqia_, 0.8281, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1329, p4inta_, 0.8281, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1330, d3sdk1_, 0.8281, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1331, d3sdi1_, 0.8281, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1332, d3mg4M_, 0.8281, 2.33, 0.155, 233, 206, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1333, p3jcpI_, 0.8281, 2.36, 0.150, 218, 206, 
1334, p3jcpB_, 0.8281, 2.36, 0.150, 218, 206, 
1335, p5ltta_, 0.8280, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1336, p5laia_, 0.8280, 2.33, 0.155, 218, 206, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1337, d5l5tM_, 0.8280, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1338, d5l5oM_, 0.8280, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1339, p5l5oa_, 0.8280, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1340, d5bxlM_, 0.8280, 2.19, 0.156, 229, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1341, p5bxla_, 0.8280, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1342, p4rura_, 0.8280, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1343, d4qv6M_, 0.8280, 2.20, 0.156, 233, 205, YCP BETA5-A49V MUTANT
1344, d4qluM_, 0.8280, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1345, p4qlua_, 0.8280, 2.20, 0.156, 218, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1346, p4qlsa_, 0.8280, 2.34, 0.155, 218, 206, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1347, d2fakM_, 0.8280, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1348, d2fak1_, 0.8280, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1349, d5l69M_, 0.8279, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1350, p5l69a_, 0.8279, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1351, d5l63M_, 0.8279, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1352, p5l63a_, 0.8279, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1353, p5l61a_, 0.8279, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1354, p4zzg2_, 0.8279, 2.45, 0.155, 218, 207, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1355, p4z1la_, 0.8279, 2.32, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1356, d4r02M_, 0.8279, 2.19, 0.156, 233, 205, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1357, d4qv0M_, 0.8279, 2.20, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1358, p4qv0a_, 0.8279, 2.20, 0.156, 218, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1359, p4qbya_, 0.8279, 2.33, 0.155, 218, 206, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1360, d4jsuM_, 0.8279, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1361, p4jsua_, 0.8279, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1362, p4inra_, 0.8279, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1363, d4hnpM_, 0.8279, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1364, d3mg8M_, 0.8279, 2.19, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1365, d3e47M_, 0.8279, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1366, d3e471_, 0.8279, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1367, d3dy31_, 0.8279, 2.33, 0.150, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1368, d1rypN_, 0.8279, 2.32, 0.150, 233, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1369, d5l6cM_, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1370, p5l6ba_, 0.8278, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1371, d5l62M_, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1372, p5l62a_, 0.8278, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1373, d5l5yM_, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1374, p5l5ya_, 0.8278, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1375, d5l5sM_, 0.8278, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1376, d5l5jM_, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1377, p5l5ja_, 0.8278, 2.19, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1378, d5czaM_, 0.8278, 2.20, 0.156, 229, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1379, p5czaa_, 0.8278, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1380, d4ya1M_, 0.8278, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1381, p4y69M_, 0.8278, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1382, p4y69a_, 0.8278, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1383, p4r02a_, 0.8278, 2.19, 0.156, 218, 205, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1384, p4qvla_, 0.8278, 2.20, 0.156, 218, 205, YCP IN COMPLEX WITH BORTEZOMIB
1385, d4quyM_, 0.8278, 2.20, 0.156, 233, 205, YCP BETA5-A49S-MUTANT
1386, p4quya_, 0.8278, 2.20, 0.156, 218, 205, YCP BETA5-A49S-MUTANT
1387, p4qbyM_, 0.8278, 2.33, 0.155, 218, 206, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1388, p4inua_, 0.8278, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1389, d4fzgM_, 0.8278, 2.34, 0.155, 233, 206, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1390, d3hyeM_, 0.8278, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1391, d3hye1_, 0.8278, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1392, d3gpwM_, 0.8278, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1393, d3gpw1_, 0.8278, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1394, p5m2ba_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1395, d5l6bM_, 0.8277, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1396, d5l67M_, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1397, d5l64M_, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1398, p5l64a_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1399, d5fggM_, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1400, p5fgga_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1401, d4y8rM_, 0.8277, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1402, p4y8ra_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1403, p4y8gM_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1404, p4y8ga_, 0.8277, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1405, d4qvlM_, 0.8277, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH BORTEZOMIB
1406, p4qv5a_, 0.8277, 2.20, 0.156, 218, 205, YCP BETA5-M45I MUTANT
1407, d4qv1M_, 0.8277, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT
1408, d3mg61_, 0.8277, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1409, d3dy3M_, 0.8277, 2.33, 0.150, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1410, d5l68M_, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1411, p5l66a_, 0.8276, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1412, d5l60M_, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1413, p5l60a_, 0.8276, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1414, d5fg9M_, 0.8276, 2.19, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1415, p5cggM_, 0.8276, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1416, p5cgga_, 0.8276, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1417, d5bouM_, 0.8276, 2.20, 0.156, 229, 205, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1418, d4y9yM_, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1419, p4y8ma_, 0.8276, 2.20, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1420, d4qzzM_, 0.8276, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH OMURALIDE
1421, p4qzza_, 0.8276, 2.20, 0.156, 218, 205, YCP IN COMPLEX WITH OMURALIDE
1422, d4qv7M_, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT
1423, d4qv4M_, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT
1424, p4qv4a_, 0.8276, 2.20, 0.156, 218, 205, YCP BETA5-M45T MUTANT
1425, d4quxM_, 0.8276, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT
1426, p4jt0a_, 0.8276, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1427, d4inrM_, 0.8276, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1428, d4eu22_, 0.8276, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1429, d3mg6M_, 0.8276, 2.18, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1430, d3dy41_, 0.8276, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1431, d1ryp2_, 0.8276, 2.44, 0.150, 233, 207, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1432, d1jd2T_, 0.8276, 2.32, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1433, d1g0uM_, 0.8276, 2.33, 0.150, 233, 206, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1434, d1g0u1_, 0.8276, 2.33, 0.150, 233, 206, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1435, p5l5va_, 0.8275, 2.19, 0.156, 218, 205,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1436, d5l5iM_, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1437, p5l5ia_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1438, d5fgaM_, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1439, p5fgaa_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1440, d5cz6M_, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1441, p4y8tM_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1442, p4y8ta_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1443, d4y8mM_, 0.8275, 2.20, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1444, p4y8hM_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1445, p4y8ha_, 0.8275, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1446, d4qz7M_, 0.8275, 2.20, 0.156, 232, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1447, p4qwua_, 0.8275, 2.20, 0.156, 218, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1448, d4qv3M_, 0.8275, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT
1449, p4qv3a_, 0.8275, 2.20, 0.156, 218, 205, YCP BETA5-M45V MUTANT
1450, d4jsqM_, 0.8275, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1451, d3sdiM_, 0.8275, 2.19, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1452, d2gpl1_, 0.8275, 2.34, 0.155, 233, 206, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1453, p6gopa_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1454, d5l65M_, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1455, p5l65a_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1456, d5l5wM_, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1457, p5l5wa_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1458, p5l5aa_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1459, d5dkjM_, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1460, p5dkja_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1461, d5dkiM_, 0.8274, 2.33, 0.155, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1462, d5cgfM_, 0.8274, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1463, p4ya5M_, 0.8274, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1464, p4ya5a_, 0.8274, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1465, p4qz7a_, 0.8274, 2.20, 0.156, 218, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1466, p4qw1a_, 0.8274, 2.20, 0.156, 218, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1467, d4qv8M_, 0.8274, 2.20, 0.156, 233, 205, YCP BETA5-C52F MUTANT
1468, p4qv8a_, 0.8274, 2.20, 0.156, 218, 205, YCP BETA5-C52F MUTANT
1469, d4jt0M_, 0.8274, 2.34, 0.150, 233, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1470, p4jsqa_, 0.8274, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1471, d3dy4M_, 0.8274, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1472, d2gplM_, 0.8274, 2.34, 0.155, 233, 206, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1473, d2f161_, 0.8274, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1474, p6gopM_, 0.8273, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1475, d5l5zM_, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1476, p5l5za_, 0.8273, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1477, p5l5fa_, 0.8273, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1478, d5l5aM_, 0.8273, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1479, d4qwfM_, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1480, p4qwfa_, 0.8273, 2.20, 0.156, 218, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1481, d4qw6M_, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1482, p4qw6a_, 0.8273, 2.20, 0.156, 218, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1483, d4qw1M_, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1484, d4qvyM_, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1485, p4qvya_, 0.8273, 2.20, 0.156, 218, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1486, d4qvqM_, 0.8273, 2.20, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1487, p4qvqa_, 0.8273, 2.20, 0.156, 218, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1488, p4qv9a_, 0.8273, 2.20, 0.156, 218, 205, YCP BETA5-C63F MUTANT
1489, p4qlva_, 0.8273, 2.20, 0.156, 218, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1490, p4j70a_, 0.8273, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1491, p4hrca_, 0.8273, 2.20, 0.156, 218, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1492, d3wxrN_, 0.8273, 2.34, 0.155, 233, 206, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1493, d3shjM_, 0.8273, 2.34, 0.155, 233, 206, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1494, d3shj1_, 0.8273, 2.34, 0.155, 233, 206, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1495, d3nzxM_, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1496, d3nzx1_, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1497, d3gpt1_, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1498, d2f16M_, 0.8273, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1499, d1rypH_, 0.8273, 2.00, 0.225, 205, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1500, d5lttM_, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1501, d5l5fM_, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1502, d5l55M_, 0.8272, 2.20, 0.156, 228, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1503, p5l55a_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1504, p5jhsa_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1505, d5d0sM_, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1506, p5d0sa_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1507, p5cghM_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1508, p5cgha_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1509, p4y84M_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1510, p4y84a_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1511, p4y6aM_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1512, p4y6aa_, 0.8272, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1513, d4qvwM_, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1514, p4qvwa_, 0.8272, 2.20, 0.156, 218, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1515, d4qvpM_, 0.8272, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1516, p4qvpa_, 0.8272, 2.20, 0.156, 218, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1517, d4qlqM_, 0.8272, 2.20, 0.156, 233, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1518, p4qlqa_, 0.8272, 2.20, 0.156, 218, 205, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1519, d4j70M_, 0.8272, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1520, d4fzcM_, 0.8272, 2.35, 0.155, 233, 206, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1521, p4fzca_, 0.8272, 2.35, 0.155, 218, 206, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1522, d4eu2N_, 0.8272, 2.35, 0.155, 233, 206, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1523, p3un8a_, 0.8272, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1524, d3tdd1_, 0.8272, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1525, d3okjM_, 0.8272, 2.33, 0.155, 233, 206, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1526, d3gptM_, 0.8272, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1527, p5nif2_, 0.8271, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1528, p5mpcN_, 0.8271, 2.33, 0.155, 218, 206, 
1529, d5l5xM_, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1530, p5l5xa_, 0.8271, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1531, d5jhsM_, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1532, d5cz9M_, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1533, p5cz9a_, 0.8271, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1534, d5cz7M_, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1535, p5cz7a_, 0.8271, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1536, d4rurM_, 0.8271, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1537, d4qz0M_, 0.8271, 2.20, 0.156, 233, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1538, p4qz0a_, 0.8271, 2.20, 0.156, 218, 205, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1539, d4qwlM_, 0.8271, 2.20, 0.156, 233, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1540, p4qwla_, 0.8271, 2.20, 0.156, 218, 205, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1541, p4ltca_, 0.8271, 2.21, 0.156, 218, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1542, p4hrda_, 0.8271, 2.20, 0.156, 218, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1543, d3tddM_, 0.8271, 2.34, 0.155, 233, 206, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1544, d3mg81_, 0.8271, 2.20, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1545, d1jd2M_, 0.8271, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1546, d5jhrM_, 0.8270, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1547, p5jhra_, 0.8270, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1548, p5fghM_, 0.8270, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1549, p5fgha_, 0.8270, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1550, d5d0tM_, 0.8270, 2.20, 0.156, 231, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1551, p5d0ta_, 0.8270, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1552, p5cz4a_, 0.8270, 2.33, 0.155, 218, 206, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1553, p5a5b3_, 0.8270, 1.95, 0.224, 204, 201, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
1554, d4z1lM_, 0.8270, 2.20, 0.156, 229, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1555, p4y8na_, 0.8270, 2.20, 0.156, 223, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1556, p4qw7a_, 0.8270, 2.20, 0.156, 218, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1557, p4fzga_, 0.8270, 2.21, 0.156, 218, 205, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1558, p4cr33_, 0.8270, 1.95, 0.224, 204, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1559, d3un8M_, 0.8270, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1560, d3oeu1_, 0.8270, 2.21, 0.156, 233, 205, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1561, p5mp97_, 0.8269, 2.21, 0.151, 218, 205, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1562, p5l5ea_, 0.8269, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1563, d5fgiM_, 0.8269, 2.08, 0.157, 232, 204, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1564, d5d0zM_, 0.8269, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1565, p5d0za_, 0.8269, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1566, p4y8uM_, 0.8269, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1567, p4y8ua_, 0.8269, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1568, d4r00M_, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1569, p4r00a_, 0.8269, 2.20, 0.156, 218, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1570, d4qw7M_, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1571, d4qvmM_, 0.8269, 2.20, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1572, p4qvma_, 0.8269, 2.20, 0.156, 218, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1573, d4no6M_, 0.8269, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1574, p4no6a_, 0.8269, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1575, p4hnpa_, 0.8269, 2.20, 0.156, 218, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1576, p4gk7M_, 0.8269, 2.35, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1577, p4gk7a_, 0.8269, 2.35, 0.155, 218, 206, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1578, p3un4M_, 0.8269, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1579, p3un4a_, 0.8269, 2.21, 0.156, 217, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1580, d1g651_, 0.8269, 2.20, 0.156, 233, 205, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1581, d5l5eM_, 0.8268, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1582, d5l52M_, 0.8268, 2.20, 0.156, 225, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1583, p5l52a_, 0.8268, 2.20, 0.156, 215, 205, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1584, p5fgia_, 0.8268, 2.08, 0.157, 217, 204, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1585, p4ya9M_, 0.8268, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1586, p4ya9a_, 0.8268, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1587, p4ya2M_, 0.8268, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1588, p4ya2a_, 0.8268, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1589, d4no8M_, 0.8268, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1590, p4no8a_, 0.8268, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1591, d5fhsM_, 0.8267, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1592, p5fhsa_, 0.8267, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1593, d5fgeM_, 0.8267, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1594, p5fgea_, 0.8267, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1595, p4ya3M_, 0.8267, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1596, p4ya3a_, 0.8267, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1597, p4y8kM_, 0.8267, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1598, p4y8ka_, 0.8267, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1599, d4qw5M_, 0.8267, 2.21, 0.156, 233, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1600, p4qw5a_, 0.8267, 2.21, 0.156, 218, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1601, d4qw4M_, 0.8267, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH CARFILZOMIB
1602, p4qw4a_, 0.8267, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH CARFILZOMIB
1603, d1z7qN1, 0.8267, 2.33, 0.155, 233, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1604, d1rypV_, 0.8267, 2.02, 0.225, 205, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1605, p5dkia_, 0.8266, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1606, p4y77a_, 0.8266, 2.21, 0.156, 223, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1607, p1z7qb_, 0.8266, 2.32, 0.155, 217, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1608, d5fgfM_, 0.8265, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1609, p5fgfa_, 0.8265, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1610, d5d0vM_, 0.8265, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1611, p5d0va_, 0.8265, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1612, d4qz6M_, 0.8265, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1613, p4qz6a_, 0.8265, 2.21, 0.156, 218, 205, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1614, d4qz4M_, 0.8265, 2.21, 0.156, 225, 205, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1615, p4qz4a_, 0.8265, 2.21, 0.156, 215, 205, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1616, d4qz1M_, 0.8265, 2.21, 0.156, 231, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1617, p4qz1a_, 0.8265, 2.21, 0.156, 218, 205, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1618, p5t0cLB_, 0.8264, 2.03, 0.203, 205, 202, 
1619, p5t0cFA_, 0.8264, 2.03, 0.203, 205, 202, 
1620, d5fgdM_, 0.8264, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1621, p5fgda_, 0.8264, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1622, p4ya7M_, 0.8264, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1623, p4ya7a_, 0.8264, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1624, p4ya0M_, 0.8264, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1625, p4ya0a_, 0.8264, 2.34, 0.155, 218, 206, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1626, p4y81a_, 0.8264, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1627, d4qwxM_, 0.8264, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1628, p4qwxa_, 0.8264, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1629, d4qw0M_, 0.8264, 2.21, 0.156, 233, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1630, p4qw0a_, 0.8264, 2.21, 0.156, 218, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1631, d4ltcM_, 0.8264, 2.22, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1632, d3mg01_, 0.8264, 2.22, 0.156, 233, 205, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1633, d1g65M_, 0.8264, 2.21, 0.156, 233, 205, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1634, p1fntb_, 0.8264, 2.33, 0.155, 217, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1635, d5d0xM_, 0.8263, 2.20, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1636, p5d0xa_, 0.8263, 2.20, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1637, p5cgiM_, 0.8263, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1638, p5cgia_, 0.8263, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1639, p4y8qM_, 0.8263, 2.21, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1640, p4y8qa_, 0.8263, 2.21, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1641, p4y82M_, 0.8263, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1642, p4y82a_, 0.8263, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1643, p4y81M_, 0.8263, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1644, d4qz2M_, 0.8263, 2.21, 0.156, 233, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1645, p4qz2a_, 0.8263, 2.21, 0.156, 218, 205, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1646, d4qw3M_, 0.8263, 2.20, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1647, p4qw3a_, 0.8263, 2.21, 0.156, 218, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1648, d5cz4M_, 0.8262, 2.21, 0.156, 229, 205, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1649, p4y8lM_, 0.8262, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1650, p4y8la_, 0.8262, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1651, p4y74M_, 0.8262, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1652, p4y74a_, 0.8262, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1653, d4qz3M_, 0.8262, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1654, p4qz3a_, 0.8262, 2.21, 0.156, 218, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1655, d4qwrM_, 0.8262, 2.21, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1656, p4qwra_, 0.8262, 2.21, 0.156, 218, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1657, d4qwkM_, 0.8262, 2.21, 0.156, 230, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1658, p4qwka_, 0.8262, 2.21, 0.156, 218, 205, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1659, d4no1M_, 0.8262, 2.22, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1660, p4no1a_, 0.8262, 2.22, 0.156, 218, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1661, d4nnnM_, 0.8262, 2.22, 0.156, 233, 205, YCP IN COMPLEX WITH MG132
1662, p4nnna_, 0.8262, 2.22, 0.156, 218, 205, YCP IN COMPLEX WITH MG132
1663, d3mg0M_, 0.8262, 2.22, 0.156, 233, 205, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1664, p1fntN_, 0.8262, 2.33, 0.155, 217, 206, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1665, d5cz5M_, 0.8261, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1666, p5cz5a_, 0.8261, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1667, p4zzgN_, 0.8261, 2.23, 0.156, 216, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1668, p4y9zM_, 0.8261, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1669, p4y9za_, 0.8261, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1670, p4y7xM_, 0.8261, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1671, p4y7xa_, 0.8261, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1672, p4y6zM_, 0.8261, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1673, p4y6za_, 0.8261, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1674, p4x6z2_, 0.8261, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1675, p4qz5a_, 0.8261, 2.21, 0.156, 215, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1676, d4no9M_, 0.8261, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1677, p4no9a_, 0.8261, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1678, p5nifN_, 0.8260, 2.23, 0.156, 216, 205, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1679, d4qz5M_, 0.8260, 2.21, 0.156, 225, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1680, d4hrdM_, 0.8260, 2.22, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1681, d5cz8M_, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1682, p5cz8a_, 0.8259, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1683, p4y8sM_, 0.8259, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1684, p4y8sa_, 0.8259, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1685, p4y8oM_, 0.8259, 2.21, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1686, p4y8oa_, 0.8259, 2.21, 0.156, 222, 205, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1687, p4y8iM_, 0.8259, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1688, p4y8ia_, 0.8259, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1689, d4qzwM_, 0.8259, 2.21, 0.156, 233, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1690, p4qzwa_, 0.8259, 2.21, 0.156, 218, 205, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1691, d4qwiM_, 0.8259, 2.21, 0.156, 233, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1692, p4qwia_, 0.8259, 2.21, 0.156, 218, 205, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1693, d4nnwM_, 0.8259, 2.21, 0.156, 233, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1694, p4nnwa_, 0.8259, 2.21, 0.156, 218, 205, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1695, d3wxr2_, 0.8259, 2.21, 0.156, 233, 205, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1696, p4y80M_, 0.8258, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1697, p4y80a_, 0.8258, 2.21, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1698, p4y8jM_, 0.8257, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1699, p4y8ja_, 0.8257, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1700, p4qwsa_, 0.8257, 2.21, 0.156, 218, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1701, d4qwgM_, 0.8257, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1702, p4y70M_, 0.8256, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1703, p4y70a_, 0.8256, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1704, d4qwsM_, 0.8256, 2.21, 0.156, 233, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1705, p4qwga_, 0.8256, 2.21, 0.156, 218, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1706, p4y7wM_, 0.8255, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1707, p4y7wa_, 0.8255, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1708, p4x6zN_, 0.8255, 2.23, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1709, d4qzxM_, 0.8255, 2.21, 0.156, 231, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1710, p4qzxa_, 0.8255, 2.21, 0.156, 218, 205, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1711, d4qvvM_, 0.8255, 2.21, 0.156, 233, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1712, p4qvva_, 0.8255, 2.21, 0.156, 218, 205, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1713, p4y8pM_, 0.8254, 2.15, 0.157, 214, 204, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1714, p4y8nM_, 0.8254, 2.14, 0.157, 214, 204, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1715, p4y7yM_, 0.8254, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1716, p4y7ya_, 0.8254, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1717, d4qxjM_, 0.8254, 2.22, 0.156, 228, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1718, p4qxja_, 0.8254, 2.22, 0.156, 216, 205, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1719, d4qwjM_, 0.8254, 2.21, 0.156, 230, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1720, p4qwja_, 0.8254, 2.21, 0.156, 218, 205, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1721, p5mpbBA_, 0.8253, 2.45, 0.155, 218, 207, 
1722, p4y8pa_, 0.8253, 2.15, 0.157, 214, 204, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1723, p4y75M_, 0.8253, 2.16, 0.157, 214, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1724, p4y75a_, 0.8253, 2.16, 0.157, 214, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1725, p4y78M_, 0.8251, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1726, p4y78a_, 0.8250, 2.22, 0.156, 218, 205, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1727, p4y77M_, 0.8250, 2.15, 0.157, 214, 204, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1728, d4hrcM_, 0.8248, 2.24, 0.156, 233, 205, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1729, p4v7oBA_, 0.8237, 2.37, 0.155, 217, 206, 
1730, d3l5q4_, 0.8237, 2.37, 0.155, 233, 206,  
1731, p4v7oVA_, 0.8236, 2.37, 0.155, 217, 206, 
1732, d1vsyN_, 0.8236, 2.37, 0.155, 233, 206,  
1733, p4v7oN_, 0.8235, 2.37, 0.155, 217, 206, 
1734, d3l5qR_, 0.8235, 2.37, 0.155, 233, 206,  
1735, p4v7oJB_, 0.8234, 2.38, 0.155, 217, 206, 
1736, d1vsy2_, 0.8234, 2.38, 0.155, 233, 206,  
1737, p3jcpC_, 0.8233, 2.09, 0.225, 205, 200, 
1738, p5wviKA_, 0.8228, 2.27, 0.151, 217, 205, 
1739, p3jcpQA_, 0.8228, 2.10, 0.225, 205, 200, 
1740, p5mpbN_, 0.8223, 2.47, 0.159, 222, 207, 
1741, d5cz8K_, 0.8221, 2.21, 0.187, 220, 203, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1742, d5cz8Y_, 0.8220, 2.35, 0.186, 221, 204, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1743, p5a0qM_, 0.8219, 1.17, 0.495, 190, 190, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1744, p5a0qa_, 0.8219, 1.17, 0.495, 190, 190, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1745, d5fg7V_, 0.8217, 1.88, 0.191, 228, 199, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1746, d5fg7H_, 0.8215, 1.89, 0.191, 228, 199, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1747, p5t0gT_, 0.8213, 2.08, 0.203, 205, 202, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1748, d5fgeK_, 0.8209, 2.12, 0.194, 218, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1749, p3jcoI_, 0.8209, 2.29, 0.151, 217, 205, 
1750, p3jcoB_, 0.8209, 2.29, 0.151, 217, 205, 
1751, p5t0iT_, 0.8207, 2.16, 0.202, 205, 203, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1752, d5fgeY_, 0.8206, 2.11, 0.194, 218, 201, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1753, p5wviE_, 0.8204, 2.08, 0.224, 204, 201, 
1754, p5wviGA_, 0.8201, 2.02, 0.229, 204, 201, 
1755, p5wviPA_, 0.8198, 2.30, 0.151, 217, 205, 
1756, p3jcoC_, 0.8197, 2.06, 0.226, 205, 199, 
1757, p3jcoQA_, 0.8196, 2.07, 0.226, 205, 199, 
1758, d4r3oY_, 0.8194, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME
1759, d4r3oK_, 0.8194, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME
1760, p5mpcBA_, 0.8193, 2.37, 0.155, 218, 206, 
1761, p5gjrQA_, 0.8190, 1.74, 0.230, 199, 196, 
1762, p5gjrCA_, 0.8190, 1.74, 0.230, 199, 196, 
1763, d4r67Y_, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1764, p4r67m_, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1765, d4r67K_, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1766, d4r670_, 0.8189, 1.74, 0.230, 199, 196, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1767, p5gjqr_, 0.8184, 1.79, 0.230, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1768, d1iruY_, 0.8180, 1.76, 0.230, 199, 196, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1769, d1iruK_, 0.8180, 1.76, 0.230, 199, 196, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1770, p5gjqd_, 0.8178, 1.76, 0.230, 199, 196, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1771, p6epc6_, 0.8166, 2.57, 0.048, 213, 209, GROUND STATE 26S PROTEASOME (GS2)
1772, p5t0jT_, 0.8165, 2.15, 0.208, 205, 202, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1773, d5fgdY_, 0.8165, 2.05, 0.196, 216, 199, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1774, d3wxrV_, 0.8165, 1.63, 0.232, 199, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1775, p5ln33_, 0.8160, 2.19, 0.223, 205, 202, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
1776, d5d0vK_, 0.8160, 2.23, 0.194, 218, 201, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1777, p5wvkG_, 0.8158, 2.32, 0.156, 217, 205, 
1778, d5cz7Y_, 0.8153, 2.14, 0.200, 217, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1779, p5l4gW_, 0.8151, 1.83, 0.230, 199, 196, 
1780, p5l4gI_, 0.8148, 1.83, 0.230, 199, 196, 
1781, d5cz7K_, 0.8148, 2.15, 0.200, 217, 200, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1782, d5fg9H_, 0.8144, 1.86, 0.193, 230, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1783, d5fg9V_, 0.8143, 1.86, 0.193, 230, 197, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1784, p3unbl_, 0.8138, 1.63, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1785, p6avoV_, 0.8132, 1.65, 0.232, 196, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1786, p6avoT_, 0.8132, 1.65, 0.232, 196, 194, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1787, d3unbJ_, 0.8131, 1.64, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1788, d5fgdK_, 0.8128, 2.04, 0.197, 215, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1789, d3unbX_, 0.8127, 1.65, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1790, p3unbz_, 0.8126, 1.65, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1791, p5vy4Z_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1792, p5vy4X_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1793, p5vy4V_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1794, p5vy4T_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1795, p5vy4R_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1796, p5vy4P_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1797, p5vy4N_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1798, p5vy4L_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1799, p5vy4J_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1800, p5vy4H_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1801, p5vy4F_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1802, p5vy4D_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1803, p5vy4BA_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1804, p5vy4B_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1805, p5vy41_, 0.8125, 1.63, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
1806, p3unhX_, 0.8124, 1.66, 0.232, 196, 194, MOUSE 20S IMMUNOPROTEASOME
1807, p3unhJ_, 0.8124, 1.66, 0.232, 196, 194, MOUSE 20S IMMUNOPROTEASOME
1808, d3okj1_, 0.8124, 2.42, 0.147, 228, 204, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1809, p3uneJ_, 0.8123, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1810, d3unfX_, 0.8121, 1.66, 0.232, 196, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1811, d3unfJ_, 0.8121, 1.66, 0.232, 196, 194, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1812, p5t0jP_, 0.8120, 2.26, 0.214, 204, 201, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1813, p3unez_, 0.8120, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1814, p3uneX_, 0.8117, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1815, p3unel_, 0.8117, 1.66, 0.232, 196, 194, MOUSE CONSTITUTIVE 20S PROTEASOME
1816, d1pmaY_, 0.8112, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1817, d1pmaX_, 0.8112, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1818, d3c92X1, 0.8111, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1819, d3c92J1, 0.8111, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1820, d3c91X1, 0.8111, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1821, d3c91J1, 0.8111, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1822, d1pmaQ_, 0.8111, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1823, p5vy3Z_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1824, p5vy3X_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1825, p5vy3V_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1826, p5vy3T_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1827, p5vy3R_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1828, p5vy3P_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1829, p5vy3N_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1830, p5vy3L_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1831, p5vy3J_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1832, p5vy3H_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1833, p5vy3F_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1834, p5vy3D_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1835, p5vy3B_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1836, p5vy31_, 0.8110, 1.66, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
1837, d3c92W1, 0.8110, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1838, d3c92N1, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1839, d3c92I1, 0.8110, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1840, d3c9221, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1841, d3c91W1, 0.8110, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1842, d3c91N1, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1843, d3c91I1, 0.8110, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1844, d3c9121, 0.8110, 1.64, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1845, d1pmaV_, 0.8110, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1846, d1pmaU_, 0.8110, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1847, d1pmaP_, 0.8110, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1848, d1pma1_, 0.8110, 1.64, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1849, p5t0hT_, 0.8109, 2.12, 0.208, 205, 202, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1850, d3c92M1, 0.8108, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1851, d3c9211, 0.8108, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1852, d3c91M1, 0.8108, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1853, d3c9111, 0.8108, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1854, d1pmaT_, 0.8108, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1855, d4cr21_, 0.8107, 2.34, 0.224, 205, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1856, d3c92Z1, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1857, d3c92L1, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1858, d3c91Z1, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1859, d3c91L1, 0.8107, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1860, d1pmaS_, 0.8107, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1861, d1pma2_, 0.8107, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1862, d1pmaW_, 0.8106, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1863, d3c92V1, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1864, d3c92H1, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1865, d3c91V1, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1866, d3c91H1, 0.8104, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1867, d1pmaB_, 0.8104, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1868, p4cr47_, 0.8103, 2.65, 0.155, 220, 207, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1869, d3c92Y1, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1870, d3c92K1, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
1871, d3c91Y1, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1872, d3c91K1, 0.8103, 1.65, 0.219, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
1873, d1pmaR_, 0.8103, 1.65, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1874, d1yauJ_, 0.8102, 1.65, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1875, d1yauI_, 0.8101, 1.65, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1876, d1pmaZ_, 0.8101, 1.66, 0.219, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
1877, d1yauK_, 0.8100, 1.64, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1878, d1yauH_, 0.8100, 1.65, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1879, d5lexX_, 0.8099, 1.71, 0.237, 195, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1880, d5le5J_, 0.8099, 1.71, 0.237, 195, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1881, d5lf7J_, 0.8098, 1.71, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1882, d5lexJ_, 0.8098, 1.71, 0.237, 195, 194, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1883, d5le5X_, 0.8098, 1.71, 0.237, 195, 194, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1884, d1yarK_, 0.8098, 1.67, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1885, d1g0uN_, 0.8098, 1.90, 0.228, 196, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1886, d3jseH_, 0.8097, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1887, d1ya7K_, 0.8097, 1.65, 0.224, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1888, d1ya7I_, 0.8097, 1.67, 0.219, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1889, d1ya7H_, 0.8097, 1.67, 0.224, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1890, p5vfon_, 0.8096, 1.51, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1891, d1yarI_, 0.8096, 1.67, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1892, d1g0u2_, 0.8096, 1.90, 0.228, 196, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1893, d5lf7X_, 0.8095, 1.71, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1894, d5lf4J_, 0.8095, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1895, p5leyJ_, 0.8095, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1896, d3jseL_, 0.8095, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1897, d3jseK_, 0.8095, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1898, d3jseJ_, 0.8095, 1.67, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1899, d3jseI_, 0.8095, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1900, d3jrmJ_, 0.8095, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1901, d1yarJ_, 0.8095, 1.68, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1902, d5lf3J_, 0.8094, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1903, p5lezJ_, 0.8094, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1904, p5leyX_, 0.8094, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1905, d3jseM_, 0.8094, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1906, d3jrmK_, 0.8094, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1907, d3jrmI_, 0.8094, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1908, d3jrmH_, 0.8094, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1909, d1yarL_, 0.8094, 1.54, 0.220, 203, 191, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1910, d1ya7J_, 0.8094, 1.67, 0.219, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1911, p5lf0J_, 0.8093, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1912, p5lezX_, 0.8093, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1913, d4cr27_, 0.8093, 2.58, 0.155, 233, 207, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1914, p3jtlN_, 0.8093, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1915, p3jtlH_, 0.8093, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1916, d3jseN_, 0.8093, 1.67, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1917, d3jrmM_, 0.8093, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1918, d3jrmL_, 0.8093, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1919, d1yarH_, 0.8093, 1.68, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
1920, d5lf4X_, 0.8092, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1921, p5l4gM_, 0.8092, 1.64, 0.234, 200, 192, 
1922, p5l4gAA_, 0.8092, 1.65, 0.234, 199, 192, 
1923, p3jtlM_, 0.8092, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1924, p3jtlL_, 0.8092, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1925, p3jtlK_, 0.8092, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1926, p3jtlJ_, 0.8092, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1927, p3jtlI_, 0.8092, 1.66, 0.219, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1928, d1yauN_, 0.8092, 1.65, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1929, p5lf6J_, 0.8091, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1930, d5lf3X_, 0.8091, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1931, d4qwjN_, 0.8091, 1.73, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1932, p4qwjb_, 0.8091, 1.73, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1933, d4eu2H_, 0.8091, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1934, d3jrmN_, 0.8091, 1.67, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
1935, d5lf1J_, 0.8090, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1936, p5lf0X_, 0.8090, 1.73, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1937, d5lajN_, 0.8090, 1.72, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1938, p5lajb_, 0.8090, 1.72, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1939, d4r18N_, 0.8090, 1.72, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1940, d5lf1X_, 0.8089, 1.72, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1941, d4r18b_, 0.8089, 1.72, 0.229, 196, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1942, d1yauL_, 0.8089, 1.67, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
1943, d5l55N_, 0.8088, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1944, p5l55b_, 0.8088, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1945, d5jhsN_, 0.8088, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1946, p5jhsb_, 0.8088, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1947, p4y8mb_, 0.8088, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1948, p4x6zV_, 0.8088, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1949, d4qzxN_, 0.8088, 1.74, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1950, d4eu2V_, 0.8088, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1951, p6avoD_, 0.8087, 1.70, 0.202, 201, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1952, p6avoC_, 0.8087, 1.70, 0.202, 201, 193, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1953, p5lf6X_, 0.8087, 1.73, 0.237, 195, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1954, d5cz9N_, 0.8087, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1955, p5cz9b_, 0.8087, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1956, d4y8mN_, 0.8087, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1957, p4y7xN_, 0.8087, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1958, p4y7xb_, 0.8087, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1959, p4x6zH_, 0.8087, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1960, p4qzxb_, 0.8087, 1.74, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1961, d5l52N_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1962, p5l52b_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1963, d5fhsN_, 0.8086, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1964, p5fhsb_, 0.8086, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1965, p5cgiN_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1966, p5cghN_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1967, p5cggN_, 0.8086, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1968, p5cggb_, 0.8086, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1969, p4ya1b_, 0.8086, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1970, p4y80N_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1971, p4y80b_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1972, d4qxjN_, 0.8086, 1.75, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1973, p4qxjb_, 0.8086, 1.75, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1974, d4no8N_, 0.8086, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1975, p4no8b_, 0.8086, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1976, p4inub_, 0.8086, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1977, d3mkaP_, 0.8086, 2.32, 0.180, 250, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
1978, d1ya7N_, 0.8086, 1.68, 0.219, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
1979, p5nifH_, 0.8085, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1980, d5lttY_, 0.8085, 1.87, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1981, d5lttK_, 0.8085, 1.87, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1982, d5jhrN_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1983, p5jhrb_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1984, d5d0zN_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1985, p5cgib_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1986, p5cghb_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1987, p4ya5N_, 0.8085, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1988, p4ya5b_, 0.8085, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1989, p4ya3b_, 0.8085, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1990, p4y7yN_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1991, p4y7yb_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1992, p4y6vN_, 0.8085, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1993, d4qwsN_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1994, p4qwsb_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1995, d4qwkN_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1996, p4qwkb_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1997, d4qwiN_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1998, p4qwib_, 0.8085, 1.74, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1999, d4ltcN_, 0.8085, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2000, d4intN_, 0.8085, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2001, d1ya7L_, 0.8085, 1.69, 0.224, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
2002, d5l54N_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2003, p5l54b_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2004, d5fg7N_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2005, p5d0zb_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2006, d5d0sN_, 0.8084, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2007, p5d0sb_, 0.8084, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2008, d5cgfN_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2009, p5cgfb_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2010, p4zzgH_, 0.8084, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2011, p4ya3N_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2012, d4ya1N_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2013, d4y9yN_, 0.8084, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2014, p4y8qN_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2015, p4y82N_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2016, d4qv3N_, 0.8084, 1.76, 0.229, 196, 192, YCP BETA5-M45V MUTANT
2017, p4qv3b_, 0.8084, 1.76, 0.229, 196, 192, YCP BETA5-M45V MUTANT
2018, d4no9N_, 0.8084, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2019, p4no9b_, 0.8084, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2020, p4ltcb_, 0.8084, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2021, d4jt0N_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2022, p4jt0b_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2023, d4jsqN_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2024, p4jsqb_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2025, p4intb_, 0.8084, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2026, d4hnpN_, 0.8084, 1.56, 0.230, 196, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2027, d3tddN_, 0.8084, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2028, d3tdd2_, 0.8084, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2029, d1g65N_, 0.8084, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2030, d5fgeN_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2031, d5fgdN_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2032, p5fgdb_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2033, p5fg7b_, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2034, p4y8qb_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2035, p4y82b_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2036, p4y6vb_, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2037, p4y6aN_, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2038, p4y6ab_, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2039, p4y69b_, 0.8083, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2040, d4qlvN_, 0.8083, 1.73, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2041, d4qlvb_, 0.8083, 1.73, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2042, d4qlsN_, 0.8083, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2043, d4qlsb_, 0.8083, 1.72, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2044, d4inuN_, 0.8083, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2045, d4hrdN_, 0.8083, 1.73, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2046, d4hrcN_, 0.8083, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2047, p4hnpb_, 0.8083, 1.55, 0.230, 196, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2048, d3sdi2_, 0.8083, 1.55, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2049, p5m32X_, 0.8082, 1.72, 0.232, 196, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2050, d5l5vY_, 0.8082, 1.88, 0.206, 211, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2051, d5l5qY_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2052, d5l5qK_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2053, d5l5pY_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2054, d5l5pK_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2055, d5l5hY_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2056, d5l5hK_, 0.8082, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2057, p5fgeb_, 0.8082, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2058, p4zzgV_, 0.8082, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2059, p4y8uN_, 0.8082, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2060, p4y78b_, 0.8082, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2061, p4y69N_, 0.8082, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2062, d4qz3N_, 0.8082, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2063, d4qwgN_, 0.8082, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2064, p4qwgb_, 0.8082, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2065, d4qlqN_, 0.8082, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2066, d4qlqb_, 0.8082, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2067, p4inrb_, 0.8082, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2068, d4g4sH_, 0.8082, 1.56, 0.230, 196, 191, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2069, d2gplN_, 0.8082, 1.73, 0.229, 196, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2070, d2gpl2_, 0.8082, 1.73, 0.229, 196, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2071, p5ln37_, 0.8081, 2.49, 0.191, 218, 204, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2072, d5l5vK_, 0.8081, 1.88, 0.206, 211, 194,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2073, d5l5oY_, 0.8081, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2074, d5l5oK_, 0.8081, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2075, p4y8ub_, 0.8081, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2076, p4y78N_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2077, p4y77N_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2078, p4y70N_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2079, p4y70b_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2080, d4r00N_, 0.8081, 1.74, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2081, p4r00b_, 0.8081, 1.74, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2082, d4qzwN_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2083, p4qzwb_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2084, d4qz7N_, 0.8081, 1.76, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2085, p4qz7b_, 0.8081, 1.76, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2086, p4qz3b_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2087, d4qz2N_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2088, p4qz2b_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2089, d4qz0N_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2090, p4qz0b_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2091, d4qwxN_, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2092, p4qwxb_, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2093, d4qwrN_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2094, p4qwrb_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2095, d4qwlN_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2096, p4qwlb_, 0.8081, 1.75, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2097, d4no1N_, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2098, p4no1b_, 0.8081, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2099, d4j70N_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2100, p4j70b_, 0.8081, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2101, d4inrN_, 0.8081, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2102, p4hrcb_, 0.8081, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2103, d3okjN_, 0.8081, 1.75, 0.229, 196, 192, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2104, d3mg4N_, 0.8081, 1.56, 0.230, 196, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2105, d3e47N_, 0.8081, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2106, d3dy42_, 0.8081, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2107, d1g652_, 0.8081, 1.75, 0.229, 196, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2108, p5vfpFA_, 0.8080, 1.54, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2109, p5vfoN_, 0.8080, 1.54, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2110, p5nifV_, 0.8080, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2111, p5mp91_, 0.8080, 1.55, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2112, d5fggN_, 0.8080, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2113, p5fggb_, 0.8080, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2114, d5cz8N_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2115, p5cz8b_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2116, p4y81N_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2117, p4y81b_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2118, p4y77b_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2119, p4y6zb_, 0.8080, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2120, d4qz6N_, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2121, p4qz6b_, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2122, d4qw7N_, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2123, p4qw7b_, 0.8080, 1.75, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2124, d4qw4N_, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH CARFILZOMIB
2125, p4qw4b_, 0.8080, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH CARFILZOMIB
2126, d4qv7N_, 0.8080, 1.74, 0.229, 196, 192, YCP BETA5-A50V MUTANT
2127, p4qv7b_, 0.8080, 1.74, 0.229, 196, 192, YCP BETA5-A50V MUTANT
2128, d4qltN_, 0.8080, 1.73, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2129, d4qltb_, 0.8080, 1.73, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2130, p3un4N_, 0.8080, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2131, p3un4b_, 0.8080, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2132, d3e472_, 0.8080, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2133, d1yarN_, 0.8080, 1.71, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2134, p5mp9h_, 0.8079, 1.56, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2135, p5m32J_, 0.8079, 1.72, 0.232, 196, 194, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2136, d5l5sY_, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2137, d5l5sK_, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2138, d5l5jY_, 0.8079, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2139, d4z1lN_, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2140, p4z1lb_, 0.8079, 1.56, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2141, d4y8rN_, 0.8079, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2142, p4y8kN_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2143, p4y8kb_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2144, p4y8jN_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2145, p4y84N_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2146, p4y84b_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2147, p4y7wN_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2148, p4y7wb_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2149, p4y6zN_, 0.8079, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2150, p4v7oV_, 0.8079, 1.56, 0.230, 196, 191, 
2151, p4v7oPA_, 0.8079, 1.56, 0.230, 196, 191, 
2152, d4qz5N_, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2153, p4qz5b_, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2154, d4qw6N_, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2155, p4qw6b_, 0.8079, 1.75, 0.229, 196, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2156, d4quyN_, 0.8079, 1.77, 0.229, 196, 192, YCP BETA5-A49S-MUTANT
2157, p4quyb_, 0.8079, 1.77, 0.229, 196, 192, YCP BETA5-A49S-MUTANT
2158, d3wxrH_, 0.8079, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2159, d3shjN_, 0.8079, 1.73, 0.229, 196, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2160, d3shj2_, 0.8079, 1.73, 0.229, 196, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2161, d3nzjN_, 0.8079, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2162, d3nzj2_, 0.8079, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2163, d3mg42_, 0.8079, 1.56, 0.230, 196, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2164, d3gpjN_, 0.8079, 1.56, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2165, d3gpj2_, 0.8079, 1.56, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2166, d3dy3N_, 0.8079, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2167, d2fakN_, 0.8079, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2168, d2fak2_, 0.8079, 1.73, 0.229, 196, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2169, d1yauM_, 0.8079, 1.69, 0.224, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
2170, d5lttN_, 0.8078, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2171, p5lttb_, 0.8078, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2172, d5l5uY_, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2173, d5l5uK_, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2174, d5l5tN_, 0.8078, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2175, d5l5jK_, 0.8078, 1.88, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2176, d5l5eN_, 0.8078, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2177, d5fgfN_, 0.8078, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2178, p5fgfb_, 0.8078, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2179, d5cz4N_, 0.8078, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2180, p5cz4b_, 0.8078, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2181, p4y8oN_, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2182, p4y8ob_, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2183, p4y8lb_, 0.8078, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2184, p4y8jb_, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2185, p4y8hN_, 0.8078, 1.72, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2186, p4y75b_, 0.8078, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2187, d4r67Z_, 0.8078, 1.90, 0.201, 201, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2188, d4r67L_, 0.8078, 1.90, 0.201, 201, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2189, d4qw5N_, 0.8078, 1.76, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2190, p4qw5b_, 0.8078, 1.76, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2191, d4qv5N_, 0.8078, 1.77, 0.229, 196, 192, YCP BETA5-M45I MUTANT
2192, p4qv5b_, 0.8078, 1.77, 0.229, 196, 192, YCP BETA5-M45I MUTANT
2193, d4no6N_, 0.8078, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2194, p4no6b_, 0.8078, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2195, d3mg62_, 0.8078, 1.56, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2196, d3gptN_, 0.8078, 1.73, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2197, d3gpt2_, 0.8078, 1.73, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2198, d3dy32_, 0.8078, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2199, d3bdmN_, 0.8078, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2200, d3bdm1_, 0.8078, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2201, d2fnyN_, 0.8078, 1.73, 0.229, 196, 192,  
2202, d2fny2_, 0.8078, 1.73, 0.229, 196, 192,  
2203, p4y8lN_, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2204, p4y8hb_, 0.8077, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2205, p4y74b_, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2206, p4v7oH_, 0.8077, 1.56, 0.230, 196, 191, 
2207, p4r67n_, 0.8077, 1.90, 0.201, 201, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2208, d4qz4N_, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2209, p4qz4b_, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2210, d4qwfN_, 0.8077, 1.75, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2211, p4qwfb_, 0.8077, 1.76, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2212, d4qv8N_, 0.8077, 1.74, 0.229, 196, 192, YCP BETA5-C52F MUTANT
2213, p4qv8b_, 0.8077, 1.75, 0.229, 196, 192, YCP BETA5-C52F MUTANT
2214, d3un8N_, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2215, p3un8b_, 0.8077, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2216, d3nzx2_, 0.8077, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2217, d3mg72_, 0.8077, 1.56, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2218, p3j9iZ_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2219, p3j9iY_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2220, p3j9iX_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2221, p3j9iW_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2222, p3j9iV_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2223, p3j9iN_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2224, p3j9iM_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2225, p3j9iL_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2226, p3j9iK_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2227, p3j9iJ_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2228, p3j9iI_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2229, p3j9iH_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2230, p3j9i2_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2231, p3j9i1_, 0.8077, 1.87, 0.214, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
2232, d3dy4N_, 0.8077, 1.56, 0.230, 196, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2233, d5fgfY_, 0.8076, 2.05, 0.203, 214, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2234, d5ahjN_, 0.8076, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2235, p5ahjb_, 0.8076, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2236, p4y8ib_, 0.8076, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2237, p4y75N_, 0.8076, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2238, d4qvvN_, 0.8076, 1.77, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2239, p4qvvb_, 0.8076, 1.77, 0.229, 196, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2240, d3sdiN_, 0.8076, 1.58, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2241, d3nzxN_, 0.8076, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2242, d3mkaG_, 0.8076, 2.20, 0.181, 251, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2243, d3gpwN_, 0.8076, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2244, p4y9yb_, 0.8075, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2245, p4y8iN_, 0.8075, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2246, p4y74N_, 0.8075, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2247, d4r02N_, 0.8075, 1.74, 0.229, 196, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2248, d4qz1N_, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2249, p4qz1b_, 0.8075, 1.76, 0.229, 196, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2250, d4qvyN_, 0.8075, 1.77, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2251, p4qvyb_, 0.8075, 1.77, 0.229, 196, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2252, d4qv9N_, 0.8075, 1.75, 0.229, 196, 192, YCP BETA5-C63F MUTANT
2253, d4qv0N_, 0.8075, 1.75, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2254, p4qv0b_, 0.8075, 1.75, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2255, d4qluN_, 0.8075, 1.74, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2256, d4qlub_, 0.8075, 1.74, 0.229, 196, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2257, d4jsuN_, 0.8075, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2258, p4jsub_, 0.8075, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2259, d3mkaT_, 0.8075, 2.34, 0.180, 250, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2260, d3gpw2_, 0.8075, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2261, p5vfqGA_, 0.8074, 1.54, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2262, p5lezK_, 0.8074, 1.91, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2263, d5laiN_, 0.8074, 1.57, 0.230, 196, 191, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2264, p5laib_, 0.8074, 1.57, 0.230, 196, 191, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2265, d5l65N_, 0.8074, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2266, p5l65b_, 0.8074, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2267, d5l5vN_, 0.8074, 1.75, 0.229, 196, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2268, p5l5vb_, 0.8074, 1.75, 0.229, 196, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2269, d5fgfK_, 0.8074, 2.06, 0.203, 214, 197, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2270, d5fg9N_, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2271, p5fg9b_, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2272, d5d0xN_, 0.8074, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2273, p5d0xb_, 0.8074, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2274, p4ya2N_, 0.8074, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2275, p4ya0N_, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2276, p4ya0b_, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2277, p4y9zb_, 0.8074, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2278, p4y8gN_, 0.8074, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2279, p4y8gb_, 0.8074, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2280, d4rurN_, 0.8074, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2281, p4qv9b_, 0.8074, 1.75, 0.229, 196, 192, YCP BETA5-C63F MUTANT
2282, d4q1sb_, 0.8074, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2283, p4fzcb_, 0.8074, 1.76, 0.229, 196, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2284, d3hyeN_, 0.8074, 1.77, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2285, d3hye2_, 0.8074, 1.77, 0.229, 196, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2286, d1yarM_, 0.8074, 1.71, 0.219, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
2287, d1jd2N_, 0.8074, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2288, p5vfrn_, 0.8073, 1.54, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2289, d5l5sN_, 0.8073, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2290, p5l5sb_, 0.8073, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2291, p5l5pb_, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2292, d5d0wN_, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2293, p5d0wb_, 0.8073, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2294, d5d0vN_, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2295, p5d0vb_, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2296, d5d0tN_, 0.8073, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2297, p5d0tb_, 0.8073, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2298, d5bxlN_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2299, p5bxlb_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2300, d5bouN_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2301, p5boub_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2302, p4ya7N_, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2303, p4ya7b_, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2304, p4ya2b_, 0.8073, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2305, p4y9zN_, 0.8073, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2306, p4y8sN_, 0.8073, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2307, p4y8sb_, 0.8073, 1.73, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2308, p4y8nN_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2309, p4y8nb_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2310, p4rurb_, 0.8073, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2311, d4r673_, 0.8073, 1.91, 0.201, 201, 194, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2312, d4r17N_, 0.8073, 1.58, 0.230, 196, 191, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2313, p4r17b_, 0.8073, 1.58, 0.230, 196, 191, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2314, d4qw0N_, 0.8073, 1.77, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2315, p4qw0b_, 0.8073, 1.77, 0.229, 196, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2316, d4quxN_, 0.8073, 1.58, 0.230, 196, 191, YCP BETA5-A49T-MUTANT
2317, p4quxb_, 0.8073, 1.58, 0.230, 196, 191, YCP BETA5-A49T-MUTANT
2318, d4fzcN_, 0.8073, 1.77, 0.229, 196, 192, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2319, d3nzwN_, 0.8073, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2320, d3nzw2_, 0.8073, 1.74, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2321, d3mg82_, 0.8073, 1.57, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2322, p5m32N_, 0.8072, 1.84, 0.233, 202, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2323, p5m32b_, 0.8072, 1.84, 0.233, 203, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2324, d5l64N_, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2325, p5l64b_, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2326, d5l5qN_, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2327, p5l5qb_, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2328, d5l5pN_, 0.8072, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2329, d5l5hN_, 0.8072, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2330, d5czaN_, 0.8072, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2331, p5czab_, 0.8072, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2332, p4y8pN_, 0.8072, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2333, p4y8pb_, 0.8072, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2334, p4r02b_, 0.8072, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2335, d4qzzN_, 0.8072, 1.59, 0.230, 196, 191, YCP IN COMPLEX WITH OMURALIDE
2336, p4qzzb_, 0.8072, 1.59, 0.230, 196, 191, YCP IN COMPLEX WITH OMURALIDE
2337, p4qvwb_, 0.8072, 1.78, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2338, d4nnnN_, 0.8072, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH MG132
2339, p4nnnb_, 0.8072, 1.76, 0.229, 196, 192, YCP IN COMPLEX WITH MG132
2340, d4fzgN_, 0.8072, 1.57, 0.230, 196, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2341, d3oeuN_, 0.8072, 1.59, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2342, d3mkaJ_, 0.8072, 2.34, 0.180, 252, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2343, d3d292_, 0.8072, 1.74, 0.229, 196, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
2344, d1ya7M_, 0.8072, 1.71, 0.219, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
2345, p5vfpH_, 0.8071, 1.55, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2346, d5lf1Y_, 0.8071, 1.92, 0.201, 201, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2347, d5l5oN_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2348, p5l5ob_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2349, d5l5iY_, 0.8071, 1.71, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2350, p5l5hb_, 0.8071, 1.75, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2351, d5l5fY_, 0.8071, 1.89, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2352, d5l5bN_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2353, p5l5bb_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2354, p5fmgY_, 0.8071, 1.63, 0.224, 194, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2355, p5fmgK_, 0.8071, 1.63, 0.224, 194, 192, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
2356, d5fgaN_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2357, p5fgab_, 0.8071, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2358, p4ya9N_, 0.8071, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2359, p4ya9b_, 0.8071, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2360, d4qvwN_, 0.8071, 1.78, 0.229, 196, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2361, d4qv4N_, 0.8071, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT
2362, p4qv4b_, 0.8071, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT
2363, d4q1sN_, 0.8071, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2364, d4lqiN_, 0.8071, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2365, p4fzgb_, 0.8071, 1.57, 0.230, 196, 191, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2366, d3sdk2_, 0.8071, 1.59, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2367, d3oeu2_, 0.8071, 1.57, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2368, d3mkaN_, 0.8071, 2.35, 0.180, 252, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2369, d3d29N_, 0.8071, 1.74, 0.229, 196, 192, PROTEASOME INHIBITION BY FELLUTAMIDE B
2370, p5vfoq_, 0.8070, 1.97, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2371, p5l5tb_, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2372, d5l5iK_, 0.8070, 1.71, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2373, d5l5fK_, 0.8070, 1.89, 0.206, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2374, p5l5eb_, 0.8070, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2375, d5l5aN_, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2376, p5l5ab_, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2377, p5l4gN_, 0.8070, 1.71, 0.181, 195, 193, 
2378, d4ya4N_, 0.8070, 1.57, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2379, p4ya4b_, 0.8070, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2380, p4y8rb_, 0.8070, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2381, d4qw3N_, 0.8070, 1.78, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2382, p4qw3b_, 0.8070, 1.78, 0.229, 196, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2383, p5vfqH_, 0.8069, 1.56, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2384, p5lezY_, 0.8069, 1.74, 0.202, 199, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2385, d5l6cN_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2386, p5l6cb_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2387, d5l6bN_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2388, p5l6bb_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2389, d5l67N_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2390, p5l67b_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2391, d5l63N_, 0.8069, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2392, p5l63b_, 0.8069, 1.76, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2393, d5l5uN_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2394, d5l5tY_, 0.8069, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2395, d5l5jN_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2396, d5cz6N_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2397, p5cz6b_, 0.8069, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2398, d4qvmN_, 0.8069, 1.78, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2399, p4qvmb_, 0.8069, 1.78, 0.229, 196, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2400, d4qv1N_, 0.8069, 1.59, 0.230, 196, 191, YCP BETA5-M45A MUTANT
2401, p4qv1b_, 0.8069, 1.59, 0.230, 196, 191, YCP BETA5-M45A MUTANT
2402, p4qbyN_, 0.8069, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2403, p4qbyb_, 0.8069, 1.75, 0.229, 196, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2404, p4hrdb_, 0.8069, 1.57, 0.230, 196, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2405, d3sdkN_, 0.8069, 1.60, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2406, d3oev2_, 0.8069, 1.58, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2407, p5mpa1_, 0.8068, 1.58, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2408, d5lf7Y_, 0.8068, 1.92, 0.201, 201, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2409, d5lf1K_, 0.8068, 1.92, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2410, d5l6bY_, 0.8068, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2411, d5l6bK_, 0.8068, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2412, p5l5ub_, 0.8068, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2413, d5l5tK_, 0.8068, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2414, p5l5jb_, 0.8068, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2415, d5l5fN_, 0.8068, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2416, d5dkjN_, 0.8068, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2417, p5dkjb_, 0.8068, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2418, p4y8tN_, 0.8068, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2419, p4y8tb_, 0.8068, 1.74, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2420, d4qw1N_, 0.8068, 1.78, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2421, p4qw1b_, 0.8068, 1.78, 0.229, 196, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2422, d4qvlN_, 0.8068, 1.78, 0.229, 196, 192, YCP IN COMPLEX WITH BORTEZOMIB
2423, p4qvlb_, 0.8068, 1.78, 0.229, 196, 192, YCP IN COMPLEX WITH BORTEZOMIB
2424, d2f16N_, 0.8068, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2425, d2f162_, 0.8068, 1.76, 0.229, 196, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2426, p5leyK_, 0.8067, 1.92, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2427, d5l6aY_, 0.8067, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2428, d5l6aK_, 0.8067, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2429, d5l62N_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2430, d5l61N_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2431, p5l61b_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2432, d5l5rN_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2433, p5l5rb_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2434, p5l5fb_, 0.8067, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2435, d5l5dN_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2436, p5l5db_, 0.8067, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2437, d3oevN_, 0.8067, 1.60, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2438, d3mg6N_, 0.8067, 1.60, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2439, p6gopN_, 0.8066, 1.79, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2440, d5l68Y_, 0.8066, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2441, d5l68K_, 0.8066, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2442, d5l67K_, 0.8066, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2443, p5l62b_, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2444, d5l5iN_, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2445, p5l5ib_, 0.8066, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2446, p5bxnb_, 0.8066, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2447, d3mkaL_, 0.8066, 2.35, 0.180, 251, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2448, d3mkaH_, 0.8066, 2.18, 0.181, 249, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2449, d3mg8N_, 0.8066, 1.59, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2450, p6gopb_, 0.8065, 1.79, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2451, d5l6aN_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2452, p5l6ab_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2453, d5l68N_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2454, p5l68b_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2455, d5l60N_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2456, p5l60b_, 0.8065, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2457, d5l5dY_, 0.8065, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2458, d5l5dK_, 0.8065, 1.72, 0.207, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2459, p5fghN_, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2460, p5fghb_, 0.8065, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2461, d5dkiN_, 0.8065, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2462, p5dkib_, 0.8065, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2463, d4nnwN_, 0.8065, 1.77, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2464, p4nnwb_, 0.8065, 1.77, 0.229, 196, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2465, p4gk7N_, 0.8065, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2466, p4gk7b_, 0.8065, 1.77, 0.229, 196, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2467, d2zcyN_, 0.8065, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2468, d2zcy1_, 0.8065, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2469, d2h6jM1, 0.8065, 2.19, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2470, d5l66Y_, 0.8064, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2471, d5l66N_, 0.8064, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2472, d5l66K_, 0.8064, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2473, p5l66b_, 0.8064, 1.78, 0.229, 196, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2474, d4qvqN_, 0.8064, 1.78, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2475, p4qvqb_, 0.8064, 1.78, 0.229, 196, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2476, d3sdkJ_, 0.8064, 1.70, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2477, d3mg7N_, 0.8064, 1.60, 0.230, 196, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2478, d3h4pi_, 0.8064, 1.74, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2479, d2h6jN1, 0.8064, 2.19, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2480, p5vfuNA_, 0.8063, 1.53, 0.188, 193, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2481, p5vfto_, 0.8063, 1.53, 0.188, 193, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2482, p5leyY_, 0.8063, 1.75, 0.202, 199, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2483, d5l5xN_, 0.8063, 1.59, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2484, p5gjqo_, 0.8063, 1.67, 0.234, 202, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2485, d4ltcJ_, 0.8063, 1.72, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2486, d3mkaV_, 0.8063, 2.25, 0.181, 249, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2487, d3mg02_, 0.8063, 1.77, 0.229, 196, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2488, p5mpah_, 0.8062, 1.58, 0.230, 196, 191, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2489, d5m2bN_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2490, p5m2bb_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2491, d5lf4Y_, 0.8062, 1.93, 0.201, 201, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2492, p5lf0Y_, 0.8062, 1.92, 0.201, 201, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2493, p5le5b_, 0.8062, 1.68, 0.234, 203, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2494, d5l69N_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2495, p5l69b_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2496, d5l5yN_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2497, p5l5yb_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2498, p5l5xb_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2499, d5l5wN_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2500, p5l5wb_, 0.8062, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2501, d5cz7N_, 0.8062, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2502, p5cz7b_, 0.8062, 1.58, 0.230, 196, 191, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2503, d4hrcX_, 0.8062, 1.71, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2504, d2h6jK1, 0.8062, 2.20, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2505, p5vfrN_, 0.8061, 1.58, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2506, p5vfoQ_, 0.8061, 1.98, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2507, p5mpai_, 0.8061, 1.74, 0.192, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2508, d5lf7K_, 0.8061, 1.93, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2509, p5lf0K_, 0.8061, 1.92, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2510, p5lf0b_, 0.8061, 1.86, 0.233, 203, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2511, d5l69Y_, 0.8061, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2512, d5l69K_, 0.8061, 1.90, 0.216, 211, 194, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2513, p5gjrZ_, 0.8061, 1.68, 0.234, 202, 192, 
2514, p5gjrNA_, 0.8061, 1.68, 0.234, 202, 192, 
2515, d3mg0N_, 0.8061, 1.78, 0.229, 196, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2516, d2h6jL1, 0.8061, 2.19, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2517, d2h6jJ1, 0.8061, 2.20, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2518, d2h6jI1, 0.8061, 2.20, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2519, p5vfsGA_, 0.8060, 1.58, 0.236, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2520, d5le5N_, 0.8060, 1.68, 0.234, 202, 192, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2521, d4qv6N_, 0.8060, 1.60, 0.230, 196, 191, YCP BETA5-A49V MUTANT
2522, p4qv6b_, 0.8060, 1.60, 0.230, 196, 191, YCP BETA5-A49V MUTANT
2523, d3mg8J_, 0.8060, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2524, p5vfuPA_, 0.8059, 1.96, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2525, p5vftq_, 0.8059, 1.96, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2526, p5lf1b_, 0.8059, 1.68, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2527, d5l62Y_, 0.8059, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2528, d5l62K_, 0.8059, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2529, d5l61Y_, 0.8059, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2530, d5l5yK_, 0.8059, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2531, p5l4gZ_, 0.8059, 1.77, 0.207, 201, 193, 
2532, p5gjqa_, 0.8059, 1.68, 0.234, 202, 192, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2533, d4qvpN_, 0.8059, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2534, p4qvpb_, 0.8059, 1.59, 0.230, 196, 191, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2535, p3unhY_, 0.8059, 1.74, 0.212, 201, 193, MOUSE 20S IMMUNOPROTEASOME
2536, p3unhK_, 0.8059, 1.74, 0.212, 201, 193, MOUSE 20S IMMUNOPROTEASOME
2537, p3h4pe_, 0.8059, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2538, d1jd2U_, 0.8059, 1.58, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2539, d5lf4K_, 0.8058, 1.93, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2540, d5lf1N_, 0.8058, 1.69, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2541, d5l65Y_, 0.8058, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2542, d5l65K_, 0.8058, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2543, d5l61K_, 0.8058, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2544, d5l5yY_, 0.8058, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2545, p5l4gL_, 0.8058, 1.76, 0.197, 201, 193, 
2546, d4qwuN_, 0.8058, 1.76, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2547, p4qwub_, 0.8058, 1.76, 0.229, 196, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2548, d3sdkX_, 0.8058, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2549, d3h4pn_, 0.8058, 1.74, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2550, p6avoE_, 0.8057, 1.63, 0.187, 193, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2551, p6avoB_, 0.8057, 1.63, 0.187, 193, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2552, p5vfuMA_, 0.8057, 1.58, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2553, p5vftn_, 0.8057, 1.58, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2554, d5l67Y_, 0.8057, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2555, p5gjrRA_, 0.8057, 1.77, 0.197, 201, 193, 
2556, d5bxnN_, 0.8057, 1.60, 0.230, 196, 191, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2557, d4ltcX_, 0.8057, 1.73, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2558, d3mkaC_, 0.8057, 2.22, 0.181, 250, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2559, p3h4pc_, 0.8057, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2560, p3h4pa_, 0.8057, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2561, d2h6jH1, 0.8057, 2.20, 0.201, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
2562, p5vfuY_, 0.8056, 1.57, 0.236, 191, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2563, p5vftN_, 0.8056, 1.57, 0.236, 191, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2564, p5vfsH_, 0.8056, 1.58, 0.236, 191, 191, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2565, p5vfpIA_, 0.8056, 1.98, 0.224, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2566, p5mpcV_, 0.8056, 1.78, 0.229, 196, 192, 
2567, d5lf3Y_, 0.8056, 1.93, 0.201, 201, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2568, d5l6cK_, 0.8056, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2569, d5l60Y_, 0.8056, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2570, d5l60K_, 0.8056, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2571, d5l5zN_, 0.8056, 1.61, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2572, p5l5zb_, 0.8056, 1.61, 0.230, 196, 191, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2573, p5gjrDA_, 0.8056, 1.77, 0.197, 201, 193, 
2574, d4hnpJ_, 0.8056, 1.72, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2575, d3h4pk_, 0.8056, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2576, p5lf6K_, 0.8055, 1.94, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2577, d5l6cY_, 0.8055, 1.73, 0.218, 211, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2578, d5l5eK_, 0.8055, 1.74, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2579, d5l63Y_, 0.8054, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2580, d5l63K_, 0.8054, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2581, d5l5eY_, 0.8054, 1.74, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2582, p5l4gBA_, 0.8054, 1.62, 0.182, 194, 192, 
2583, p5gjrOA_, 0.8054, 1.73, 0.187, 195, 193, 
2584, p4cr41_, 0.8054, 2.33, 0.224, 205, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2585, d3mg6J_, 0.8054, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2586, d3h4pl_, 0.8054, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2587, p5m32Y_, 0.8053, 1.78, 0.197, 201, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2588, p5lf7b_, 0.8053, 1.87, 0.233, 203, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2589, d5lf3K_, 0.8053, 1.94, 0.201, 200, 194, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2590, p5lf0N_, 0.8053, 1.69, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2591, d5l5xY_, 0.8053, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2592, d5l5xK_, 0.8053, 1.91, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2593, d4qvnN_, 0.8053, 1.60, 0.230, 196, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2594, p4qvnb_, 0.8053, 1.60, 0.230, 196, 191, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2595, d3oeuX_, 0.8053, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2596, d3oeuJ_, 0.8053, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2597, p3h4pg_, 0.8053, 1.76, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2598, p5vfuCA_, 0.8052, 1.75, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2599, p5vftR_, 0.8052, 1.75, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2600, p5m32K_, 0.8052, 1.78, 0.197, 200, 193, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2601, d5lf7N_, 0.8052, 1.87, 0.233, 202, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2602, p5leyb_, 0.8052, 1.69, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2603, d4intJ_, 0.8052, 1.73, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2604, d3unfV_, 0.8052, 1.75, 0.181, 219, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2605, d3unfH_, 0.8052, 1.75, 0.181, 219, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2606, d3mg8X_, 0.8052, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2607, d3mg7J_, 0.8052, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2608, d3mg6X_, 0.8052, 1.71, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2609, p3h4pd_, 0.8052, 1.76, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2610, p5vfqJA_, 0.8051, 1.99, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2611, p5leyN_, 0.8051, 1.69, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2612, d5le5H_, 0.8051, 1.72, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2613, d4r3oH_, 0.8051, 1.69, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
2614, d4hrdX_, 0.8051, 1.73, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2615, d3unfY_, 0.8051, 1.74, 0.212, 201, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2616, d4r3oV_, 0.8050, 1.69, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME
2617, d3unfK_, 0.8050, 1.74, 0.212, 201, 193, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2618, p3h4pb_, 0.8050, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2619, d5lf1H_, 0.8049, 1.73, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2620, d5l64Y_, 0.8049, 1.92, 0.211, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2621, d5l64K_, 0.8049, 1.92, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2622, d4jsqX_, 0.8049, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2623, d4jsqJ_, 0.8049, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2624, d4intX_, 0.8049, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2625, p3unep_, 0.8049, 1.70, 0.229, 202, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
2626, d3h4pm_, 0.8049, 1.75, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2627, d1jd2Q_, 0.8049, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2628, p5lf6Y_, 0.8048, 1.77, 0.202, 201, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2629, p5lf6N_, 0.8048, 1.70, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2630, d5lf1V_, 0.8048, 1.73, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2631, d4hrcJ_, 0.8048, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2632, d3nzwX_, 0.8048, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2633, d3nzwJ_, 0.8048, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2634, d3mg7X_, 0.8048, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2635, p5lf6b_, 0.8047, 1.70, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2636, d4hnpX_, 0.8047, 1.73, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2637, d3oevJ_, 0.8047, 1.72, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2638, d1jd2J_, 0.8047, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2639, p1fntV_, 0.8047, 1.61, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2640, p5vfsI_, 0.8046, 1.65, 0.193, 193, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2641, d4hrdJ_, 0.8046, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2642, p3uneN_, 0.8046, 1.88, 0.228, 202, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2643, p3uneH_, 0.8046, 1.74, 0.192, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2644, p3uneb_, 0.8046, 1.88, 0.228, 202, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2645, d3h4ph_, 0.8046, 1.76, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2646, p3h4pf_, 0.8046, 1.76, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2647, d1q5rN_, 0.8046, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2648, d1q5rM_, 0.8046, 2.23, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2649, d1q5rL_, 0.8046, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2650, d1q5rI_, 0.8046, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2651, p1fntH_, 0.8046, 1.62, 0.230, 196, 191, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2652, p6bdfZ_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2653, p6bdfX_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2654, p6bdfV_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2655, p6bdfT_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2656, p6bdfR_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2657, p6bdfP_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2658, p6bdfN_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2659, p6bdfL_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2660, p6bdfJ_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2661, p6bdfH_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2662, p6bdfF_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2663, p6bdfD_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2664, p6bdfB_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2665, p6bdf1_, 0.8045, 1.62, 0.221, 201, 190, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
2666, p5vfor_, 0.8045, 1.78, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2667, p5t0gR_, 0.8045, 1.75, 0.207, 201, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2668, d5le5V_, 0.8045, 1.73, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2669, p5gjqs_, 0.8045, 1.78, 0.207, 201, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2670, p3unex_, 0.8045, 1.74, 0.192, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2671, d3nzjX_, 0.8045, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2672, d3nzjJ_, 0.8045, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2673, d3mg4J_, 0.8045, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2674, d1q5rK_, 0.8045, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2675, d1q5rJ_, 0.8045, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2676, d1q5rH_, 0.8045, 2.24, 0.196, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
2677, p5lexb_, 0.8044, 1.71, 0.234, 203, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2678, p5gjqe_, 0.8044, 1.78, 0.202, 201, 193, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2679, d3sdiX_, 0.8044, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2680, d3sdiJ_, 0.8044, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2681, d3nzxX_, 0.8044, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2682, d3nzxJ_, 0.8044, 1.74, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2683, p3ipmM_, 0.8044, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2684, p3ipmK_, 0.8044, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2685, p3ipmH_, 0.8044, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2686, d1iruH_, 0.8044, 1.70, 0.234, 202, 192, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2687, p5lf4b_, 0.8043, 1.88, 0.233, 203, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2688, p5lf3b_, 0.8043, 1.70, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2689, d5lexN_, 0.8043, 1.71, 0.234, 202, 192, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2690, d5l5zK_, 0.8043, 1.93, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2691, d4inrJ_, 0.8043, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2692, d3okjJ_, 0.8043, 1.74, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2693, p3ipmN_, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2694, p3ipmL_, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2695, p3ipmJ_, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2696, p3ipmI_, 0.8043, 1.73, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
2697, d1j2qI_, 0.8043, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2698, d1j2qH_, 0.8043, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2699, d1iruV_, 0.8043, 1.70, 0.234, 202, 192, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2700, p5vfuBA_, 0.8042, 1.99, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2701, p5vftQ_, 0.8042, 1.99, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2702, p5vfsHA_, 0.8042, 1.65, 0.193, 193, 192, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2703, d5l5zY_, 0.8042, 1.93, 0.216, 211, 194, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2704, d4jsuX_, 0.8042, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2705, d4jsuJ_, 0.8042, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2706, d4inrX_, 0.8042, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2707, p3une4_, 0.8042, 1.73, 0.229, 202, 192, MOUSE CONSTITUTIVE 20S PROTEASOME
2708, d3okjX_, 0.8042, 1.74, 0.228, 198, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2709, d1j2qL_, 0.8042, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2710, d1j2qJ_, 0.8042, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2711, p6avoF_, 0.8041, 1.81, 0.208, 199, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2712, p6avoA_, 0.8041, 1.81, 0.208, 199, 192, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2713, p5vfqK_, 0.8041, 2.01, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2714, p5vfpK_, 0.8041, 2.00, 0.230, 199, 196, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2715, p5mp92_, 0.8041, 1.76, 0.192, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2716, d5lf4N_, 0.8041, 1.88, 0.233, 202, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2717, p5a5b1_, 0.8041, 2.40, 0.224, 205, 201, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2718, p4gk7X_, 0.8041, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2719, p4gk7J_, 0.8041, 1.74, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2720, p4cr31_, 0.8041, 2.40, 0.224, 205, 201, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2721, d1j2qN_, 0.8041, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2722, d1j2qM_, 0.8041, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2723, d5lexY_, 0.8040, 1.79, 0.197, 199, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2724, p3un4J_, 0.8040, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2725, d1j2qK_, 0.8040, 1.64, 0.262, 202, 191, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2726, p5vfqL_, 0.8039, 1.78, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2727, p5t0cGB_, 0.8039, 1.56, 0.188, 193, 191, 
2728, p5t0cAA_, 0.8039, 1.56, 0.188, 193, 191, 
2729, p3un4X_, 0.8039, 1.75, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2730, d1g65X_, 0.8039, 1.76, 0.228, 198, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2731, p5vfsKA_, 0.8038, 1.79, 0.207, 201, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2732, d5m2bY_, 0.8038, 1.76, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2733, d5m2bK_, 0.8038, 1.76, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2734, p5leyV_, 0.8038, 1.74, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2735, d4r67V_, 0.8038, 1.72, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2736, d4r67H_, 0.8038, 1.72, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2737, d4cr22_, 0.8038, 1.70, 0.192, 223, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2738, p3unej_, 0.8038, 1.75, 0.192, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2739, p3unbx_, 0.8038, 1.74, 0.192, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2740, d3unbb_, 0.8038, 1.89, 0.228, 202, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2741, d3okj2_, 0.8038, 1.75, 0.230, 195, 191, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2742, d3mg0X_, 0.8038, 1.77, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2743, d3mg0J_, 0.8038, 1.76, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2744, d3h4pj_, 0.8038, 1.77, 0.281, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2745, p5vfpJA_, 0.8037, 1.78, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2746, p4r67x_, 0.8037, 1.72, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2747, d4r3oW_, 0.8037, 1.74, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2748, d4r3oI_, 0.8037, 1.74, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2749, d4inuJ_, 0.8037, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2750, d4inrK_, 0.8037, 1.99, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2751, d3mg4K_, 0.8037, 2.00, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2752, d3l5qD1, 0.8037, 1.56, 0.232, 195, 190,  
2753, d2f16X_, 0.8037, 1.76, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2754, d1vsyH1, 0.8037, 1.56, 0.232, 195, 190,  
2755, p5vfsL_, 0.8036, 1.79, 0.207, 201, 193, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2756, p5vfoR_, 0.8036, 1.78, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2757, p5lf6H_, 0.8036, 1.74, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2758, p5lezN_, 0.8036, 1.72, 0.234, 202, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2759, p5lezb_, 0.8036, 1.72, 0.234, 203, 192, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2760, p5leyH_, 0.8036, 1.74, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2761, p4r67j_, 0.8036, 1.72, 0.234, 202, 192, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2762, d2f16J_, 0.8036, 1.76, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2763, d5lf7H_, 0.8035, 1.74, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2764, d4jt0Y_, 0.8035, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2765, d4jt0K_, 0.8035, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2766, d4inuX_, 0.8035, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2767, d3unb4_, 0.8035, 1.90, 0.228, 202, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2768, d3sdkV_, 0.8035, 1.77, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2769, d1vsyV1, 0.8035, 1.56, 0.232, 195, 190,  
2770, p5vfpL_, 0.8034, 1.79, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2771, d5lf7V_, 0.8034, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2772, p5lf6V_, 0.8034, 1.75, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2773, p5lf0H_, 0.8034, 1.74, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2774, d4inrY_, 0.8034, 1.99, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2775, p3uneV_, 0.8034, 1.75, 0.192, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
2776, d3l5qB1, 0.8034, 1.56, 0.232, 195, 190,  
2777, p5vfrq_, 0.8033, 2.00, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2778, p5vfqKA_, 0.8033, 1.80, 0.207, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2779, p5mpa2_, 0.8033, 1.79, 0.192, 196, 193, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2780, d4jt0X_, 0.8033, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2781, d4jt0J_, 0.8033, 1.76, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2782, d1g65J_, 0.8033, 1.76, 0.228, 198, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2783, d1g0uH_, 0.8033, 1.75, 0.192, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2784, d5lexK_, 0.8032, 1.79, 0.202, 200, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2785, d5le5Y_, 0.8032, 1.79, 0.197, 199, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2786, p5vfuQA_, 0.8031, 1.79, 0.202, 201, 193, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2787, p5vftr_, 0.8031, 1.79, 0.202, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2788, d5lf4H_, 0.8031, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2789, d4r3oZ_, 0.8031, 1.80, 0.197, 201, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2790, d3un8J_, 0.8031, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2791, d3mg4X_, 0.8031, 1.78, 0.228, 198, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2792, p5vfsK_, 0.8030, 1.99, 0.230, 199, 196, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2793, d5lf4V_, 0.8030, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2794, p5lf0V_, 0.8030, 1.75, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2795, d5lexH_, 0.8030, 1.75, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2796, d4r3oL_, 0.8030, 1.80, 0.197, 201, 193, HUMAN CONSTITUTIVE 20S PROTEASOME
2797, d4fzgX_, 0.8030, 1.77, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2798, d4fzgJ_, 0.8030, 1.77, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2799, d3un8X_, 0.8030, 1.77, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2800, d3mg4Y_, 0.8030, 2.01, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2801, d3d29J_, 0.8030, 1.76, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
2802, p5vfsJA_, 0.8029, 1.99, 0.230, 199, 196, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2803, p5lezH_, 0.8029, 1.75, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2804, d5lexV_, 0.8029, 1.75, 0.187, 220, 193, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2805, d5le5K_, 0.8029, 1.80, 0.197, 201, 193, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2806, d4inuY_, 0.8029, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2807, d4inuK_, 0.8029, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2808, d4fzcJ_, 0.8029, 1.77, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2809, d3d29X_, 0.8029, 1.76, 0.228, 198, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
2810, p5vfrQ_, 0.8028, 2.04, 0.230, 199, 196, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2811, d5lf3H_, 0.8028, 1.75, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2812, d4jsuK_, 0.8028, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2813, d4jsqY_, 0.8028, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2814, d4jsqK_, 0.8028, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2815, d4fzcX_, 0.8028, 1.77, 0.228, 198, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2816, p3un4Y_, 0.8028, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2817, p3un4K_, 0.8028, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2818, d3mg6V_, 0.8028, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2819, p5lezV_, 0.8027, 1.76, 0.187, 195, 193, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2820, p5a0qZ_, 0.8027, 1.69, 0.199, 192, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2821, p5a0qL_, 0.8027, 1.69, 0.199, 192, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2822, d4jsuY_, 0.8027, 2.00, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2823, d5lf3V_, 0.8026, 1.76, 0.187, 220, 193, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2824, d5l5rK_, 0.8026, 1.77, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2825, d4intY_, 0.8026, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2826, d3sdiV_, 0.8026, 1.77, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2827, d3oevY_, 0.8026, 2.01, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2828, d3mg7H_, 0.8026, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2829, d1rypY_, 0.8026, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2830, d1g0uV_, 0.8026, 1.77, 0.192, 222, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2831, p5vfrR_, 0.8025, 1.80, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2832, p5t0jO_, 0.8025, 1.72, 0.187, 195, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2833, p5t0cJB_, 0.8025, 1.80, 0.207, 201, 193, 
2834, p5t0cDA_, 0.8025, 1.80, 0.207, 201, 193, 
2835, d5l5rY_, 0.8025, 1.78, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2836, d4r02Y_, 0.8025, 2.01, 0.195, 212, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2837, p5wvkK_, 0.8024, 1.73, 0.228, 198, 193, 
2838, p5cghV_, 0.8024, 1.78, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2839, p5a5b7_, 0.8024, 2.72, 0.155, 218, 207, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2840, d4r67I_, 0.8024, 1.75, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2841, d4inrH_, 0.8024, 1.77, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2842, d4hnpV_, 0.8024, 1.77, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2843, p4cr37_, 0.8024, 2.72, 0.155, 218, 207, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2844, d3unbp_, 0.8024, 1.72, 0.229, 202, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2845, d3oevK_, 0.8024, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2846, d3mg8V_, 0.8024, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2847, d3mg7V_, 0.8024, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2848, d5l5vV_, 0.8023, 1.78, 0.192, 226, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2849, d5l5vH_, 0.8023, 1.78, 0.192, 226, 193,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2850, d5l5bK_, 0.8023, 1.78, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2851, p5cghH_, 0.8023, 1.78, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2852, p4r67y_, 0.8023, 1.76, 0.187, 195, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2853, d4r02V_, 0.8023, 1.78, 0.192, 226, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2854, d4intK_, 0.8023, 2.01, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2855, d4eu2I_, 0.8023, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2856, d3unbY_, 0.8023, 1.96, 0.206, 201, 194, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2857, d5l60V_, 0.8022, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2858, d5l60H_, 0.8022, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2859, d5l5bY_, 0.8022, 1.78, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2860, p4x6zW_, 0.8022, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2861, d4qwjY_, 0.8022, 2.02, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2862, d4qwjK_, 0.8022, 2.01, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2863, d3unbN_, 0.8022, 1.73, 0.229, 202, 192, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2864, d3un8K_, 0.8022, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2865, d3shjK_, 0.8022, 2.02, 0.195, 212, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2866, d3sdiH_, 0.8022, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2867, d3oevV_, 0.8022, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2868, d3mkaE_, 0.8022, 2.23, 0.182, 248, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2869, d3gpwX_, 0.8022, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2870, d3gpwJ_, 0.8022, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2871, d3gptY_, 0.8022, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2872, d3gptK_, 0.8022, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2873, d5l6cV_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2874, d5l6cH_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2875, d5l5tV_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2876, d5l5tH_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2877, d5l5qV_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2878, d5l5qH_, 0.8021, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2879, p5gjqp_, 0.8021, 1.59, 0.188, 193, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2880, p4r67k_, 0.8021, 1.76, 0.187, 195, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2881, d4r02K_, 0.8021, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2882, d3unbV_, 0.8021, 1.76, 0.192, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2883, d3shjY_, 0.8021, 2.02, 0.195, 212, 195, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2884, d3oeuV_, 0.8021, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2885, d3mka2_, 0.8021, 2.20, 0.182, 246, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
2886, d3hyeY_, 0.8021, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2887, d3gpwY_, 0.8021, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2888, d3gpwK_, 0.8021, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2889, d3gptJ_, 0.8021, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2890, d5l64V_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2891, d5l64H_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2892, d5l61V_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2893, d5l61H_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2894, d5l5sV_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2895, d5l5sH_, 0.8020, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2896, d5l55V_, 0.8020, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2897, d5l55H_, 0.8020, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2898, d5jhrY_, 0.8020, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2899, d5jhrK_, 0.8020, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2900, p5gjqb_, 0.8020, 1.60, 0.188, 193, 191, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2901, d5fhsY_, 0.8020, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2902, p4y8kY_, 0.8020, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2903, d4r67W_, 0.8020, 1.76, 0.187, 220, 193, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2904, d4q1sJ_, 0.8020, 1.80, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2905, d3mg8H_, 0.8020, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2906, d3hyeK_, 0.8020, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2907, d3gptX_, 0.8020, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2908, d1rypK_, 0.8020, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2909, d1iruZ_, 0.8020, 1.81, 0.202, 201, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2910, d1iruL_, 0.8020, 1.81, 0.202, 201, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2911, p5vfuZ_, 0.8019, 1.60, 0.188, 193, 191, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2912, p5vftO_, 0.8019, 1.60, 0.188, 193, 191, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2913, p5vfrr_, 0.8019, 1.81, 0.207, 201, 193, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2914, d5l5hV_, 0.8019, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2915, d5l5hH_, 0.8019, 1.78, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2916, d5fhsK_, 0.8019, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2917, p4y8kV_, 0.8019, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2918, p4y8kK_, 0.8019, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2919, p4y7xY_, 0.8019, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2920, p4y7xK_, 0.8019, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2921, d4r02H_, 0.8019, 1.78, 0.192, 226, 193, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2922, d4qluV_, 0.8019, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2923, d4qluH_, 0.8019, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2924, d4lqiJ_, 0.8019, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2925, d4hnpH_, 0.8019, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2926, p4cr42_, 0.8019, 1.76, 0.192, 197, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2927, d3un8Y_, 0.8019, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2928, d3nzjY_, 0.8019, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2929, d3nzjV_, 0.8019, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2930, d3nzjK_, 0.8019, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2931, d3mg6H_, 0.8019, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2932, d3gpjY_, 0.8019, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2933, d3gpjX_, 0.8019, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2934, d2zcyX_, 0.8019, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2935, d2zcyJ_, 0.8019, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2936, d2gplX_, 0.8019, 1.78, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2937, d2gplJ_, 0.8019, 1.78, 0.228, 198, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2938, d2fakY_, 0.8019, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2939, p5wvkA_, 0.8018, 1.82, 0.229, 196, 192, 
2940, p5mpcH_, 0.8018, 1.83, 0.229, 196, 192, 
2941, d5l67V_, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2942, d5l67H_, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2943, d5fggY_, 0.8018, 2.01, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2944, d5fggK_, 0.8018, 2.01, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2945, d5d0tV_, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2946, d5d0tH_, 0.8018, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2947, p4y8kH_, 0.8018, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2948, p4y7yY_, 0.8018, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2949, p4y7yK_, 0.8018, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2950, p4x6zI_, 0.8018, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2951, d4qvwY_, 0.8018, 2.02, 0.190, 212, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2952, d4qvwK_, 0.8018, 2.02, 0.190, 212, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2953, d4q1sH_, 0.8018, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2954, d4ltcV_, 0.8018, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2955, d4lqiX_, 0.8018, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2956, d4j70J_, 0.8018, 1.78, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2957, d4intV_, 0.8018, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2958, d4intH_, 0.8018, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2959, p3unhV_, 0.8018, 1.60, 0.183, 193, 191, MOUSE 20S IMMUNOPROTEASOME
2960, p3unhN_, 0.8018, 1.67, 0.215, 199, 191, MOUSE 20S IMMUNOPROTEASOME
2961, p3unhH_, 0.8018, 1.60, 0.183, 193, 191, MOUSE 20S IMMUNOPROTEASOME
2962, p3unhb_, 0.8018, 1.67, 0.215, 199, 191, MOUSE 20S IMMUNOPROTEASOME
2963, d3sdkH_, 0.8018, 1.78, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2964, d3oeuY_, 0.8018, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2965, d3oeuH_, 0.8018, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2966, d3nzjH_, 0.8018, 1.78, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2967, d3gpjK_, 0.8018, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2968, d3gpjJ_, 0.8018, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2969, d2fakK_, 0.8018, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2970, d1g65Y_, 0.8018, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2971, d5lttV_, 0.8017, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2972, d5lttH_, 0.8017, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2973, d5l5iV_, 0.8017, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2974, d5l5iH_, 0.8017, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2975, p5fghY_, 0.8017, 2.02, 0.190, 197, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2976, d5fggX_, 0.8017, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2977, d5fggJ_, 0.8017, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2978, d5d0xY_, 0.8017, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2979, d5cz9Y_, 0.8017, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2980, d5cz9K_, 0.8017, 2.02, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2981, d4qlsV_, 0.8017, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2982, d4qlsH_, 0.8017, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2983, d4inrV_, 0.8017, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2984, d3unb1_, 0.8017, 1.80, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2985, d3mg4V_, 0.8017, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2986, d1z7qV1, 0.8017, 1.58, 0.232, 195, 190, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2987, d1z7qH1, 0.8017, 1.58, 0.232, 195, 190, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2988, p6gopY_, 0.8016, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2989, p6gopK_, 0.8016, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2990, d5laiV_, 0.8016, 1.79, 0.192, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2991, d5laiH_, 0.8016, 1.79, 0.192, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2992, d5l5uV_, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2993, d5l5uH_, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2994, d5l5rH_, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2995, d5l5pV_, 0.8016, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2996, d5fgiJ_, 0.8016, 1.69, 0.229, 195, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2997, d5d0xK_, 0.8016, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2998, p5cggV_, 0.8016, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2999, p5cggH_, 0.8016, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3000, p4y81V_, 0.8016, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3001, d4qwkY_, 0.8016, 2.02, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3002, d4qwkK_, 0.8016, 2.02, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3003, d4qw3Y_, 0.8016, 2.02, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3004, d4qw3K_, 0.8016, 2.02, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3005, d4ltcK_, 0.8016, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3006, d4lqiV_, 0.8016, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3007, d4lqiH_, 0.8016, 1.78, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3008, d4j70X_, 0.8016, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3009, p3uneK_, 0.8016, 1.80, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3010, d3unbH_, 0.8016, 1.77, 0.192, 220, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3011, d3oevH_, 0.8016, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3012, d3mg4H_, 0.8016, 1.79, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3013, d2fakJ_, 0.8016, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3014, d1g65K_, 0.8016, 2.01, 0.195, 212, 195, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3015, d5l69V_, 0.8015, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3016, d5l69H_, 0.8015, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3017, d5l5rV_, 0.8015, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3018, d5l5pH_, 0.8015, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3019, d5jhsV_, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3020, d5jhsH_, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3021, p5gjrAA_, 0.8015, 1.60, 0.188, 193, 191, 
3022, p4y81H_, 0.8015, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3023, d4qwsY_, 0.8015, 2.02, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3024, d4qwsK_, 0.8015, 2.02, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3025, d4qwiY_, 0.8015, 2.02, 0.190, 212, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3026, d4qwiK_, 0.8015, 2.02, 0.190, 212, 195, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3027, d4q1sX_, 0.8015, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3028, d4inuH_, 0.8015, 1.79, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3029, d3tddX_, 0.8015, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3030, d3tddJ_, 0.8015, 1.78, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3031, d3okjH_, 0.8015, 1.79, 0.192, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3032, d3hyeX_, 0.8015, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3033, d3hyeJ_, 0.8015, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3034, d2fakX_, 0.8015, 1.79, 0.228, 198, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3035, d5m2bV_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3036, d5m2bH_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3037, d5l62V_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3038, d5l62H_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3039, d5l5oV_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3040, d5l5oH_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3041, d5l5jV_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3042, d5l5jH_, 0.8014, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3043, d5l5aY_, 0.8014, 1.79, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3044, d5l5aK_, 0.8014, 1.79, 0.202, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3045, d5dkiY_, 0.8014, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3046, d5dkiK_, 0.8014, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3047, p4y8qY_, 0.8014, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3048, p4y8qV_, 0.8014, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3049, p4y8qH_, 0.8014, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3050, p4y7xV_, 0.8014, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3051, p4y7xH_, 0.8014, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3052, d4qz7V_, 0.8014, 1.79, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3053, d4qz7H_, 0.8014, 1.79, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3054, d4qwrY_, 0.8014, 2.02, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3055, d4qwrK_, 0.8014, 2.02, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3056, d4qwlX_, 0.8014, 1.70, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3057, d4qwlJ_, 0.8014, 1.70, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3058, d4qwkV_, 0.8014, 1.80, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3059, d4qw6J_, 0.8014, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3060, d4qw1Y_, 0.8014, 2.02, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3061, d4qw1K_, 0.8014, 2.02, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3062, d4qvlY_, 0.8014, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BORTEZOMIB
3063, d4ltcY_, 0.8014, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3064, d4ltcH_, 0.8014, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3065, d3okjV_, 0.8014, 1.79, 0.192, 222, 193, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3066, d3nzwV_, 0.8014, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3067, d3nzwH_, 0.8014, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3068, d3mg8Y_, 0.8014, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3069, d3mg0K_, 0.8014, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3070, d3bdmX_, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3071, d3bdmJ_, 0.8014, 1.79, 0.228, 198, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3072, d5jhrX_, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3073, d5jhrJ_, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3074, p5fghK_, 0.8013, 1.86, 0.191, 197, 194, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3075, d5dkjY_, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3076, d5dkjK_, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3077, d5d0sX_, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3078, d5d0sJ_, 0.8013, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3079, d5bxnY_, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3080, p4y8qK_, 0.8013, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3081, p4y75H_, 0.8013, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3082, d4qwkH_, 0.8013, 1.80, 0.192, 222, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3083, d4qw6X_, 0.8013, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3084, d4qw5X_, 0.8013, 1.70, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3085, d4q1sV_, 0.8013, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3086, d4no1Y_, 0.8013, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3087, d4no1K_, 0.8013, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3088, d4hrcK_, 0.8013, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3089, d3unfN_, 0.8013, 1.69, 0.215, 199, 191, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3090, d3unfb_, 0.8013, 1.69, 0.215, 199, 191, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3091, d3unbK_, 0.8013, 1.81, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3092, d3shjX_, 0.8013, 1.79, 0.228, 198, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3093, d3okjY_, 0.8013, 2.02, 0.195, 212, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3094, d3okjK_, 0.8013, 2.02, 0.195, 212, 195, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3095, d3bdmY_, 0.8013, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3096, d2f16K_, 0.8013, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3097, d1jd2H_, 0.8013, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3098, d1g0uX_, 0.8013, 1.81, 0.228, 198, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3099, d5lajV_, 0.8012, 1.80, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3100, d5l65V_, 0.8012, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3101, d5l65H_, 0.8012, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3102, d5l54V_, 0.8012, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3103, d5l54H_, 0.8012, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3104, d5l52V_, 0.8012, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3105, d5l52H_, 0.8012, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3106, d5d0vY_, 0.8012, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3107, d5d0tY_, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3108, d5d0tK_, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3109, d5cgfH_, 0.8012, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3110, d5bxnK_, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3111, p4y75V_, 0.8012, 1.79, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3112, d4rurH_, 0.8012, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3113, d4r18V_, 0.8012, 1.80, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3114, d4r18H_, 0.8012, 1.80, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3115, d4r17H_, 0.8012, 1.80, 0.192, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3116, d4qzwY_, 0.8012, 2.03, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3117, d4qw7Y_, 0.8012, 2.02, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3118, d4qw7X_, 0.8012, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3119, d4qw7K_, 0.8012, 2.02, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3120, d4qw7J_, 0.8012, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3121, d4qw5J_, 0.8012, 1.70, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3122, d4qvpY_, 0.8012, 2.02, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3123, d4qvpK_, 0.8012, 2.02, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3124, d4qvlK_, 0.8012, 2.02, 0.195, 212, 195, YCP IN COMPLEX WITH BORTEZOMIB
3125, d4no8V_, 0.8012, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3126, d4no8H_, 0.8012, 1.79, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3127, d4hrcH_, 0.8012, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3128, p4gk7Y_, 0.8012, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3129, p4gk7K_, 0.8012, 2.02, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3130, d3shjJ_, 0.8012, 1.79, 0.228, 198, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3131, d3mg7K_, 0.8012, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3132, d3l5qY_, 0.8012, 1.79, 0.192, 222, 193,  
3133, d3bdmK_, 0.8012, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3134, d2gplK_, 0.8012, 2.03, 0.195, 212, 195, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3135, d1z7qW1, 0.8012, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3136, d1z7qI1, 0.8012, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3137, d5lajH_, 0.8011, 1.80, 0.192, 226, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3138, d5l6aV_, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3139, d5l6aH_, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3140, d5l5yV_, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3141, d5l5yH_, 0.8011, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3142, d5l5eV_, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3143, d5l5eH_, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3144, d5fhsV_, 0.8011, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3145, d5fhsH_, 0.8011, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3146, d5fgiX_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3147, d5fgeX_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3148, d5fgaH_, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3149, d5d0vJ_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3150, d5d0sY_, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3151, d5d0sK_, 0.8011, 2.02, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3152, d5cz9H_, 0.8011, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3153, d5cz5Y_, 0.8011, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3154, d5cz5K_, 0.8011, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3155, p5cggX_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3156, p5cggJ_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3157, d5cgfV_, 0.8011, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3158, p4ya9X_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3159, p4ya9J_, 0.8011, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3160, p4y8oV_, 0.8011, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3161, p4y8lH_, 0.8011, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3162, p4y82V_, 0.8011, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3163, p4y82H_, 0.8011, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3164, p4y6vV_, 0.8011, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3165, d4r17V_, 0.8011, 1.80, 0.192, 226, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3166, d4qzwK_, 0.8011, 2.03, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3167, d4qz6X_, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3168, d4qz6J_, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3169, d4qz0X_, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3170, d4qz0J_, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3171, d4qwgV_, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3172, d4qwgH_, 0.8011, 1.80, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3173, d4qw6Y_, 0.8011, 2.02, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3174, d4qvnK_, 0.8011, 2.02, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3175, d4qvnJ_, 0.8011, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3176, d4qvmY_, 0.8011, 2.03, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3177, d4qvmK_, 0.8011, 2.03, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3178, d4hrdV_, 0.8011, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3179, d3mg7Y_, 0.8011, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3180, d3mg6Y_, 0.8011, 2.02, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3181, d3l5qM_, 0.8011, 1.79, 0.192, 222, 193,  
3182, d2f16Y_, 0.8011, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3183, d1vsyW_, 0.8011, 1.79, 0.192, 222, 193,  
3184, d1vsyI_, 0.8011, 1.79, 0.192, 222, 193,  
3185, d1rypL_, 0.8011, 2.03, 0.190, 212, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3186, d5l63H_, 0.8010, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3187, d5l5wH_, 0.8010, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3188, d5jhsX_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3189, d5jhsJ_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3190, p5fghV_, 0.8010, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3191, p5fghH_, 0.8010, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3192, d5fgeJ_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3193, d5fgeH_, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3194, d5fgdV_, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3195, d5fgdH_, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3196, d5fgaV_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3197, d5d0zJ_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3198, d5d0wV_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3199, d5d0wH_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3200, d5d0vX_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3201, d5czaH_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3202, d5cz9X_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3203, d5cz9V_, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3204, d5cz9J_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3205, d5cz8X_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3206, d5cz8J_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3207, d5ahjX_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3208, d5ahjJ_, 0.8010, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3209, p4y8oH_, 0.8010, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3210, d4y8mV_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3211, d4y8mH_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3212, p4y82Y_, 0.8010, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3213, p4y82K_, 0.8010, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3214, p4y78K_, 0.8010, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3215, p4y6vH_, 0.8010, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3216, p4x6zY_, 0.8010, 1.76, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3217, d4rurV_, 0.8010, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3218, d4qwrJ_, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3219, d4qwjV_, 0.8010, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3220, d4qwjH_, 0.8010, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3221, d4qwgY_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3222, d4qwfX_, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3223, d4qwfJ_, 0.8010, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3224, d4qw6K_, 0.8010, 2.02, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3225, d4qvyY_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3226, d4qvyK_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3227, d4qvvY_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3228, d4qvvK_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3229, d4qvqY_, 0.8010, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3230, d4qvqK_, 0.8010, 2.02, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3231, d4qvnY_, 0.8010, 2.02, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3232, d4qv7H_, 0.8010, 1.80, 0.192, 226, 193, YCP BETA5-A50V MUTANT
3233, d4qv6Y_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT
3234, d4qv6K_, 0.8010, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT
3235, d3wxrY_, 0.8010, 1.81, 0.228, 198, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3236, d3un8H_, 0.8010, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3237, d3shjV_, 0.8010, 1.80, 0.192, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3238, d3nzxV_, 0.8010, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3239, d3nzxH_, 0.8010, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3240, d1jd2O_, 0.8010, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3241, d1g0uK_, 0.8010, 2.04, 0.195, 212, 195, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3242, d1g0uJ_, 0.8010, 1.81, 0.228, 198, 193, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3243, p5t0gO_, 0.8009, 1.61, 0.188, 193, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3244, p5mpbW_, 0.8009, 1.81, 0.192, 196, 193, 
3245, d5l68V_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3246, d5l68H_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3247, d5l63V_, 0.8009, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3248, d5l5wV_, 0.8009, 1.79, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3249, d5l5bH_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3250, d5l55X_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3251, d5l55J_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3252, d5fgiY_, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3253, d5fgiK_, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3254, d5fgeV_, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3255, d5d0zY_, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3256, d5d0zX_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3257, d5d0zK_, 0.8009, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3258, d5d0tX_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3259, d5d0tJ_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3260, d5czaV_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3261, d5cz4H_, 0.8009, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3262, d5bouV_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3263, d5bouH_, 0.8009, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3264, p4y8sY_, 0.8009, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3265, p4y8sK_, 0.8009, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3266, p4y8pX_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3267, p4y8pJ_, 0.8009, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3268, p4y80Y_, 0.8009, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3269, p4y80K_, 0.8009, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3270, p4y77H_, 0.8009, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3271, d4qz6Y_, 0.8009, 2.03, 0.185, 212, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3272, d4qz6K_, 0.8009, 2.03, 0.185, 212, 195, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3273, d4qwrX_, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3274, d4qwlY_, 0.8009, 2.02, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3275, d4qwgK_, 0.8009, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3276, d4qw5Y_, 0.8009, 2.03, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3277, d4qw5K_, 0.8009, 2.03, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3278, d4qvqX_, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3279, d4qvnX_, 0.8009, 1.70, 0.229, 195, 192, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3280, d4qv7V_, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-A50V MUTANT
3281, d4qv5V_, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45I MUTANT
3282, d4qv5H_, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45I MUTANT
3283, d4qv3V_, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45V MUTANT
3284, d4qv3H_, 0.8009, 1.80, 0.192, 226, 193, YCP BETA5-M45V MUTANT
3285, d4qltV_, 0.8009, 1.80, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3286, d4qltH_, 0.8009, 1.80, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3287, d4j70K_, 0.8009, 2.04, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3288, d4eu2W_, 0.8009, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3289, d3un8V_, 0.8009, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3290, d3shjH_, 0.8009, 1.80, 0.192, 222, 193, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3291, d3mg6K_, 0.8009, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3292, d2fnyK_, 0.8009, 2.04, 0.195, 212, 195,  
3293, d5l5bV_, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3294, d5l5aV_, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3295, d5jhsY_, 0.8008, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3296, d5jhsK_, 0.8008, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3297, d5fggV_, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3298, d5d0sV_, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3299, p5cggY_, 0.8008, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3300, p4ya7J_, 0.8008, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3301, d4y9yH_, 0.8008, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3302, p4y8nV_, 0.8008, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3303, p4y8nH_, 0.8008, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3304, p4y8iV_, 0.8008, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3305, p4y8gX_, 0.8008, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3306, p4y8gJ_, 0.8008, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3307, p4y7wY_, 0.8008, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3308, p4y78Y_, 0.8008, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3309, p4y77V_, 0.8008, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3310, d4r00Y_, 0.8008, 2.04, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3311, d4r00K_, 0.8008, 2.04, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3312, d4qz5Y_, 0.8008, 2.03, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3313, d4qz5K_, 0.8008, 2.03, 0.190, 212, 195, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3314, d4qz2X_, 0.8008, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3315, d4qz2J_, 0.8008, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3316, d4qwlK_, 0.8008, 2.03, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3317, d4qwlH_, 0.8008, 1.80, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3318, d4qwiV_, 0.8008, 1.81, 0.192, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3319, d4qwiH_, 0.8008, 1.81, 0.192, 222, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3320, d4qwfK_, 0.8008, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3321, d4qvqJ_, 0.8008, 1.70, 0.229, 195, 192, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3322, d4quxV_, 0.8008, 1.80, 0.192, 226, 193, YCP BETA5-A49T-MUTANT
3323, d4quxH_, 0.8008, 1.80, 0.192, 226, 193, YCP BETA5-A49T-MUTANT
3324, d4inuV_, 0.8008, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3325, d4hrdK_, 0.8008, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3326, d4hrdH_, 0.8008, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3327, p3uneY_, 0.8008, 1.81, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3328, d3e47Y_, 0.8008, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3329, d3e47K_, 0.8008, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3330, d2fnyY_, 0.8008, 2.04, 0.195, 212, 195,  
3331, d1jd2K_, 0.8008, 2.02, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3332, d1g65H_, 0.8008, 1.79, 0.192, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3333, p5mpbV_, 0.8007, 1.66, 0.230, 196, 191, 
3334, d5l5wY_, 0.8007, 1.80, 0.212, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3335, d5l5wK_, 0.8007, 1.80, 0.212, 211, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3336, d5l5aH_, 0.8007, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3337, d5l52X_, 0.8007, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3338, d5l52J_, 0.8007, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3339, d5fhsX_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3340, d5fhsJ_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3341, d5fggH_, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3342, d5d0sH_, 0.8007, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3343, d5cz5X_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3344, d5cz5J_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3345, d5cz4V_, 0.8007, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3346, p5cghY_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3347, p5cghK_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3348, p5cggK_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3349, p4ya7X_, 0.8007, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3350, d4y9yV_, 0.8007, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3351, p4y8lY_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3352, p4y8lK_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3353, p4y8iH_, 0.8007, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3354, p4y8hX_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3355, p4y8hJ_, 0.8007, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3356, p4y81Y_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3357, p4y81K_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3358, p4y7wK_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3359, p4y77Y_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3360, p4y70Y_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3361, p4y70K_, 0.8007, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3362, d4qz4X_, 0.8007, 1.71, 0.229, 195, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3363, d4qz4J_, 0.8007, 1.71, 0.229, 195, 192, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3364, d4qwsV_, 0.8007, 1.81, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3365, d4qwsH_, 0.8007, 1.81, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3366, d4qwlV_, 0.8007, 1.80, 0.192, 222, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3367, d4qwfY_, 0.8007, 2.03, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3368, d4qw4X_, 0.8007, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH CARFILZOMIB
3369, d4qw4J_, 0.8007, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH CARFILZOMIB
3370, d4qw1X_, 0.8007, 1.70, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3371, d4qvpX_, 0.8007, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3372, d4qvpJ_, 0.8007, 1.70, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3373, d4qv4V_, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-M45T MUTANT
3374, d4qv4H_, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-M45T MUTANT
3375, d4qv1V_, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-M45A MUTANT
3376, d4qv1H_, 0.8007, 1.80, 0.192, 226, 193, YCP BETA5-M45A MUTANT
3377, d4qv0K_, 0.8007, 2.04, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3378, d4qlvH_, 0.8007, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3379, d4qlqX_, 0.8007, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3380, d4qlqJ_, 0.8007, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3381, d4no8Y_, 0.8007, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3382, d3oeuK_, 0.8007, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3383, d3nzxY_, 0.8007, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3384, d3nzxK_, 0.8007, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3385, d2fakH_, 0.8007, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3386, d1rypZ_, 0.8007, 2.04, 0.190, 212, 195, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3387, p1fntW_, 0.8007, 1.68, 0.193, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3388, d5l5dV_, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3389, d5l5dH_, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3390, d5jhrV_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3391, d5jhrH_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3392, d5cz6V_, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3393, d5cz6H_, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3394, d5cz5V_, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3395, d5cz5H_, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3396, p5cghX_, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3397, p5cghJ_, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3398, d4z1lK_, 0.8006, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3399, d4ya4V_, 0.8006, 1.80, 0.197, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3400, d4ya4H_, 0.8006, 1.80, 0.197, 226, 193, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3401, d4ya1H_, 0.8006, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3402, p4y9zJ_, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3403, p4y8lJ_, 0.8006, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3404, p4y77K_, 0.8006, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3405, d4qzxY_, 0.8006, 2.03, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3406, d4qzxK_, 0.8006, 2.03, 0.195, 212, 195, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3407, d4qwxX_, 0.8006, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3408, d4qwxJ_, 0.8006, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3409, d4qw7H_, 0.8006, 1.81, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3410, d4qw4V_, 0.8006, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
3411, d4qw4H_, 0.8006, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH CARFILZOMIB
3412, d4qw1J_, 0.8006, 1.70, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3413, d4qw0Y_, 0.8006, 2.04, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3414, d4qv9Y_, 0.8006, 2.04, 0.195, 212, 195, YCP BETA5-C63F MUTANT
3415, d4qv9K_, 0.8006, 2.04, 0.195, 212, 195, YCP BETA5-C63F MUTANT
3416, d4qv8V_, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-C52F MUTANT
3417, d4qv8H_, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-C52F MUTANT
3418, d4quyV_, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-A49S-MUTANT
3419, d4quyH_, 0.8006, 1.80, 0.192, 226, 193, YCP BETA5-A49S-MUTANT
3420, d4qlvV_, 0.8006, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3421, d4qlsY_, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3422, d4qlsK_, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3423, d4no8K_, 0.8006, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3424, d4nnnJ_, 0.8006, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH MG132
3425, d4jt0V_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3426, d4jt0H_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3427, d4jsqV_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3428, d4jsqH_, 0.8006, 1.80, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3429, d4j70V_, 0.8006, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3430, p3unbj_, 0.8006, 1.79, 0.197, 195, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3431, d3mg8K_, 0.8006, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3432, d2fakV_, 0.8006, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3433, d1g65V_, 0.8006, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3434, p1fntI_, 0.8006, 1.68, 0.193, 195, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3435, p5mp9i_, 0.8005, 1.70, 0.198, 194, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3436, p5m32V_, 0.8005, 1.69, 0.187, 193, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3437, d5l6bV_, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3438, d5l6bH_, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3439, d5l5xV_, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3440, d5l5xH_, 0.8005, 1.80, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3441, d5fgfX_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3442, d5d0zV_, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3443, d5d0zH_, 0.8005, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3444, p5cgiX_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3445, p5cgiJ_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3446, d4z1lY_, 0.8005, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3447, p4ya2X_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3448, p4ya2J_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3449, p4y9zY_, 0.8005, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3450, p4y9zX_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3451, p4y8sX_, 0.8005, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3452, p4y8sJ_, 0.8005, 1.70, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3453, p4y8lX_, 0.8005, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3454, d4qzzY_, 0.8005, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH OMURALIDE
3455, d4qzzK_, 0.8005, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH OMURALIDE
3456, d4qzwX_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3457, d4qz7X_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3458, d4qz7J_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3459, d4qz5V_, 0.8005, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3460, d4qz5H_, 0.8005, 1.81, 0.192, 222, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3461, d4qz3Y_, 0.8005, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3462, d4qz3X_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3463, d4qz3J_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3464, d4qz1X_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3465, d4qz1J_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3466, d4qwuJ_, 0.8005, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3467, d4qw7V_, 0.8005, 1.81, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3468, d4qw0K_, 0.8005, 2.04, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3469, d4qv8Y_, 0.8005, 2.04, 0.195, 212, 195, YCP BETA5-C52F MUTANT
3470, d4qv8K_, 0.8005, 2.04, 0.195, 212, 195, YCP BETA5-C52F MUTANT
3471, d4qluX_, 0.8005, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3472, d4qluJ_, 0.8005, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3473, d4nnwX_, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3474, d4nnwJ_, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3475, d4nnnX_, 0.8005, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH MG132
3476, d4hrdY_, 0.8005, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3477, d4hnpY_, 0.8005, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3478, d4hnpK_, 0.8005, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3479, d4eu2K_, 0.8005, 1.78, 0.228, 196, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3480, p3unem_, 0.8005, 1.81, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3481, d3sdiK_, 0.8005, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3482, d3dy3V_, 0.8005, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3483, d3dy3H_, 0.8005, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3484, d1jd2R_, 0.8005, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3485, d1iruW_, 0.8005, 1.79, 0.192, 220, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3486, d5l54Y_, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3487, d5l54K_, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3488, d5l52Y_, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3489, d5l52K_, 0.8004, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3490, d5fgfV_, 0.8004, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3491, d5fgfH_, 0.8004, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3492, d5fgdX_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3493, d5fgdJ_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3494, d5bxnJ_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3495, d4z1lH_, 0.8004, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3496, p4ya7Y_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3497, p4ya7K_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3498, p4ya2Y_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3499, p4ya2K_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3500, d4ya1V_, 0.8004, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3501, p4y9zK_, 0.8004, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3502, p4y8pV_, 0.8004, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3503, p4y8pH_, 0.8004, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3504, p4y8kX_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3505, p4y8kJ_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3506, p4y8jK_, 0.8004, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3507, p4y77X_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3508, p4y77J_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3509, p4y75Y_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3510, p4y75X_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3511, p4y75K_, 0.8004, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3512, p4y75J_, 0.8004, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3513, p4y6zK_, 0.8004, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3514, d4r02X_, 0.8004, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3515, d4qzwJ_, 0.8004, 1.71, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3516, d4qw6V_, 0.8004, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3517, d4qw6H_, 0.8004, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3518, d4qv0Y_, 0.8004, 2.04, 0.185, 212, 195, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3519, d4qlvY_, 0.8004, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3520, d4qlvK_, 0.8004, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3521, d4no8J_, 0.8004, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3522, p3une1_, 0.8004, 1.82, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME
3523, p3unbm_, 0.8004, 1.82, 0.207, 201, 193, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3524, p3un4V_, 0.8004, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3525, p3un4H_, 0.8004, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3526, d3oevX_, 0.8004, 1.72, 0.229, 197, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3527, d3nzwY_, 0.8004, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3528, d3nzwK_, 0.8004, 2.03, 0.195, 212, 195, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3529, d3e47X_, 0.8004, 1.82, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3530, d3e47J_, 0.8004, 1.82, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3531, d2fnyX_, 0.8004, 1.82, 0.228, 198, 193,  
3532, d2fnyJ_, 0.8004, 1.82, 0.228, 198, 193,  
3533, d1iruI_, 0.8004, 1.79, 0.192, 220, 193, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3534, d5fgfJ_, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3535, d5bxnX_, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3536, d4z1lV_, 0.8003, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3537, p4y8oK_, 0.8003, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3538, p4y8jY_, 0.8003, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3539, p4y8iY_, 0.8003, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3540, p4y8iK_, 0.8003, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3541, p4y8gV_, 0.8003, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3542, p4y8gH_, 0.8003, 1.80, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3543, p4y7yX_, 0.8003, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3544, p4y74Y_, 0.8003, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3545, p4y6zY_, 0.8003, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3546, d4qzxX_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3547, d4qzxJ_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3548, d4qz5X_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3549, d4qz5J_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3550, d4qz3K_, 0.8003, 2.03, 0.190, 212, 195, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3551, d4qxjX_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3552, d4qxjJ_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3553, d4qwsX_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3554, d4qwsJ_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3555, d4qwrV_, 0.8003, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3556, d4qwrH_, 0.8003, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3557, d4qwkX_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3558, d4qwkJ_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3559, d4qwiX_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3560, d4qwiJ_, 0.8003, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3561, d4qw4Y_, 0.8003, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH CARFILZOMIB
3562, d4qw4K_, 0.8003, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH CARFILZOMIB
3563, d4qvyV_, 0.8003, 1.81, 0.192, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3564, d4qvyH_, 0.8003, 1.81, 0.192, 226, 193, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3565, d4qvlJ_, 0.8003, 1.70, 0.229, 195, 192, YCP IN COMPLEX WITH BORTEZOMIB
3566, d4qv0H_, 0.8003, 1.81, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3567, d4qlqV_, 0.8003, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3568, d4qlqH_, 0.8003, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3569, d4no9X_, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3570, d4no9J_, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3571, d4no9H_, 0.8003, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3572, d4no8X_, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3573, d4no1X_, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3574, d4no1J_, 0.8003, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3575, d4nnnK_, 0.8003, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH MG132
3576, d4j70H_, 0.8003, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3577, d3wxrW_, 0.8003, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3578, d3wxrI_, 0.8003, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3579, d3mg0Y_, 0.8003, 2.03, 0.195, 212, 195, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3580, d3d29V_, 0.8003, 1.81, 0.192, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3581, d3d29H_, 0.8003, 1.81, 0.192, 222, 193, PROTEASOME INHIBITION BY FELLUTAMIDE B
3582, d2zcyY_, 0.8003, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3583, d2zcyK_, 0.8003, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3584, d2gplY_, 0.8003, 1.88, 0.196, 212, 194, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3585, d1g0uY_, 0.8003, 1.88, 0.196, 212, 194, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3586, p5t0cZ_, 0.8002, 1.65, 0.236, 191, 191, 
3587, p5t0cFB_, 0.8002, 1.65, 0.236, 191, 191, 
3588, p5m32H_, 0.8002, 1.70, 0.187, 193, 192, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3589, d5l55Y_, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3590, d5l55K_, 0.8002, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3591, d5fgaY_, 0.8002, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3592, d5fgaK_, 0.8002, 2.05, 0.190, 212, 195, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3593, d5d0wY_, 0.8002, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3594, d5d0wK_, 0.8002, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3595, p5cgiY_, 0.8002, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3596, p5cgiK_, 0.8002, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3597, d5cgfY_, 0.8002, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3598, p5a5b2_, 0.8002, 1.76, 0.192, 197, 193, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3599, p4ya9Y_, 0.8002, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3600, p4y8pY_, 0.8002, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3601, p4y8oY_, 0.8002, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3602, p4y8jX_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3603, p4y8jJ_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3604, p4y8iX_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3605, p4y8iJ_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3606, p4y8hV_, 0.8002, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3607, p4y84X_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3608, p4y84J_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3609, p4y7yJ_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3610, p4y74K_, 0.8002, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3611, p4y74J_, 0.8002, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3612, d4qz3V_, 0.8002, 1.81, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3613, d4qz3H_, 0.8002, 1.81, 0.192, 222, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3614, d4qw5V_, 0.8002, 1.81, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3615, d4qw5H_, 0.8002, 1.81, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3616, d4qv0V_, 0.8002, 1.81, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3617, d4qltX_, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3618, d4qltJ_, 0.8002, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3619, d4no9V_, 0.8002, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3620, d4no1V_, 0.8002, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3621, d4no1H_, 0.8002, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3622, d4nnnY_, 0.8002, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH MG132
3623, d4hrcV_, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3624, p4cr32_, 0.8002, 1.76, 0.192, 197, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3625, d3tddY_, 0.8002, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3626, d3tddK_, 0.8002, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3627, d3sdiY_, 0.8002, 2.04, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3628, p3jcpRA_, 0.8002, 1.81, 0.192, 196, 193, 
3629, p3jcpD_, 0.8002, 1.81, 0.192, 196, 193, 
3630, d3e47V_, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3631, d2fnyV_, 0.8002, 1.81, 0.192, 222, 193,  
3632, d1rypW_, 0.8002, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3633, d1rypI_, 0.8002, 1.80, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3634, d5cgfK_, 0.8001, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3635, d5ahjY_, 0.8001, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3636, d5ahjK_, 0.8001, 2.03, 0.195, 212, 195, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3637, p4ya9K_, 0.8001, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3638, p4y8pK_, 0.8001, 2.03, 0.195, 197, 195, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3639, p4y8hH_, 0.8001, 1.81, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3640, p4y74X_, 0.8001, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3641, d4qwfV_, 0.8001, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3642, d4qwfH_, 0.8001, 1.81, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3643, d4qvmX_, 0.8001, 1.71, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3644, d4qvmJ_, 0.8001, 1.71, 0.229, 195, 192, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3645, d4qv9V_, 0.8001, 1.81, 0.192, 226, 193, YCP BETA5-C63F MUTANT
3646, d4qv9H_, 0.8001, 1.81, 0.192, 226, 193, YCP BETA5-C63F MUTANT
3647, d4qluY_, 0.8001, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3648, d4qluK_, 0.8001, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3649, d4qltY_, 0.8001, 2.03, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3650, d4qltK_, 0.8001, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3651, d4qlsX_, 0.8001, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3652, d4qlsJ_, 0.8001, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3653, d4g4sK_, 0.8001, 1.73, 0.229, 195, 192, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3654, d4fzcV_, 0.8001, 1.81, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3655, d4fzcH_, 0.8001, 1.81, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3656, d3e47H_, 0.8001, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3657, d3bdmV_, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3658, d3bdmH_, 0.8001, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3659, d2fnyH_, 0.8001, 1.81, 0.192, 222, 193,  
3660, d5l5fV_, 0.8000, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3661, d5l5fH_, 0.8000, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3662, d5dkjJ_, 0.8000, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3663, d5cz8V_, 0.8000, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3664, d5cz8H_, 0.8000, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3665, p5a0qW_, 0.8000, 1.57, 0.189, 198, 190, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3666, p5a0qI_, 0.8000, 1.57, 0.189, 198, 190, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3667, p4y82X_, 0.8000, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3668, p4y82J_, 0.8000, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3669, p4y7wX_, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3670, p4y7wJ_, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3671, p4y70X_, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3672, p4y70J_, 0.8000, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3673, d4r00V_, 0.8000, 1.81, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3674, d4r00H_, 0.8000, 1.81, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3675, d4qzwV_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3676, d4qzwH_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3677, d4qz4V_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3678, d4qz4H_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3679, d4qz0Y_, 0.8000, 2.04, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3680, d4qz0V_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3681, d4qz0K_, 0.8000, 2.04, 0.195, 212, 195, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3682, d4qz0H_, 0.8000, 1.81, 0.192, 222, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3683, d4qxjY_, 0.8000, 2.04, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3684, d4qxjV_, 0.8000, 1.82, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3685, d4qxjK_, 0.8000, 2.04, 0.200, 212, 195, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3686, d4qxjH_, 0.8000, 1.82, 0.192, 222, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3687, d4qvwJ_, 0.8000, 1.71, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3688, d4qvlX_, 0.8000, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH BORTEZOMIB
3689, d4qv6V_, 0.8000, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT
3690, d4qv6H_, 0.8000, 1.80, 0.192, 226, 193, YCP BETA5-A49V MUTANT
3691, d4quyK_, 0.8000, 2.05, 0.190, 212, 195, YCP BETA5-A49S-MUTANT
3692, p4qbyY_, 0.8000, 2.03, 0.195, 197, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3693, p4qbyK_, 0.8000, 2.03, 0.195, 197, 195, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3694, d4lqiY_, 0.8000, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3695, d4eu2L_, 0.8000, 2.04, 0.190, 212, 195, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3696, d3sdkY_, 0.8000, 2.04, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3697, d3dy4V_, 0.8000, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3698, d5lf3N1, 0.7999, 1.70, 0.236, 201, 191, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3699, d5l54J_, 0.7999, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3700, d5fg7Y_, 0.7999, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3701, d5fg7K_, 0.7999, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3702, d5dkjX_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3703, d5dkjV_, 0.7999, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3704, d5czaY_, 0.7999, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3705, d5czaK_, 0.7999, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3706, p4y8qX_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3707, p4y8qJ_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3708, p4y80X_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3709, p4y80J_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3710, p4y6zX_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3711, p4y6zJ_, 0.7999, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3712, d4qzxV_, 0.7999, 1.82, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3713, d4qzxH_, 0.7999, 1.82, 0.192, 222, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3714, d4qwxV_, 0.7999, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3715, d4qwxH_, 0.7999, 1.81, 0.192, 222, 193, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3716, d4qwuX_, 0.7999, 1.72, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3717, d4lqiK_, 0.7999, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3718, d4eu2Y_, 0.7999, 1.81, 0.228, 196, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3719, d3sdkK_, 0.7999, 2.04, 0.195, 212, 195, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3720, d3dy4H_, 0.7999, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3721, p5mpa5_, 0.7998, 1.89, 0.196, 197, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3722, d5l5zV_, 0.7998, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3723, d5l54X_, 0.7998, 1.71, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3724, d5dkjH_, 0.7998, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3725, d5d0vV_, 0.7998, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3726, d4ya4Y_, 0.7998, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3727, d4ya4K_, 0.7998, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3728, d4y8rV_, 0.7998, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3729, d4y8rK_, 0.7998, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3730, d4y8rH_, 0.7998, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3731, p4y78X_, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3732, p4y78J_, 0.7998, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3733, p4v7oK_, 0.7998, 1.82, 0.228, 198, 193, 
3734, d4qzzV_, 0.7998, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH OMURALIDE
3735, d4qzzH_, 0.7998, 1.81, 0.192, 226, 193, YCP IN COMPLEX WITH OMURALIDE
3736, d4qz6V_, 0.7998, 1.82, 0.192, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3737, d4qz6H_, 0.7998, 1.82, 0.192, 222, 193, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3738, d4qwgX_, 0.7998, 1.72, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3739, d4qwgJ_, 0.7998, 1.72, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3740, d4qvwX_, 0.7998, 1.72, 0.229, 195, 192, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3741, d4qv6J_, 0.7998, 1.72, 0.229, 195, 192, YCP BETA5-A49V MUTANT
3742, d4qv4Y_, 0.7998, 1.89, 0.196, 212, 194, YCP BETA5-M45T MUTANT
3743, d4qv4K_, 0.7998, 1.89, 0.196, 212, 194, YCP BETA5-M45T MUTANT
3744, d4qv1Y_, 0.7998, 1.89, 0.201, 212, 194, YCP BETA5-M45A MUTANT
3745, d4qv1K_, 0.7998, 1.89, 0.201, 212, 194, YCP BETA5-M45A MUTANT
3746, d4quxK_, 0.7998, 1.89, 0.191, 212, 194, YCP BETA5-A49T-MUTANT
3747, p4qbyJ_, 0.7998, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3748, d4no6X_, 0.7998, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3749, d4no6J_, 0.7998, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3750, d4j70Y_, 0.7998, 1.88, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3751, d4g4sI_, 0.7998, 1.81, 0.192, 220, 193, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3752, d3tddH_, 0.7998, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3753, d3mkaR_, 0.7998, 2.09, 0.184, 246, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
3754, d3l5qO_, 0.7998, 1.82, 0.228, 198, 193,  
3755, d3gpjV_, 0.7998, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3756, d3gpjH_, 0.7998, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3757, d3dy3X_, 0.7998, 1.82, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3758, d3dy3J_, 0.7998, 1.82, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3759, d2gplV_, 0.7998, 1.81, 0.192, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3760, d2gplH_, 0.7998, 1.81, 0.192, 222, 193, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3761, d5l5zH_, 0.7997, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3762, d5dkiV_, 0.7997, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3763, d5dkiH_, 0.7997, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3764, d5d0vH_, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3765, d5cz6Y_, 0.7997, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3766, d5cz6K_, 0.7997, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3767, d5ahjV_, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3768, d5ahjH_, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3769, p4y8hY_, 0.7997, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3770, p4v7oY_, 0.7997, 1.82, 0.228, 198, 193, 
3771, p4v7oGB_, 0.7997, 1.82, 0.228, 198, 193, 
3772, d4r02J_, 0.7997, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3773, d4qz4Y_, 0.7997, 2.04, 0.190, 212, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3774, d4qz4K_, 0.7997, 2.04, 0.190, 212, 195, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3775, d4qwjX_, 0.7997, 1.72, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3776, d4qwjJ_, 0.7997, 1.72, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3777, d4qv7Y_, 0.7997, 2.05, 0.190, 212, 195, YCP BETA5-A50V MUTANT
3778, d4qv7K_, 0.7997, 2.05, 0.190, 212, 195, YCP BETA5-A50V MUTANT
3779, d4qv5K_, 0.7997, 1.89, 0.196, 212, 194, YCP BETA5-M45I MUTANT
3780, d4qv3Y_, 0.7997, 1.89, 0.196, 212, 194, YCP BETA5-M45V MUTANT
3781, d4qv3K_, 0.7997, 1.89, 0.196, 212, 194, YCP BETA5-M45V MUTANT
3782, d4quxY_, 0.7997, 1.89, 0.191, 212, 194, YCP BETA5-A49T-MUTANT
3783, p4qbyX_, 0.7997, 1.71, 0.229, 195, 192, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3784, d4no9Y_, 0.7997, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3785, d4no9K_, 0.7997, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3786, d4no6K_, 0.7997, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3787, d4jsuV_, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3788, d4jsuH_, 0.7997, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3789, d4fzgV_, 0.7997, 1.81, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3790, d3tddV_, 0.7997, 1.81, 0.192, 222, 193, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3791, d3l5q1_, 0.7997, 1.82, 0.228, 198, 193,  
3792, d3dy4Y_, 0.7997, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3793, d3dy4K_, 0.7997, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3794, d1vsyY_, 0.7997, 1.82, 0.228, 198, 193,  
3795, d5l66V_, 0.7996, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3796, d5l66H_, 0.7996, 1.81, 0.192, 226, 193, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3797, p4zzgZ_, 0.7996, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3798, p4ya0Y_, 0.7996, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3799, p4ya0K_, 0.7996, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3800, p4y8hK_, 0.7996, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3801, p4y81J_, 0.7996, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3802, p4v7oSA_, 0.7996, 1.82, 0.228, 198, 193, 
3803, d4qz2V_, 0.7996, 1.82, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3804, d4qz2H_, 0.7996, 1.82, 0.192, 222, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3805, d4qwxK_, 0.7996, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3806, d4qw0V_, 0.7996, 1.82, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3807, d4qw0H_, 0.7996, 1.82, 0.192, 226, 193, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3808, d4qv6X_, 0.7996, 1.72, 0.229, 195, 192, YCP BETA5-A49V MUTANT
3809, d4qv5Y_, 0.7996, 1.89, 0.196, 212, 194, YCP BETA5-M45I MUTANT
3810, d4no6Y_, 0.7996, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3811, d4fzgH_, 0.7996, 1.81, 0.192, 222, 193, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3812, d3mg0H_, 0.7996, 1.82, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3813, d3gpwV_, 0.7996, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3814, d3gpwH_, 0.7996, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3815, d2zcyV_, 0.7996, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3816, d2zcyH_, 0.7996, 1.81, 0.192, 222, 193, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3817, d1vsyK_, 0.7996, 1.82, 0.228, 198, 193,  
3818, p6gopX_, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3819, p6gopJ_, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3820, d5d0xV_, 0.7995, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3821, d5d0xH_, 0.7995, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3822, p4zzgL_, 0.7995, 1.88, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3823, p4y8oX_, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3824, p4y8oJ_, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3825, p4y81X_, 0.7995, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3826, d4qz1V_, 0.7995, 1.82, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3827, d4qz1H_, 0.7995, 1.82, 0.192, 222, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3828, d4qwxY_, 0.7995, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3829, d4hrcY_, 0.7995, 2.04, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3830, d3wxrL_, 0.7995, 2.05, 0.195, 212, 195, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3831, d3mg0V_, 0.7995, 1.82, 0.192, 222, 193, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3832, d3dy3Y_, 0.7995, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3833, d3dy3K_, 0.7995, 2.05, 0.195, 212, 195, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3834, d5lajY_, 0.7994, 1.90, 0.196, 212, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3835, d5lajK_, 0.7994, 1.90, 0.196, 212, 194, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3836, d5cz7V_, 0.7994, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3837, d5cz7H_, 0.7994, 1.82, 0.192, 226, 193, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3838, p4ya5Y_, 0.7994, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3839, p4ya5K_, 0.7994, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3840, p4ya3Y_, 0.7994, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3841, p4ya3K_, 0.7994, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3842, p4y8tX_, 0.7994, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3843, p4y8tJ_, 0.7994, 1.72, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3844, p4y8gK_, 0.7994, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3845, p4y69K_, 0.7994, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3846, d4qz7Y_, 0.7994, 2.04, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3847, d4qz7K_, 0.7994, 2.04, 0.190, 212, 195, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3848, d4qz2Y_, 0.7994, 2.04, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3849, d4qz2K_, 0.7994, 2.04, 0.195, 212, 195, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3850, d4qw3J_, 0.7994, 1.72, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3851, d4qvwV_, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3852, d4qvwH_, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3853, d4qvvV_, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3854, d4qvvH_, 0.7994, 1.82, 0.192, 226, 193, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3855, d4qvlV_, 0.7994, 1.82, 0.192, 226, 193, YCP IN COMPLEX WITH BORTEZOMIB
3856, d4qvlH_, 0.7994, 1.82, 0.192, 226, 193, YCP IN COMPLEX WITH BORTEZOMIB
3857, d4qlqY_, 0.7994, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3858, d4qlqK_, 0.7994, 2.04, 0.195, 212, 195, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3859, d4fzcY_, 0.7994, 2.05, 0.195, 212, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3860, d4fzcK_, 0.7994, 2.05, 0.195, 212, 195, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3861, d3d29Y_, 0.7994, 2.04, 0.195, 212, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
3862, d3d29K_, 0.7994, 2.04, 0.195, 212, 195, PROTEASOME INHIBITION BY FELLUTAMIDE B
3863, d5l63X_, 0.7993, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3864, d5l63J_, 0.7993, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3865, d5l61X_, 0.7993, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3866, d5l61J_, 0.7993, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3867, p4zzgY_, 0.7993, 1.82, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3868, p4y8gY_, 0.7993, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3869, p4y84Y_, 0.7993, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3870, p4y84K_, 0.7993, 2.04, 0.195, 197, 195, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3871, p4y6vY_, 0.7993, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3872, p4y6vK_, 0.7993, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3873, p4y69Y_, 0.7993, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3874, p4x6zL_, 0.7993, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3875, d4nnwV_, 0.7993, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3876, d4nnwH_, 0.7993, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3877, d3hyeH_, 0.7993, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3878, p5nifZ_, 0.7992, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3879, p5nifL_, 0.7992, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3880, p5mpcW_, 0.7992, 1.85, 0.192, 196, 193, 
3881, d5l5wX_, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3882, d5l5wJ_, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3883, d5cz4K_, 0.7992, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3884, d4y9yY_, 0.7992, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3885, d4y9yK_, 0.7992, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3886, p4y8uK_, 0.7992, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3887, p4y8tV_, 0.7992, 1.82, 0.192, 196, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3888, p4y8tH_, 0.7992, 1.82, 0.192, 196, 193, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3889, p4y8nY_, 0.7992, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3890, p4y8nK_, 0.7992, 1.89, 0.196, 197, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3891, p4y7xX_, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3892, p4y7xJ_, 0.7992, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3893, p4v7oTA_, 0.7992, 1.89, 0.191, 196, 194, 
3894, p4v7oL_, 0.7992, 1.89, 0.191, 197, 194, 
3895, d4qw3X_, 0.7992, 1.73, 0.229, 195, 192, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3896, d4fzgK_, 0.7992, 2.05, 0.195, 212, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3897, d3wxrZ_, 0.7992, 1.89, 0.196, 212, 194, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3898, d3l5qP_, 0.7992, 1.89, 0.191, 212, 194,  
3899, d3hyeV_, 0.7992, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3900, d1vsyL_, 0.7992, 1.89, 0.191, 212, 194,  
3901, p5mp95_, 0.7991, 1.89, 0.196, 197, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3902, d5l64J_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3903, d5l62X_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3904, d5l62J_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3905, d5l5zX_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3906, d5l5zJ_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3907, d5l5xX_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3908, d5l5xJ_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3909, d5fgaJ_, 0.7991, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3910, d5cz4Y_, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3911, p4y8uY_, 0.7991, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3912, p4x6zZ_, 0.7991, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3913, p4v7oZ_, 0.7991, 1.89, 0.191, 197, 194, 
3914, d4rurY_, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3915, d4rurK_, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3916, d4qz1Y_, 0.7991, 2.05, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3917, d4qz1K_, 0.7991, 2.05, 0.195, 212, 195, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3918, d4qw1V_, 0.7991, 1.82, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3919, d4qw1H_, 0.7991, 1.82, 0.192, 226, 193, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3920, d4qv8X_, 0.7991, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT
3921, d4qv8J_, 0.7991, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT
3922, d4quyY_, 0.7991, 1.90, 0.191, 212, 194, YCP BETA5-A49S-MUTANT
3923, d4qlvX_, 0.7991, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3924, d4qlvJ_, 0.7991, 1.72, 0.229, 195, 192, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3925, d4q1sK_, 0.7991, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3926, d4nnnH_, 0.7991, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH MG132
3927, d4fzgY_, 0.7991, 2.05, 0.195, 212, 195, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3928, d3l5q2_, 0.7991, 1.89, 0.191, 212, 194,  
3929, d3dy4J_, 0.7991, 1.83, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3930, p5nifY_, 0.7990, 1.83, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3931, d5l64X_, 0.7990, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3932, d5bouY_, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3933, d5bouK_, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3934, d4ya1Y_, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3935, d4ya1K_, 0.7990, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3936, p4y6aY_, 0.7990, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3937, p4y6aK_, 0.7990, 1.90, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3938, p4x6zK_, 0.7990, 1.84, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3939, p4v7oHB_, 0.7990, 1.89, 0.191, 197, 194, 
3940, d4r00X_, 0.7990, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3941, d4r00J_, 0.7990, 1.73, 0.229, 195, 192, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3942, d4qw3V_, 0.7990, 1.82, 0.192, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3943, d4qw3H_, 0.7990, 1.82, 0.192, 226, 193, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3944, d4qvmV_, 0.7990, 1.82, 0.192, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3945, d4qvmH_, 0.7990, 1.82, 0.192, 226, 193, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3946, d4no6V_, 0.7990, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3947, d4no6H_, 0.7990, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3948, d4nnnV_, 0.7990, 1.82, 0.192, 222, 193, YCP IN COMPLEX WITH MG132
3949, d3gptV_, 0.7990, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3950, d3gptH_, 0.7990, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3951, d3dy4X_, 0.7990, 1.83, 0.228, 198, 193, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3952, d1vsyZ_, 0.7990, 1.89, 0.191, 212, 194,  
3953, p5wvkH_, 0.7989, 1.67, 0.230, 196, 191, 
3954, p5t0cIB_, 0.7989, 2.03, 0.224, 199, 196, 
3955, p5t0cCA_, 0.7989, 2.03, 0.224, 199, 196, 
3956, d5fgaX_, 0.7989, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3957, d5dkiJ_, 0.7989, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3958, d5bxlY_, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3959, d5bxlK_, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3960, d4y8rY_, 0.7989, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3961, d4qzzJ_, 0.7989, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH OMURALIDE
3962, d4qv5X_, 0.7989, 1.74, 0.229, 195, 192, YCP BETA5-M45I MUTANT
3963, d4qv1X_, 0.7989, 1.73, 0.229, 195, 192, YCP BETA5-M45A MUTANT
3964, d4qv1J_, 0.7989, 1.73, 0.229, 195, 192, YCP BETA5-M45A MUTANT
3965, d4qv0X_, 0.7989, 1.74, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3966, d4qv0J_, 0.7989, 1.74, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3967, d4eu2Z_, 0.7989, 1.90, 0.191, 212, 194, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3968, d2f16H_, 0.7989, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3969, d5l60X_, 0.7988, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3970, d5l60J_, 0.7988, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3971, d5l5yX_, 0.7988, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3972, d5l5yJ_, 0.7988, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3973, d5dkiX_, 0.7988, 1.73, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3974, d4y8mY_, 0.7988, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3975, d4y8mK_, 0.7988, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3976, d4qzzX_, 0.7988, 1.73, 0.229, 195, 192, YCP IN COMPLEX WITH OMURALIDE
3977, d4qvvX_, 0.7988, 1.72, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3978, d4qv9X_, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-C63F MUTANT
3979, d4qv9J_, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-C63F MUTANT
3980, d4qv5J_, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-M45I MUTANT
3981, d4qv4J_, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-M45T MUTANT
3982, d4quyJ_, 0.7988, 1.74, 0.229, 195, 192, YCP BETA5-A49S-MUTANT
3983, d2f16V_, 0.7988, 1.82, 0.192, 222, 193, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3984, d5fg9Y_, 0.7987, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3985, d5fg9K_, 0.7987, 1.90, 0.196, 212, 194, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3986, d5d0xX_, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3987, d5d0xJ_, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3988, d5cz7X_, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3989, d5cz7J_, 0.7987, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3990, d4qvyX_, 0.7987, 1.73, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3991, d4qvyJ_, 0.7987, 1.73, 0.229, 195, 192, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3992, d4quyX_, 0.7987, 1.74, 0.229, 195, 192, YCP BETA5-A49S-MUTANT
3993, d4g4sL_, 0.7987, 2.05, 0.195, 212, 195, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3994, p5mpcI_, 0.7986, 1.73, 0.198, 194, 192, 
3995, p5fghX_, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3996, p5fghJ_, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3997, d5czaX_, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3998, d5czaJ_, 0.7986, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3999, p4zzgK_, 0.7986, 1.84, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4000, d4qvqV_, 0.7986, 1.83, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4001, d4qvqH_, 0.7986, 1.83, 0.192, 226, 193, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4002, d4qv3X_, 0.7986, 1.74, 0.229, 195, 192, YCP BETA5-M45V MUTANT
4003, d4qv3J_, 0.7986, 1.74, 0.229, 195, 192, YCP BETA5-M45V MUTANT
4004, p3jcpUA_, 0.7986, 1.91, 0.196, 212, 194, 
4005, p3jcpG_, 0.7986, 1.91, 0.196, 212, 194, 
4006, d4ya4X_, 0.7985, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4007, d4ya4J_, 0.7985, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4008, d4qvpV_, 0.7985, 1.83, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4009, d4qvpH_, 0.7985, 1.83, 0.192, 226, 193, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4010, d4qv4X_, 0.7985, 1.74, 0.229, 195, 192, YCP BETA5-M45T MUTANT
4011, d5d0wX_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4012, d5d0wJ_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4013, d5cz6X_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4014, d5cz6J_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4015, d5bxlX_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4016, d5bxlJ_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4017, p4y8tY_, 0.7984, 1.91, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4018, p4y8tK_, 0.7984, 1.91, 0.196, 197, 194, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4019, d4y8rJ_, 0.7984, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4020, d4qw0J_, 0.7984, 1.74, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4021, d4qvvJ_, 0.7984, 1.74, 0.229, 195, 192, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4022, d4qvnV_, 0.7984, 1.83, 0.192, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4023, d4qvnH_, 0.7984, 1.83, 0.192, 226, 193, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4024, d4nnwY_, 0.7984, 2.05, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4025, d4nnwK_, 0.7984, 2.05, 0.195, 212, 195, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4026, p6gopV_, 0.7983, 1.83, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4027, p6gopH_, 0.7983, 1.83, 0.192, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4028, d4y8rX_, 0.7983, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4029, d4qw0X_, 0.7983, 1.74, 0.229, 195, 192, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4030, p3jcpTA_, 0.7983, 1.97, 0.227, 198, 194, 
4031, p3jcpF_, 0.7983, 1.97, 0.227, 198, 194, 
4032, p5nifK_, 0.7982, 1.85, 0.228, 196, 193, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4033, d4y9yJ_, 0.7982, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4034, d4qv7X_, 0.7982, 1.75, 0.229, 195, 192, YCP BETA5-A50V MUTANT
4035, d5cgfX_, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4036, d5cgfJ_, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4037, d5bxnV_, 0.7981, 1.89, 0.187, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4038, d4y9yX_, 0.7981, 1.74, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4039, p1fntY_, 0.7981, 1.88, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4040, p1fntK_, 0.7981, 1.88, 0.228, 198, 193, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4041, p5vfpGA_, 0.7980, 1.74, 0.193, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4042, d4ya1X_, 0.7980, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4043, d4qwuV_, 0.7980, 1.83, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4044, d4qwuH_, 0.7980, 1.83, 0.192, 226, 193, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4045, d4quxJ_, 0.7980, 1.74, 0.229, 195, 192, YCP BETA5-A49T-MUTANT
4046, d5fg7X_, 0.7979, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4047, d5fg7J_, 0.7979, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4048, d4ya1J_, 0.7979, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4049, p4y8uX_, 0.7979, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4050, p4y8uJ_, 0.7979, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4051, d4quxX_, 0.7979, 1.75, 0.229, 195, 192, YCP BETA5-A49T-MUTANT
4052, p5mp94_, 0.7978, 1.75, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4053, d5bouX_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4054, d5bouJ_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4055, d4z1lX_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4056, d4z1lJ_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4057, d4y8mX_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4058, d4y8mJ_, 0.7978, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4059, d4r18X_, 0.7978, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4060, d4r18J_, 0.7978, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4061, d4r17X_, 0.7978, 1.74, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4062, d4r17J_, 0.7978, 1.74, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4063, d4qv7J_, 0.7978, 1.76, 0.229, 195, 192, YCP BETA5-A50V MUTANT
4064, d5lajX_, 0.7977, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4065, d5lajJ_, 0.7977, 1.74, 0.229, 195, 192, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4066, p4v7oW_, 0.7977, 1.65, 0.194, 194, 191, 
4067, d5fg9X_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4068, d5fg9J_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4069, p4y6aX_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4070, p4y6aJ_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4071, p4y69X_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4072, p4y69J_, 0.7976, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4073, p4v7oQA_, 0.7976, 1.65, 0.194, 194, 191, 
4074, p4v7oI_, 0.7976, 1.65, 0.194, 194, 191, 
4075, p4v7oEB_, 0.7976, 1.65, 0.194, 194, 191, 
4076, d3wxrK_, 0.7976, 1.82, 0.229, 197, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4077, p5vfro_, 0.7975, 1.76, 0.193, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4078, p5vfqHA_, 0.7975, 1.75, 0.193, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4079, p5mp9l_, 0.7975, 1.91, 0.196, 197, 194, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4080, p4y8nJ_, 0.7975, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4081, p4y8lV_, 0.7975, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4082, p4zzgW_, 0.7974, 1.65, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4083, p4y6vX_, 0.7974, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4084, p4y6vJ_, 0.7974, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4085, p4y6aH_, 0.7974, 1.66, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4086, p4ya5H_, 0.7973, 1.66, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4087, p4y8nX_, 0.7973, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4088, p4y6aV_, 0.7973, 1.66, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4089, d4rurX_, 0.7973, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4090, d4rurJ_, 0.7973, 1.75, 0.229, 195, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4091, p5wvkD_, 0.7972, 1.79, 0.228, 198, 193, 
4092, p5nifW_, 0.7972, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4093, p5mpbH_, 0.7972, 1.86, 0.229, 196, 192, 
4094, p4ya5V_, 0.7972, 1.66, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4095, p4ya5J_, 0.7972, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4096, p1fntZ_, 0.7972, 1.92, 0.191, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4097, p1fntL_, 0.7972, 1.92, 0.191, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4098, p5vfqI_, 0.7971, 1.76, 0.193, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4099, p5vfoO_, 0.7971, 1.76, 0.193, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4100, p4ya5X_, 0.7971, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4101, p4y84H_, 0.7971, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4102, p4y6zV_, 0.7971, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4103, p4y6zH_, 0.7971, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4104, p4y69H_, 0.7971, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4105, p1z7qL_, 0.7971, 1.92, 0.191, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4106, p6epf6_, 0.7970, 2.66, 0.053, 213, 208, GROUND STATE 26S PROTEASOME (GS1)
4107, p5nifI_, 0.7970, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4108, p4zzgI_, 0.7970, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4109, p4y8uH_, 0.7970, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4110, p4y84V_, 0.7970, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4111, p4y69V_, 0.7970, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4112, p1z7qZ_, 0.7970, 1.92, 0.191, 197, 194, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4113, d5laiX_, 0.7969, 1.76, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4114, d5laiJ_, 0.7969, 1.76, 0.229, 195, 192, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4115, d5bxlH_, 0.7969, 2.02, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4116, p4y8uV_, 0.7969, 1.66, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4117, p5vfoo_, 0.7968, 1.76, 0.193, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4118, p5mpal_, 0.7968, 1.93, 0.196, 197, 194, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4119, p4ya3V_, 0.7968, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4120, p4ya3J_, 0.7968, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4121, p4ya3H_, 0.7968, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4122, p4ya0H_, 0.7968, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4123, d5bxnH_, 0.7967, 2.02, 0.192, 222, 193, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4124, p4ya3X_, 0.7967, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4125, p4ya0V_, 0.7967, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4126, p4y80V_, 0.7967, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4127, p4y80H_, 0.7967, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4128, d5cz4X_, 0.7966, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4129, p4ya0X_, 0.7966, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4130, p4ya0J_, 0.7966, 1.76, 0.229, 195, 192, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4131, d5cz4J_, 0.7965, 1.77, 0.229, 195, 192, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4132, p5cgiV_, 0.7965, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4133, p5cgiH_, 0.7965, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4134, p5fmgX_, 0.7964, 1.49, 0.207, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4135, p5fmgJ_, 0.7964, 1.49, 0.207, 191, 188, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4136, p4y74V_, 0.7963, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4137, p4y74H_, 0.7963, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4138, p4y70V_, 0.7963, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4139, p5vfpI_, 0.7962, 1.77, 0.193, 193, 192, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4140, p4y7wV_, 0.7962, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4141, p4y70H_, 0.7962, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4142, p4y7wH_, 0.7961, 1.67, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4143, d3mkaX_, 0.7961, 2.46, 0.180, 249, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4144, p5wvkE_, 0.7960, 1.95, 0.196, 197, 194, 
4145, p4y8jV_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4146, p4y8jH_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4147, p4y7yV_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4148, p4y7yH_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4149, p4y78V_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4150, p4y78H_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4151, p4qbyV_, 0.7960, 1.68, 0.194, 194, 191, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4152, p4qbyH_, 0.7960, 1.68, 0.194, 194, 191, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4153, p4gk7H_, 0.7960, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4154, d5l5dX_, 0.7959, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4155, d5l5dJ_, 0.7959, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4156, d5bxlV_, 0.7959, 1.89, 0.193, 222, 192, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4157, p4ya2V_, 0.7959, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4158, p4ya2H_, 0.7959, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4159, p4gk7V_, 0.7959, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4160, p4y9zV_, 0.7958, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4161, p4y9zH_, 0.7958, 1.68, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4162, p5mpbZ_, 0.7957, 1.94, 0.196, 197, 194, 
4163, p4ya7V_, 0.7957, 1.68, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4164, p4ya7H_, 0.7957, 1.68, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4165, d5l6bJ_, 0.7956, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4166, d5l5jX_, 0.7956, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4167, d5l5jJ_, 0.7956, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4168, p5mp9k_, 0.7955, 1.80, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4169, d5l6bX_, 0.7955, 1.79, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4170, d5l5oJ_, 0.7955, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4171, p4ya9V_, 0.7955, 1.68, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4172, p4ya9H_, 0.7955, 1.68, 0.199, 194, 191, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4173, p5t0gN_, 0.7954, 1.70, 0.236, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4174, d5l5uX_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4175, d5l5uJ_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4176, d5l5tX_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4177, d5l5tJ_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4178, d5l5oX_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4179, d5l5iX_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4180, d5l5iJ_, 0.7954, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4181, d4r18Y_, 0.7954, 1.89, 0.197, 211, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4182, d4r18K_, 0.7954, 1.89, 0.197, 211, 193, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4183, d5l5hX_, 0.7953, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4184, d5l5hJ_, 0.7953, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4185, p5vfrO_, 0.7952, 1.78, 0.193, 193, 192, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4186, d5l6aX_, 0.7952, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4187, d5l6aJ_, 0.7952, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4188, d5l68X_, 0.7952, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4189, d5l68J_, 0.7952, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4190, p4y8sH_, 0.7952, 1.69, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4191, p6epe3_, 0.7951, 2.23, 0.050, 205, 199, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4192, d5l65X_, 0.7951, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4193, d5l65J_, 0.7951, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4194, d5l5sX_, 0.7951, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4195, d5l5sJ_, 0.7951, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4196, p4y8sV_, 0.7951, 1.69, 0.194, 194, 191, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4197, p5t0hO_, 0.7950, 1.82, 0.192, 195, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4198, d5l66X_, 0.7950, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4199, d5l66J_, 0.7950, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4200, d5lttJ_, 0.7949, 1.80, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4201, d5l5qX_, 0.7949, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4202, d5l5qJ_, 0.7949, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4203, d5l5fX_, 0.7949, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4204, d5l5fJ_, 0.7949, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4205, d1z7qK1, 0.7949, 1.86, 0.229, 197, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4206, d5m2bJ_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4207, d5lttX_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4208, d5l5vX_, 0.7948, 1.81, 0.229, 195, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4209, d5l5vJ_, 0.7948, 1.81, 0.229, 195, 192,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4210, d5l5rX_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4211, d5l5rJ_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4212, d5l5pX_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4213, d5l5pJ_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4214, d5l5bJ_, 0.7948, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4215, d4r17Y_, 0.7948, 1.90, 0.197, 211, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4216, d4r17K_, 0.7948, 1.90, 0.197, 211, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4217, d1z7qY1, 0.7948, 1.86, 0.229, 197, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4218, d5m2bX_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4219, d5l6cX_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4220, d5l6cJ_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4221, d5l67X_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4222, d5l67J_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4223, d5l5bX_, 0.7947, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4224, p5mpak_, 0.7946, 1.78, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4225, d5l69X_, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4226, d5l69J_, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4227, d5l5eX_, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4228, d5l5eJ_, 0.7946, 1.81, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4229, p3jcoRA_, 0.7946, 1.86, 0.192, 196, 193, 
4230, p3jcoD_, 0.7946, 1.86, 0.192, 196, 193, 
4231, d5laiY_, 0.7944, 1.91, 0.197, 211, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4232, d5laiK_, 0.7944, 1.91, 0.197, 211, 193, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4233, d5l5aJ_, 0.7943, 1.82, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4234, p5wviEA_, 0.7942, 2.15, 0.222, 205, 198, 
4235, d5l5aX_, 0.7942, 1.82, 0.229, 195, 192, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4236, d4q1sY_, 0.7939, 1.91, 0.197, 211, 193, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4237, d5ts0W_, 0.7937, 2.02, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4238, p5ln31_, 0.7936, 2.32, 0.226, 214, 199, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4239, d4qwuY_, 0.7936, 2.13, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4240, d4qwuK_, 0.7936, 2.12, 0.195, 212, 195, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4241, p5mpbK_, 0.7935, 1.80, 0.229, 195, 192, 
4242, p3jcoTA_, 0.7930, 2.02, 0.227, 198, 194, 
4243, p3jcoF_, 0.7930, 2.02, 0.227, 198, 194, 
4244, p5mpa4_, 0.7929, 1.81, 0.229, 195, 192, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4245, d5trrW_, 0.7926, 2.04, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4246, p5lzpI_, 0.7926, 2.04, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4247, p3jcoUA_, 0.7926, 1.99, 0.196, 212, 194, 
4248, p5lzpC_, 0.7925, 2.04, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4249, d5ts0I_, 0.7924, 2.04, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4250, p5t0iN_, 0.7924, 1.74, 0.236, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4251, d5trsW_, 0.7923, 2.04, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4252, d5trrI_, 0.7923, 2.04, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4253, d5tryW_, 0.7922, 2.03, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4254, p3jcoG_, 0.7922, 1.99, 0.196, 212, 194, 
4255, d5tryI_, 0.7919, 2.05, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4256, p5lzpK_, 0.7919, 2.05, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4257, d5trgI_, 0.7918, 2.04, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4258, p5lzpE_, 0.7918, 2.05, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4259, p5wviQA_, 0.7917, 2.18, 0.222, 205, 198, 
4260, d5trsI_, 0.7916, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4261, d5trgY_, 0.7916, 2.05, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4262, p5mpcL_, 0.7916, 2.00, 0.196, 212, 194, 
4263, p5lzpR_, 0.7915, 2.06, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4264, d3mi0E_, 0.7915, 2.04, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4265, d5thoW_, 0.7914, 2.05, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4266, d5thoI_, 0.7914, 2.05, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4267, p5lzpU_, 0.7914, 2.06, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4268, p5lzpT_, 0.7913, 2.06, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4269, d3mi0L_, 0.7913, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4270, p5ts0b_, 0.7912, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4271, d5trrY_, 0.7912, 2.05, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4272, p5mpbI_, 0.7912, 1.95, 0.192, 196, 193, 
4273, p5lzpO_, 0.7912, 2.06, 0.181, 223, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4274, p5lzpG_, 0.7912, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4275, p5ts0a_, 0.7911, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4276, d5trgK_, 0.7911, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4277, p5lzpN_, 0.7911, 2.05, 0.181, 221, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4278, d5trsY_, 0.7910, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4279, p6bgoZ_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4280, p6bgoY_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4281, p6bgoX_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4282, p6bgoW_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4283, p6bgoU_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4284, p6bgoT_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4285, p6bgoS_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4286, p6bgoR_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4287, p6bgoQ_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4288, p6bgoP_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4289, p6bgoc_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4290, p6bgob_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4291, p6bgoa_, 0.7909, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4292, p6bglZ_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4293, p6bglY_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4294, p6bglX_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4295, p6bglW_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4296, p6bglV_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4297, p6bglU_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4298, p6bglT_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4299, p6bglS_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4300, p6bglR_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4301, p6bglQ_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4302, p6bglP_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4303, p6bglb_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4304, p6bgla_, 0.7909, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4305, d5ts0H_, 0.7909, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4306, p5lzpP_, 0.7909, 2.07, 0.181, 221, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4307, p5lzpF_, 0.7909, 2.08, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4308, d3mi02_, 0.7909, 2.05, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4309, p6epf7_, 0.7908, 2.56, 0.039, 216, 203, GROUND STATE 26S PROTEASOME (GS1)
4310, p6bgoV_, 0.7908, 2.07, 0.181, 222, 193, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4311, p6bglc_, 0.7908, 2.07, 0.181, 222, 193, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4312, p5trya_, 0.7908, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4313, d5trrL_, 0.7908, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4314, p5lzpL_, 0.7908, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4315, p5lzpA_, 0.7908, 2.07, 0.181, 222, 193, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4316, d3mi0G_, 0.7908, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4317, p5trrb_, 0.7907, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4318, p5trra_, 0.7907, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4319, d3mi0H_, 0.7907, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4320, d5trrZ_, 0.7906, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4321, d5trgX_, 0.7906, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4322, d3mi0N_, 0.7906, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4323, p5tryb_, 0.7905, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4324, d5trrM_, 0.7905, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4325, d3mi0P_, 0.7905, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4326, p5wvkI_, 0.7904, 1.74, 0.194, 194, 191, 
4327, d5tryY_, 0.7904, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4328, d5trsL_, 0.7904, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4329, d5thoY_, 0.7904, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4330, p5mpbY_, 0.7904, 1.88, 0.229, 195, 192, 
4331, p5a0qY_, 0.7904, 1.52, 0.235, 189, 187, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4332, p5a0qK_, 0.7904, 1.52, 0.235, 189, 187, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4333, d3mi0J_, 0.7904, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4334, d3krdL_, 0.7904, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4335, d5ts0L_, 0.7903, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4336, d5trgW_, 0.7903, 2.05, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4337, d5trgV_, 0.7903, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4338, d5thoN_, 0.7903, 2.05, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4339, d3mi0X_, 0.7903, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4340, d3mi0T_, 0.7903, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4341, d5ts0Z_, 0.7902, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4342, d5tryL_, 0.7902, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4343, d5trgM_, 0.7902, 2.06, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4344, d3mi0C_, 0.7902, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4345, d3krdE_, 0.7902, 2.04, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4346, d3hfaR_, 0.7902, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4347, d5ts0N_, 0.7901, 2.04, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4348, p5trsa_, 0.7901, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4349, d5trgH_, 0.7901, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4350, d3mkaZ_, 0.7901, 2.22, 0.184, 245, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4351, d3mi0V1, 0.7901, 2.06, 0.181, 234, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4352, d3hfaZ_, 0.7901, 2.07, 0.181, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4353, d3hfaV_, 0.7901, 2.07, 0.181, 226, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4354, d3hfaL_, 0.7901, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4355, d5ts0M_, 0.7900, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4356, d5tryZ_, 0.7900, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4357, p5trsb_, 0.7900, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4358, d5thoL_, 0.7900, 2.06, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4359, d3mi0Z_, 0.7900, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4360, d3hfaP_, 0.7900, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4361, d3hfaN_, 0.7900, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4362, d5trgL_, 0.7899, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4363, p5thob_, 0.7899, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4364, p5t0hR_, 0.7899, 1.94, 0.202, 201, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4365, d3hfaX_, 0.7899, 2.07, 0.181, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4366, d3hfaT_, 0.7899, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4367, d3hfaC_, 0.7899, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4368, d3hfa2_, 0.7899, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4369, d5thoZ_, 0.7898, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4370, d3hfaJ_, 0.7898, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4371, d5ts0Y_, 0.7897, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4372, d5trsZ_, 0.7897, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4373, p5trga_, 0.7897, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4374, p5thoa_, 0.7897, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4375, p5mpcY_, 0.7897, 1.89, 0.229, 195, 192, 
4376, d3hfaH_, 0.7897, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4377, d3hfaG_, 0.7897, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4378, d3hfaE_, 0.7897, 2.07, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4379, d5trrN_, 0.7896, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4380, d5thoV_, 0.7896, 2.08, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4381, d5ts0V_, 0.7895, 2.09, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4382, d5tryM_, 0.7895, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4383, p5t0gQ_, 0.7895, 2.16, 0.230, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4384, d5trrV_, 0.7894, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4385, d5trrH_, 0.7894, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4386, d5trgN_, 0.7894, 2.07, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4387, d3krd2_, 0.7894, 2.06, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4388, d5trrJ_, 0.7893, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4389, d5trgJ_, 0.7893, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4390, p5trgb_, 0.7893, 2.08, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4391, d5thoM_, 0.7893, 2.08, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4392, p5fmgZ_, 0.7893, 1.53, 0.219, 189, 187, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4393, p5fmgL_, 0.7893, 1.53, 0.219, 189, 187, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4394, d3mi0R1, 0.7893, 2.07, 0.181, 234, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4395, d5tryN_, 0.7892, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4396, d5trsM_, 0.7892, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4397, d5trsH_, 0.7892, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4398, d5thoH_, 0.7892, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4399, d5trsN_, 0.7891, 2.06, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4400, d5trgZ_, 0.7891, 2.07, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4401, p5mpcZ_, 0.7891, 2.01, 0.196, 197, 194, 
4402, d5tryX_, 0.7890, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4403, d5trrX_, 0.7890, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4404, d3krdN_, 0.7889, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4405, d5tryH_, 0.7888, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4406, p5t0jN_, 0.7888, 1.79, 0.236, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4407, p5wviFA_, 0.7887, 1.96, 0.192, 196, 193, 
4408, d5trsJ_, 0.7887, 2.09, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4409, d3krdT_, 0.7887, 2.07, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4410, d3krdG_, 0.7887, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4411, d5ts0J_, 0.7886, 2.08, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4412, d5ts0X_, 0.7885, 2.10, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4413, d5trsX_, 0.7885, 2.10, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4414, d3krdX_, 0.7885, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4415, d3krdJ_, 0.7885, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4416, d3krdC_, 0.7885, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4417, d5trsV_, 0.7883, 2.10, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4418, d3krdV_, 0.7883, 2.08, 0.181, 229, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4419, d3krdH_, 0.7883, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4420, d5thoJ_, 0.7882, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4421, d3krdP_, 0.7882, 2.08, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4422, d5thoK_, 0.7881, 2.10, 0.181, 223, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4423, d3krdR_, 0.7881, 2.08, 0.181, 229, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4424, p5wvkL_, 0.7880, 2.06, 0.196, 197, 194, 
4425, d5thoX_, 0.7880, 2.10, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4426, d5tryJ_, 0.7879, 2.10, 0.181, 222, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4427, d3krdZ_, 0.7879, 2.09, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4428, d5tryV_, 0.7878, 2.11, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4429, d5trrK_, 0.7878, 2.11, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4430, d1q5qN_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4431, d1q5qM_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4432, d1q5qL_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4433, d1q5qK_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4434, d1q5qJ_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4435, d1q5qI_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4436, d1q5qH_, 0.7876, 2.00, 0.207, 224, 193, THE RHODOCOCCUS 20S PROTEASOME
4437, p5mpcK_, 0.7875, 1.85, 0.229, 195, 192, 
4438, d5ts0K_, 0.7873, 2.11, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4439, p5fmgV_, 0.7873, 1.72, 0.185, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4440, p5fmgH_, 0.7873, 1.72, 0.185, 191, 189, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4441, p5t0iO_, 0.7872, 1.85, 0.187, 193, 192, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4442, d5tryK_, 0.7870, 2.12, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4443, d5trsK_, 0.7869, 2.12, 0.181, 223, 193, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4444, d2fhhR_, 0.7867, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4445, d2fhhN_, 0.7867, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4446, d2fhhG_, 0.7867, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4447, d2fhhZ_, 0.7866, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4448, d2fhhX_, 0.7866, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4449, d2fhhT_, 0.7866, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4450, d2fhhJ_, 0.7866, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4451, d2fhhH_, 0.7866, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4452, d2fhhC_, 0.7865, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4453, p5t0iR_, 0.7864, 2.02, 0.207, 201, 193, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4454, d2fhhV_, 0.7864, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4455, d2fhhP_, 0.7864, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4456, d2fhhE_, 0.7864, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4457, d2fhhL_, 0.7863, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4458, d2fhh2_, 0.7862, 2.11, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4459, p5wviHA_, 0.7861, 1.98, 0.228, 198, 193, 
4460, p2fhgG_, 0.7847, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4461, p2fhgZ_, 0.7846, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4462, p2fhgN_, 0.7846, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4463, p2fhgJ_, 0.7846, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4464, p2fhg2_, 0.7846, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4465, p2fhgX_, 0.7845, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4466, p2fhgV_, 0.7845, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4467, p2fhgT_, 0.7845, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4468, p2fhgR_, 0.7845, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4469, p2fhgC_, 0.7845, 2.14, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4470, p2fhgP_, 0.7844, 2.14, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4471, p2fhgL_, 0.7844, 2.13, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4472, p2fhgH_, 0.7844, 2.14, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4473, p2fhgE_, 0.7843, 2.14, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4474, p5wviTA_, 0.7842, 2.01, 0.228, 198, 193, 
4475, p5wviC_, 0.7841, 1.90, 0.198, 194, 192, 
4476, p5t0hN_, 0.7839, 1.88, 0.236, 191, 191, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4477, d3mfeC_, 0.7834, 2.10, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4478, p5mpbL_, 0.7833, 2.11, 0.196, 200, 194, 
4479, d3mfeP_, 0.7830, 2.11, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4480, p5fmgN_, 0.7824, 1.60, 0.177, 187, 186, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4481, p5fmgb_, 0.7824, 1.60, 0.177, 187, 186, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4482, p5wviSA_, 0.7809, 2.11, 0.196, 212, 194, 
4483, d3mfeH_, 0.7809, 2.12, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4484, p6epd3_, 0.7792, 2.33, 0.051, 205, 198, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4485, p5wviIA_, 0.7792, 2.12, 0.196, 197, 194, 
4486, d3sdiT_, 0.7782, 2.93, 0.216, 242, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4487, d4nnwF_, 0.7781, 3.04, 0.215, 243, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4488, d4r17F_, 0.7780, 3.05, 0.215, 243, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4489, d4nnwT_, 0.7780, 3.04, 0.215, 243, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4490, d3dy3F_, 0.7780, 3.05, 0.215, 244, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4491, d4r17T_, 0.7779, 3.05, 0.215, 243, 200, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4492, p5t0jR_, 0.7778, 2.25, 0.201, 201, 194, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4493, p4y8gF_, 0.7778, 3.06, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4494, p4y84T_, 0.7778, 3.07, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4495, d4cr2G_, 0.7778, 2.99, 0.221, 245, 199, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4496, d3un8F_, 0.7778, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4497, d3sdkF_, 0.7778, 2.95, 0.211, 236, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4498, p4y8gT_, 0.7777, 3.06, 0.215, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4499, d3sdkT_, 0.7777, 2.92, 0.216, 236, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4500, p4zzgG_, 0.7776, 2.98, 0.211, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4501, p4x6zU_, 0.7776, 2.98, 0.216, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4502, d4intF_, 0.7776, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4503, d3un8T_, 0.7776, 3.06, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4504, d3d29T_, 0.7776, 3.04, 0.210, 244, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4505, d3d29F_, 0.7776, 3.04, 0.210, 244, 200, PROTEASOME INHIBITION BY FELLUTAMIDE B
4506, p4x6zG_, 0.7775, 3.00, 0.216, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4507, d4r02F_, 0.7775, 2.97, 0.221, 243, 199, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4508, d4inrF_, 0.7775, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4509, d4inuT_, 0.7774, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4510, d5l5dT_, 0.7772, 2.94, 0.216, 243, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4511, d5l5dF_, 0.7772, 2.94, 0.216, 243, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4512, d4j70F_, 0.7772, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4513, d4intT_, 0.7772, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4514, d4inrT_, 0.7772, 3.07, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4515, d3gpjT_, 0.7772, 3.05, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4516, p5mpag_, 0.7771, 2.87, 0.217, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4517, p5fmgW_, 0.7771, 1.60, 0.189, 186, 185, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4518, p5fmgI_, 0.7771, 1.60, 0.189, 186, 185, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4519, d3nzjT_, 0.7771, 3.07, 0.210, 244, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4520, d3nzjF_, 0.7771, 3.07, 0.210, 244, 200, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4521, d5l69F_, 0.7770, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4522, d4qluF_, 0.7770, 2.96, 0.221, 243, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4523, d3gpjF_, 0.7770, 3.05, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4524, d2zcyT_, 0.7770, 3.03, 0.220, 244, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4525, d2zcyF_, 0.7770, 3.03, 0.220, 244, 200, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4526, d5l69T_, 0.7769, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4527, d4r18T_, 0.7769, 2.83, 0.217, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4528, d4r18F_, 0.7769, 2.83, 0.217, 243, 198, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4529, d4no1T_, 0.7769, 3.06, 0.215, 243, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4530, d4no1F_, 0.7769, 3.06, 0.215, 243, 200, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4531, d4jsqT_, 0.7769, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4532, d4jsqF_, 0.7769, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4533, d3mg8T_, 0.7769, 2.81, 0.217, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4534, p4y8hF_, 0.7768, 3.05, 0.220, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4535, d4qluT_, 0.7768, 2.96, 0.221, 243, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4536, d3oevF_, 0.7768, 2.96, 0.211, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4537, d3gpwF_, 0.7768, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4538, d5laiF_, 0.7767, 2.82, 0.217, 243, 198, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4539, p4y8hT_, 0.7767, 3.05, 0.220, 243, 200, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4540, d4j70T_, 0.7767, 3.08, 0.210, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4541, d3oevT_, 0.7767, 2.82, 0.217, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4542, d3mfeG_, 0.7767, 2.22, 0.181, 222, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4543, d3hyeF_, 0.7767, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4544, d3gpwT_, 0.7767, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4545, d5laiT_, 0.7766, 2.82, 0.217, 243, 198, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4546, d4q1sF_, 0.7766, 3.00, 0.211, 244, 199, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4547, d3hyeT_, 0.7766, 3.06, 0.210, 244, 200, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4548, d1jd21_, 0.7766, 2.98, 0.211, 244, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4549, d1g65T_, 0.7766, 3.04, 0.215, 244, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4550, d1g65F_, 0.7766, 3.04, 0.215, 244, 200, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4551, d5m2bT_, 0.7765, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4552, d5m2bF_, 0.7765, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4553, d4qlvT_, 0.7765, 2.98, 0.216, 243, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4554, d4qlvF_, 0.7765, 2.98, 0.216, 243, 199, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4555, d5l63T_, 0.7764, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4556, d5l63F_, 0.7764, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4557, d5l5sT_, 0.7764, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4558, d5l5sF_, 0.7764, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
4559, d5l5jF_, 0.7764, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4560, d5bouT_, 0.7764, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4561, d5bouF_, 0.7764, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
4562, p4zzgU_, 0.7764, 2.74, 0.213, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4563, d4qz7F_, 0.7764, 2.83, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4564, d4qltF_, 0.7764, 2.81, 0.222, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4565, d3sdiF_, 0.7764, 2.77, 0.213, 242, 197, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4566, d3oeuT_, 0.7764, 2.82, 0.217, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4567, d3mg6F_, 0.7764, 2.96, 0.211, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4568, d3dy3T_, 0.7764, 2.81, 0.217, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4569, d3bdmT_, 0.7764, 2.82, 0.212, 244, 198, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4570, d5l68T_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4571, d5l68F_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4572, d5l64F_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4573, d5l61T_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4574, d5l61F_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4575, d5l60T_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4576, d5l60F_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4577, d5l5yT_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4578, d5l5yF_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4579, d5l5wF_, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4580, d5l5jT_, 0.7763, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4581, d5l5iT_, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4582, d5l5iF_, 0.7763, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
4583, p4y8tF_, 0.7763, 2.80, 0.222, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4584, d4qz7T_, 0.7763, 2.83, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4585, d4qltT_, 0.7763, 2.81, 0.222, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4586, d3oeuF_, 0.7763, 2.97, 0.216, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
4587, d3mg7T_, 0.7763, 2.82, 0.217, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4588, d3bdmF_, 0.7763, 2.82, 0.212, 244, 198, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4589, d5l65F_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4590, d5l64T_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4591, d5l62T_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4592, d5l62F_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4593, d5l5zT_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4594, d5l5zF_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4595, d5l5wT_, 0.7762, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4596, d5l5tT_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4597, d5l5tF_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4598, d5l5hF_, 0.7762, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4599, p4y8tT_, 0.7762, 2.80, 0.222, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4600, p4y6vT_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4601, p4y6vF_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
4602, d4rurT_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4603, d4rurF_, 0.7762, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
4604, d3mg8F_, 0.7762, 2.96, 0.216, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4605, d3mg6T_, 0.7762, 2.82, 0.217, 237, 198, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4606, d3mfeV_, 0.7762, 2.19, 0.181, 224, 193, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4607, p5t0jQ_, 0.7761, 2.23, 0.230, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4608, d5l6cT_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4609, d5l6cF_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4610, d5l6aF_, 0.7761, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4611, d5l65T_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4612, d5l5rT_, 0.7761, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4613, d5l5rF_, 0.7761, 2.81, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4614, d5l5qF_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4615, d5l5pT_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4616, d5l5pF_, 0.7761, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4617, d5l5hT_, 0.7761, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4618, d5l54F_, 0.7761, 2.82, 0.222, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4619, d5cz6F_, 0.7761, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4620, p4y84F_, 0.7761, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4621, d4r02T_, 0.7761, 2.99, 0.221, 243, 199, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4622, d4qz1T_, 0.7761, 2.85, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4623, d4qz1F_, 0.7761, 2.85, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4624, d4qlsT_, 0.7761, 2.81, 0.222, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4625, d4qlsF_, 0.7761, 2.81, 0.222, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4626, d3nzxT_, 0.7761, 3.07, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4627, d3nzxF_, 0.7761, 3.07, 0.210, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4628, d3mg7F_, 0.7761, 2.96, 0.216, 237, 199, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4629, d3dy4T_, 0.7761, 2.81, 0.217, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4630, d3dy4F_, 0.7761, 2.81, 0.217, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4631, p5mp9g_, 0.7760, 2.73, 0.213, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4632, d5l6aT_, 0.7760, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4633, d5l66T_, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4634, d5l66F_, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4635, d5l5qT_, 0.7760, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
4636, d5l54T_, 0.7760, 2.82, 0.222, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4637, d5cz6T_, 0.7760, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
4638, p4y8oT_, 0.7760, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4639, p4y8oF_, 0.7760, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4640, d4qvyT_, 0.7760, 2.83, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4641, d4qvyF_, 0.7760, 2.83, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
4642, d4qlqT_, 0.7760, 2.82, 0.217, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4643, d4qlqF_, 0.7760, 2.82, 0.217, 243, 198, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4644, p4gk7T_, 0.7760, 3.05, 0.215, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4645, p4gk7F_, 0.7760, 3.05, 0.215, 244, 200, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4646, d5l5vT_, 0.7759, 2.84, 0.217, 243, 198,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4647, d5l5vF_, 0.7759, 2.84, 0.217, 243, 198,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4648, d5l5oT_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4649, d5l5oF_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4650, d5l5aT_, 0.7759, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4651, d5l5aF_, 0.7759, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
4652, p4ya9F_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4653, p4ya5T_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4654, p4ya5F_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
4655, p4y8sT_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4656, p4y8sF_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4657, p4y8nT_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4658, p4y8nF_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
4659, p4y81T_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4660, p4y81F_, 0.7759, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4661, p4y75T_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4662, p4y75F_, 0.7759, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4663, d4qvmT_, 0.7759, 2.84, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4664, d4qvmF_, 0.7759, 2.84, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
4665, d4no6T_, 0.7759, 2.99, 0.221, 243, 199, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4666, d4no6F_, 0.7759, 2.99, 0.221, 243, 199, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4667, d4inuF_, 0.7759, 2.84, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4668, d3mg4F_, 0.7759, 2.76, 0.213, 244, 197, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4669, d1jd2F_, 0.7759, 2.98, 0.211, 244, 199, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4670, d5l67F_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4671, d5l5xT_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4672, d5l5xF_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4673, d5l5uT_, 0.7758, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4674, d5l5uF_, 0.7758, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4675, d5l5eT_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4676, d5l5eF_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
4677, d5dkiT_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4678, d5dkiF_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
4679, p5cghT_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4680, p5cghF_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4681, p4ya9T_, 0.7758, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4682, p4y69T_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4683, p4y69F_, 0.7758, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
4684, d4hnpF_, 0.7758, 2.88, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4685, d3okjF_, 0.7758, 3.06, 0.215, 244, 200, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4686, d5l6bT_, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4687, d5l6bF_, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4688, d5l67T_, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
4689, d5l5fT_, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4690, d5l5fF_, 0.7757, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
4691, p5fghT_, 0.7757, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4692, p5fghF_, 0.7757, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
4693, d5fggT_, 0.7757, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4694, d5bxlT_, 0.7757, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4695, d5bxlF_, 0.7757, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4696, p4y74F_, 0.7757, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4697, p4v7oOA_, 0.7757, 2.74, 0.218, 244, 197, 
4698, p4v7oCB_, 0.7757, 2.74, 0.218, 244, 197, 
4699, d4qz4F_, 0.7757, 2.83, 0.217, 243, 198, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4700, d4qw4T_, 0.7757, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4701, d4qw4F_, 0.7757, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH CARFILZOMIB
4702, d4qw3T_, 0.7757, 2.85, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4703, d4qw3F_, 0.7757, 2.86, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4704, d4qvlT_, 0.7757, 2.82, 0.217, 243, 198, YCP IN COMPLEX WITH BORTEZOMIB
4705, d4qvlF_, 0.7757, 2.82, 0.217, 243, 198, YCP IN COMPLEX WITH BORTEZOMIB
4706, d4qv6T_, 0.7757, 2.81, 0.217, 243, 198, YCP BETA5-A49V MUTANT
4707, d4qv6F_, 0.7757, 2.81, 0.217, 243, 198, YCP BETA5-A49V MUTANT
4708, d4quxT_, 0.7757, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT
4709, d4quxF_, 0.7757, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT
4710, d3mg0F_, 0.7757, 2.83, 0.212, 244, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4711, d1vsyU_, 0.7757, 2.74, 0.218, 244, 197,  
4712, d1vsyG_, 0.7757, 2.74, 0.218, 244, 197,  
4713, p5nifU_, 0.7756, 2.75, 0.213, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4714, p5nifG_, 0.7756, 2.75, 0.213, 244, 197, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4715, d5bxnT_, 0.7756, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4716, d5bxnF_, 0.7756, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4717, p4ya2T_, 0.7756, 2.74, 0.218, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4718, p4ya2F_, 0.7756, 2.74, 0.218, 243, 197, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4719, d4y9yF_, 0.7756, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4720, p4y8iT_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4721, p4y8iF_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
4722, p4y74T_, 0.7756, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4723, p4y6zT_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4724, p4y6zF_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4725, p4y6aT_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4726, p4y6aF_, 0.7756, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
4727, p4v7oU_, 0.7756, 2.74, 0.213, 244, 197, 
4728, d4qz4T_, 0.7756, 2.83, 0.217, 243, 198, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4729, d4qvwT_, 0.7756, 2.83, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4730, d4qvwF_, 0.7756, 2.83, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
4731, d3l5qX_, 0.7756, 2.74, 0.213, 244, 197,  
4732, d5cz4T_, 0.7755, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4733, d5cz4F_, 0.7755, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
4734, d4ya4T_, 0.7755, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4735, p4ya0T_, 0.7755, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4736, p4ya0F_, 0.7755, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4737, d4y9yT_, 0.7755, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT
4738, p4y8kT_, 0.7755, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4739, p4y8kF_, 0.7755, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4740, p4y77T_, 0.7755, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4741, p4y77F_, 0.7755, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4742, d4qwxF_, 0.7755, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4743, d4qwfF_, 0.7755, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4744, d4qvqT_, 0.7755, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4745, d4qvqF_, 0.7755, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
4746, d4qvnT_, 0.7755, 2.83, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4747, d4qvnF_, 0.7755, 2.83, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4748, d5lttT_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4749, d5lttF_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
4750, d5l5bT_, 0.7754, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4751, d5l5bF_, 0.7754, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4752, d5dkjT_, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4753, d5dkjF_, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
4754, d5cz7T_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4755, d5cz7F_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4756, d4ya4F_, 0.7754, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4757, p4y8pT_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4758, p4y8pF_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4759, d4y8mT_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4760, d4y8mF_, 0.7754, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
4761, p4y7xT_, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4762, p4y7xF_, 0.7754, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4763, d4qwxT_, 0.7754, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4764, d4qwkF_, 0.7754, 2.86, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4765, d4qwfT_, 0.7754, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4766, d4qw0T_, 0.7754, 2.85, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4767, d4qw0F_, 0.7754, 2.85, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
4768, d4no9T_, 0.7754, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4769, d4no9F_, 0.7754, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4770, d4g4sG_, 0.7754, 2.59, 0.224, 246, 196, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4771, d3wxrG1, 0.7754, 2.84, 0.212, 236, 198, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4772, d3shjT_, 0.7754, 3.08, 0.210, 244, 200, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4773, d3shjF_, 0.7754, 3.08, 0.210, 244, 200, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4774, d1rypU_, 0.7754, 2.79, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4775, d5fgdT_, 0.7753, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4776, d5fgdF_, 0.7753, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4777, d5fg9T_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4778, d5fg9F_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
4779, d5d0xF_, 0.7753, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4780, d5d0vT_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4781, d5d0vF_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4782, d5ahjT_, 0.7753, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4783, d5ahjF_, 0.7753, 2.94, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4784, p4ya7F_, 0.7753, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4785, p4ya3T_, 0.7753, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4786, p4ya3F_, 0.7753, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4787, p4y9zT_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4788, p4y9zF_, 0.7753, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4789, d4qwuT_, 0.7753, 2.83, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4790, d4qwuF_, 0.7753, 2.83, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
4791, d4qwkT_, 0.7753, 2.86, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4792, d4ltcT_, 0.7753, 3.02, 0.211, 244, 199, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4793, p6gopT_, 0.7752, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4794, p6gopF_, 0.7752, 2.82, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4795, d5fggF_, 0.7752, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4796, d5fgeT_, 0.7752, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4797, d5fgeF_, 0.7752, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4798, d5d0xT_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
4799, d5cz9T_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4800, d5cz9F_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
4801, p4ya7T_, 0.7752, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4802, p4y8uT_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4803, p4y8uF_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
4804, p4y82T_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4805, p4y82F_, 0.7752, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4806, p4v7oG_, 0.7752, 2.72, 0.218, 244, 197, 
4807, d4qw6T_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4808, d4qw6F_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4809, d4qw1T_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4810, d4qw1F_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4811, d4qv1F_, 0.7752, 2.83, 0.217, 243, 198, YCP BETA5-M45A MUTANT
4812, d4qv0T_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4813, d4qv0F_, 0.7752, 2.84, 0.217, 243, 198, YCP BETA5-A49T-A50V-DOUBLE MUTANT
4814, p4qbyT_, 0.7752, 2.88, 0.217, 243, 198, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4815, p4qbyF_, 0.7752, 2.88, 0.217, 243, 198, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4816, d3nzwF_, 0.7752, 2.83, 0.212, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4817, d3l5qL_, 0.7752, 2.72, 0.218, 244, 197,  
4818, d2f16T_, 0.7752, 3.07, 0.215, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4819, d2f16F_, 0.7752, 3.07, 0.215, 244, 200, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4820, d5fgaF_, 0.7751, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4821, d5d0wF_, 0.7751, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4822, d5d0tT_, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4823, d5d0tF_, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
4824, d5czaT_, 0.7751, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4825, d5czaF_, 0.7751, 2.83, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT
4826, d4ya1T_, 0.7751, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4827, d4ya1F_, 0.7751, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-H116N MUTANT
4828, p4y70F_, 0.7751, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4829, d4qzzF_, 0.7751, 2.84, 0.217, 243, 198, YCP IN COMPLEX WITH OMURALIDE
4830, d4qw7T_, 0.7751, 2.85, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4831, d4qw7F_, 0.7751, 2.85, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
4832, d4qv1T_, 0.7751, 2.83, 0.217, 243, 198, YCP BETA5-M45A MUTANT
4833, d4quyT_, 0.7751, 2.83, 0.217, 243, 198, YCP BETA5-A49S-MUTANT
4834, d4quyF_, 0.7751, 2.83, 0.217, 243, 198, YCP BETA5-A49S-MUTANT
4835, p5t0hQ_, 0.7750, 2.35, 0.230, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4836, d5l55T_, 0.7750, 2.95, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4837, d5l55F_, 0.7750, 2.95, 0.221, 243, 199, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4838, d5fgiT_, 0.7750, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4839, d5fgiF_, 0.7750, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4840, d5fgaT_, 0.7750, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
4841, p5cggT_, 0.7750, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4842, p5cggF_, 0.7750, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
4843, p4y80T_, 0.7750, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4844, p4y80F_, 0.7750, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
4845, p4y7wF_, 0.7750, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4846, p4y70T_, 0.7750, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
4847, d4qz5T_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4848, d4qz5F_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
4849, d4qz2F_, 0.7750, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4850, d4qz0T_, 0.7750, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4851, d4qz0F_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4852, d4qwiF_, 0.7750, 2.86, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4853, d4qvpT_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4854, d4qvpF_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
4855, d4qv8F_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-C52F MUTANT
4856, d4qv5T_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45I MUTANT
4857, d4qv5F_, 0.7750, 2.83, 0.217, 243, 198, YCP BETA5-M45I MUTANT
4858, d4qv4T_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT
4859, d4qv4F_, 0.7750, 2.84, 0.217, 243, 198, YCP BETA5-M45T MUTANT
4860, d4q1sT_, 0.7750, 2.80, 0.217, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4861, d3mg4T_, 0.7750, 2.87, 0.212, 244, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4862, d1g0uF_, 0.7750, 2.83, 0.212, 242, 198, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4863, d5jhsT_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4864, d5jhsF_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
4865, d5jhrT_, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4866, d5jhrF_, 0.7749, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
4867, p4y8lT_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4868, p4y8lF_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
4869, p4y8jT_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4870, p4y8jF_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
4871, p4y7wT_, 0.7749, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
4872, d4qz2T_, 0.7749, 2.85, 0.217, 243, 198, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4873, d4qwiT_, 0.7749, 2.86, 0.217, 243, 198, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
4874, d4qw5T_, 0.7749, 2.85, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4875, d4qw5F_, 0.7749, 2.85, 0.217, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4876, d4qv8T_, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-C52F MUTANT
4877, d4qv7T_, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT
4878, d4qv7F_, 0.7749, 2.84, 0.217, 243, 198, YCP BETA5-A50V MUTANT
4879, d4hrdF_, 0.7749, 2.79, 0.213, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4880, d4hnpT_, 0.7749, 2.87, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4881, d3nzwT_, 0.7749, 2.81, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4882, d3mg0T_, 0.7749, 2.83, 0.212, 244, 198, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4883, d3gptT_, 0.7749, 2.83, 0.212, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4884, d3gptF_, 0.7749, 2.83, 0.212, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4885, d1rypG_, 0.7749, 2.80, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4886, d5fgfT_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4887, d5fgfF_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4888, d5fg7T_, 0.7748, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4889, d5fg7F_, 0.7748, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA2-T1A MUTANT
4890, p4y8qT_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4891, p4y8qF_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4892, p4y78T_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4893, p4y78F_, 0.7748, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4894, d4qzwT_, 0.7748, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4895, d4qzwF_, 0.7748, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4896, d4fzgT_, 0.7748, 2.85, 0.212, 244, 198, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4897, d4fzgF_, 0.7748, 2.85, 0.212, 244, 198, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4898, d5lajT_, 0.7747, 2.75, 0.223, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4899, d5lajF_, 0.7747, 2.75, 0.223, 243, 197, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4900, d5d0wT_, 0.7747, 2.81, 0.222, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4901, d4z1lF_, 0.7747, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4902, d4y8rT_, 0.7747, 2.81, 0.222, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4903, d4y8rF_, 0.7747, 2.81, 0.222, 243, 198, YEAST 20S PROTEASOME BETA2-H116D MUTANT
4904, d4qwlF_, 0.7747, 2.85, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4905, d4qvvT_, 0.7747, 2.86, 0.217, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4906, d4qvvF_, 0.7747, 2.86, 0.217, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
4907, d4nnnT_, 0.7747, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH MG132
4908, d4nnnF_, 0.7747, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH MG132
4909, d2fnyT_, 0.7747, 2.84, 0.212, 244, 198,  
4910, d5d0zF_, 0.7746, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4911, d5d0sF_, 0.7746, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4912, p5cgiT_, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4913, p5cgiF_, 0.7746, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4914, d5cgfT_, 0.7746, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4915, d5cgfF_, 0.7746, 2.84, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-G48C MUTANT
4916, d4z1lT_, 0.7746, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
4917, d4r00T_, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4918, d4r00F_, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
4919, d4qzzT_, 0.7746, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH OMURALIDE
4920, d4qz6T_, 0.7746, 2.83, 0.222, 243, 198, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4921, d4qz6F_, 0.7746, 2.83, 0.222, 243, 198, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4922, d4qz3T_, 0.7746, 2.83, 0.222, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4923, d4qz3F_, 0.7746, 2.83, 0.222, 243, 198, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4924, d4qwlT_, 0.7746, 2.85, 0.217, 243, 198, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4925, d4qwgT_, 0.7746, 2.79, 0.218, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4926, d4qwgF_, 0.7746, 2.79, 0.218, 243, 197, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4927, d4no8T_, 0.7746, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4928, d4no8F_, 0.7746, 2.82, 0.222, 243, 198, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4929, d4eu2G_, 0.7746, 2.77, 0.218, 244, 197, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4930, p5mpaG_, 0.7745, 2.87, 0.212, 243, 198, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4931, d5d0zT_, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4932, d5d0sT_, 0.7745, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
4933, d5cz5T_, 0.7745, 2.87, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4934, d5cz5F_, 0.7745, 2.87, 0.217, 243, 198, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4935, p4y7yT_, 0.7745, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4936, p4y7yF_, 0.7745, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
4937, d4qwjF_, 0.7745, 2.87, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4938, d4jsuT_, 0.7745, 2.84, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4939, d4jsuF_, 0.7745, 2.84, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4940, d4hrcT_, 0.7745, 2.86, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4941, d2fnyF_, 0.7745, 2.82, 0.217, 244, 198,  
4942, d2fakT_, 0.7745, 2.84, 0.217, 244, 198, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4943, d2fakF_, 0.7745, 2.84, 0.217, 244, 198, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4944, d1g0uT_, 0.7745, 2.84, 0.212, 242, 198, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4945, p5mpcG_, 0.7744, 2.89, 0.217, 243, 198, 
4946, d5l52F_, 0.7744, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4947, d5fhsT_, 0.7744, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4948, d5fhsF_, 0.7744, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
4949, d4qxjT_, 0.7744, 2.85, 0.222, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4950, d4qxjF_, 0.7744, 2.85, 0.222, 243, 198, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4951, d4qwjT_, 0.7744, 2.88, 0.217, 243, 198, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
4952, d4lqiF_, 0.7744, 2.82, 0.217, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4953, d3okjT_, 0.7744, 2.84, 0.212, 244, 198, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4954, d3e47T_, 0.7744, 2.83, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4955, d3e47F_, 0.7744, 2.83, 0.217, 244, 198, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4956, d5l52T_, 0.7743, 2.85, 0.217, 243, 198, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4957, d4ltcF_, 0.7743, 2.78, 0.213, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4958, d4lqiT_, 0.7743, 2.82, 0.217, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4959, d4jt0T_, 0.7743, 2.85, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4960, d4jt0F_, 0.7743, 2.85, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4961, p3un4T_, 0.7743, 2.85, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4962, p3un4F_, 0.7743, 2.85, 0.212, 244, 198, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4963, d3tddF_, 0.7743, 2.84, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4964, d4qv3T_, 0.7742, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT
4965, d4qv3F_, 0.7742, 2.85, 0.217, 243, 198, YCP BETA5-M45V MUTANT
4966, p4cr44_, 0.7742, 2.20, 0.223, 198, 193, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4967, d3tddT_, 0.7742, 2.84, 0.212, 244, 198, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4968, d3mfeJ_, 0.7742, 2.20, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4969, d5cz8T_, 0.7741, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4970, d5cz8F_, 0.7741, 2.86, 0.217, 243, 198, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
4971, d4qzxT_, 0.7741, 2.87, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4972, d4qzxF_, 0.7741, 2.87, 0.217, 243, 198, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4973, d3wxrU1, 0.7741, 2.95, 0.211, 236, 199, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4974, p5mp9G_, 0.7740, 2.74, 0.218, 243, 197, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4975, d4fzcF_, 0.7740, 2.86, 0.212, 244, 198, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4976, d3mfeX_, 0.7740, 2.21, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4977, d4qv9T_, 0.7739, 2.81, 0.222, 243, 198, YCP BETA5-C63F MUTANT
4978, d4qv9F_, 0.7739, 2.81, 0.222, 243, 198, YCP BETA5-C63F MUTANT
4979, d4hrcF_, 0.7739, 2.80, 0.213, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4980, d4fzcT_, 0.7739, 2.86, 0.212, 244, 198, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4981, d3mfeT_, 0.7739, 2.21, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4982, d4qwsT_, 0.7738, 2.80, 0.218, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4983, d4qwsF_, 0.7738, 2.80, 0.218, 243, 197, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4984, d4qwrT_, 0.7738, 2.79, 0.218, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4985, d4qwrF_, 0.7738, 2.79, 0.218, 243, 197, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4986, d2gplT_, 0.7738, 2.83, 0.217, 244, 198, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4987, d2gplF_, 0.7738, 2.83, 0.217, 244, 198, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4988, d4hrdT_, 0.7736, 2.78, 0.213, 244, 197, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4989, d3mfeL_, 0.7733, 2.23, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4990, d4eu2U_, 0.7731, 3.03, 0.211, 244, 199, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4991, d3mfe2_, 0.7731, 2.23, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4992, p4cr45_, 0.7730, 2.21, 0.191, 212, 194, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4993, d3mfeN_, 0.7730, 2.22, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4994, d3mfeR_, 0.7727, 2.22, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4995, d1z7qU1, 0.7726, 3.18, 0.215, 243, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4996, d1z7qG1, 0.7726, 3.18, 0.215, 243, 200, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4997, d3mfeE_, 0.7723, 2.23, 0.182, 221, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4998, p5t0iQ_, 0.7721, 2.32, 0.204, 199, 196, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4999, p5wvkBA_, 0.7717, 2.85, 0.218, 244, 197, 
5000, p5mpbU_, 0.7717, 2.97, 0.217, 243, 198, 
